CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: zoledronic acid
Accession: CHEBI:46557
browse the term
Definition: An imidazole compound having a 2,2-bis(phosphono)-2-hydroxyethane-1-yl substituent at the 1-position.
Synonyms: exact_synonym: [1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid)
related_synonym: (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid; (1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid; Formula=C5H10N2O7P2; InChI=1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14); InChIKey=XRASPMIURGNCCH-UHFFFAOYSA-N; Reclast; SMILES=OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O; ZOL
xref: Beilstein:9205049; CAS:118072-93-8; Chemspider:61986; DrugBank:DB00399; Drug_Central:2868; Gmelin:2609374; KEGG:D08689
xref_mesh: MESH:C088658
xref: PDBeChem:ZOL; PMCID:PMC8090009; PMID:12183663; PMID:15161327; PMID:15324309; PMID:16414486; PMID:17691952; PMID:18982915; PMID:19751105; PMID:33908127; PMID:33984339; PMID:34081204; PMID:34157824; PMID:34324430; PMID:34341833; PMID:34393156; PMID:34413050; PMID:34435997; PMID:34447747; PMID:34475752; PMID:34560734; PMID:34585443; Patent:US4939130; Wikipedia:Zoledronic_Acid
G
2310009B15Rik
RIKEN cDNA 2310009B15 gene
decreases expression
ISO
zoledronic acid results in decreased expression of C1ORF53 mRNA
CTD
PMID:24714768
NCBI chr 1:138,779,717...138,784,592
Ensembl chr 1:138,779,721...138,784,590
G
2310057J18Rik
RIKEN cDNA 2310057J18 gene
increases expression
ISO
zoledronic acid results in increased expression of C6ORF58 mRNA
CTD
PMID:24714768
NCBI chr10:28,848,284...28,862,302
Ensembl chr10:28,848,284...28,862,299
G
5031439G07Rik
RIKEN cDNA 5031439G07 gene
decreases expression
ISO
zoledronic acid results in decreased expression of KIAA0930 mRNA
CTD
PMID:24714768
NCBI chr15:84,828,137...84,872,503
Ensembl chr15:84,828,137...84,872,752
G
A4galt
alpha 1,4-galactosyltransferase
increases expression
ISO
zoledronic acid results in increased expression of A4GALT mRNA
CTD
PMID:24714768
NCBI chr15:83,110,923...83,135,930
Ensembl chr15:83,110,923...83,135,975
G
AA467197
expressed sequence AA467197
increases expression
ISO
zoledronic acid results in increased expression of C15ORF48 mRNA
CTD
PMID:24714768
NCBI chr 2:122,479,807...122,482,996
Ensembl chr 2:122,478,906...122,483,111
G
Aadat
aminoadipate aminotransferase
decreases expression
ISO
zoledronic acid results in decreased expression of AADAT mRNA
CTD
PMID:24714768
NCBI chr 8:60,958,877...60,998,711
Ensembl chr 8:60,958,966...60,998,711
G
Aars1
alanyl-tRNA synthetase 1
decreases expression
ISO
Zoledronic Acid results in decreased expression of AARS1 mRNA
CTD
PMID:25596134
NCBI chr 8:111,759,781...111,784,237
Ensembl chr 8:111,759,776...111,784,296
G
Abca12
ATP-binding cassette, sub-family A member 12
increases expression
ISO
zoledronic acid results in increased expression of ABCA12 mRNA
CTD
PMID:24714768
NCBI chr 1:71,282,249...71,454,069
Ensembl chr 1:71,281,435...71,454,069
G
Abca4
ATP-binding cassette, sub-family A member 4
increases expression
ISO
zoledronic acid results in increased expression of ABCA4 mRNA
CTD
PMID:20977926 PMID:24714768
NCBI chr 3:121,837,547...121,973,719
Ensembl chr 3:121,838,092...121,973,772
G
Abcb6
ATP-binding cassette, sub-family B member 6
decreases expression
ISO
zoledronic acid results in decreased expression of ABCB6 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 1:75,148,284...75,157,066
Ensembl chr 1:75,148,361...75,157,036
G
Abcc5
ATP-binding cassette, sub-family C member 5
decreases expression
ISO
zoledronic acid results in decreased expression of ABCC5 mRNA
CTD
PMID:24714768
NCBI chr16:20,150,053...20,245,178
Ensembl chr16:20,150,053...20,245,144
G
Abcg2
ATP binding cassette subfamily G member 2 (Junior blood group)
increases expression
ISO
zoledronic acid results in increased expression of ABCG2 mRNA
CTD
PMID:18225567
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
G
Abhd17c
abhydrolase domain containing 17C
decreases expression
ISO
zoledronic acid results in decreased expression of ABHD17C mRNA
CTD
PMID:24714768
NCBI chr 7:83,758,564...83,801,101
Ensembl chr 7:83,758,564...83,801,101
G
Abi3bp
ABI family member 3 binding protein
decreases expression
ISO
zoledronic acid results in decreased expression of ABI3BP mRNA
CTD
PMID:24714768
NCBI chr16:56,298,179...56,510,498
Ensembl chr16:56,298,241...56,510,498
G
Abtb3
ankyrin repeat and BTB domain containing 3
decreases expression
ISO
Zoledronic Acid results in decreased expression of ABTB3 mRNA
CTD
PMID:24714768
NCBI chr10:85,220,835...85,496,156
Ensembl chr10:85,222,678...85,496,156
G
Acaa1b
acetyl-Coenzyme A acyltransferase 1B
decreases expression
EXP
zoledronic acid results in decreased expression of ACAA1 mRNA
CTD
PMID:28871336
NCBI chr 9:118,977,111...118,986,149
Ensembl chr 9:118,977,091...118,986,161
G
Acadl
acyl-Coenzyme A dehydrogenase, long-chain
decreases expression
EXP
zoledronic acid results in decreased expression of ACADL mRNA
CTD
PMID:28871336
NCBI chr 1:66,869,998...66,902,468
Ensembl chr 1:66,869,998...66,902,436
G
Acadm
acyl-Coenzyme A dehydrogenase, medium chain
decreases expression
EXP
zoledronic acid results in decreased expression of ACADM mRNA
CTD
PMID:28871336
NCBI chr 3:153,627,990...153,650,280
Ensembl chr 3:153,627,994...153,650,269
G
Acat2
acetyl-Coenzyme A acetyltransferase 2
increases expression
ISO
zoledronic acid results in increased expression of ACAT2 mRNA
CTD
PMID:24714768
NCBI chr17:13,161,929...13,179,612
Ensembl chr17:13,161,777...13,179,634
G
Acbd4
acyl-Coenzyme A binding domain containing 4
decreases expression
ISO
zoledronic acid results in decreased expression of ACBD4 mRNA
CTD
PMID:20977926
NCBI chr11:102,992,524...103,003,026
Ensembl chr11:102,992,508...103,005,229
G
Acmsd
amino carboxymuconate semialdehyde decarboxylase
decreases expression
ISO
zoledronic acid results in decreased expression of ACMSD mRNA
CTD
PMID:24714768
NCBI chr 1:127,657,149...127,695,723
Ensembl chr 1:127,657,150...127,695,715
G
Acox1
acyl-Coenzyme A oxidase 1, palmitoyl
multiple interactions decreases expression
EXP ISO
Fenofibrate inhibits the reaction [zoledronic acid results in decreased expression of ACOX1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of ACOX1 mRNA] zoledronic acid results in decreased expression of ACOX1 mRNA; zoledronic acid results in decreased expression of ACOX1 protein
CTD
PMID:28871336
NCBI chr11:116,062,714...116,089,605
Ensembl chr11:116,062,714...116,089,871
G
Acox2
acyl-Coenzyme A oxidase 2, branched chain
decreases expression multiple interactions
EXP
zoledronic acid results in decreased expression of ACOX2 mRNA Fenofibrate inhibits the reaction [zoledronic acid results in decreased expression of ACOX2 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of ACOX2 mRNA]
CTD
PMID:28871336
NCBI chr14:14,210,406...14,244,262
Ensembl chr14:14,210,420...14,244,262
G
Acp3
acid phosphatase 3
decreases expression
ISO
Zoledronic Acid results in decreased expression of ACP3 mRNA
CTD
PMID:24714768
NCBI chr 9:104,165,439...104,214,921
Ensembl chr 9:104,165,450...104,214,947
G
Acsl1
acyl-CoA synthetase long-chain family member 1
decreases expression
ISO
zoledronic acid results in decreased expression of ACSL1 mRNA; zoledronic acid results in decreased expression of ACSL1 protein
CTD
PMID:25596134 PMID:28871336
NCBI chr 8:46,924,214...46,989,088
Ensembl chr 8:46,924,074...46,989,088
G
Acsl3
acyl-CoA synthetase long-chain family member 3
decreases expression
ISO
zoledronic acid results in decreased expression of ACSL3 protein
CTD
PMID:28871336
NCBI chr 1:78,635,600...78,685,462
Ensembl chr 1:78,635,542...78,685,460
G
Acsl5
acyl-CoA synthetase long-chain family member 5
increases expression
ISO
zoledronic acid results in increased expression of ACSL5 mRNA
CTD
PMID:24714768
NCBI chr19:55,240,298...55,285,060
Ensembl chr19:55,240,370...55,286,152
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
decreases expression
ISO
zoledronic acid results in decreased expression of ACSM3 mRNA
CTD
PMID:24714768
NCBI chr 7:119,360,106...119,384,119
Ensembl chr 7:119,360,146...119,386,736
G
Acss2
acyl-CoA synthetase short-chain family member 2
increases expression
ISO
zoledronic acid results in increased expression of ACSS2 mRNA
CTD
PMID:24714768
NCBI chr 2:155,359,963...155,404,663
Ensembl chr 2:155,359,868...155,427,644
G
Acta2
actin alpha 2, smooth muscle, aorta
multiple interactions increases expression
EXP ISO
Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of ACTA2 protein]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of ACTA2 protein] 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [zoledronic acid results in increased expression of ACTA2 protein]
CTD
PMID:28871336
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
G
Actbl2
actin, beta-like 2
increases expression
ISO
zoledronic acid results in increased expression of ACTBL2 mRNA
CTD
PMID:24714768
NCBI chr13:111,391,547...111,394,283
Ensembl chr13:111,391,547...111,394,283
G
Actg2
actin, gamma 2, smooth muscle, enteric
decreases expression
ISO
zoledronic acid results in decreased expression of ACTG2 mRNA
CTD
PMID:24714768
NCBI chr 6:83,489,891...83,513,233
Ensembl chr 6:83,489,887...83,513,247
G
Actn1
actinin, alpha 1
decreases expression
ISO
zoledronic acid results in decreased expression of ACTN1 protein
CTD
PMID:28871336
NCBI chr12:80,214,316...80,307,165
Ensembl chr12:80,214,321...80,307,145
G
Actn4
actinin alpha 4
decreases expression
ISO
zoledronic acid results in decreased expression of ACTN4 protein
CTD
PMID:28871336
NCBI chr 7:28,592,673...28,661,799
Ensembl chr 7:28,592,673...28,661,765
G
Adam17
a disintegrin and metallopeptidase domain 17
multiple interactions decreases activity increases expression
ISO
ADAM17 protein promotes the reaction [zoledronic acid results in decreased expression of TNFSF11 protein] zoledronic acid results in decreased activity of ADAM17 protein zoledronic acid results in increased expression of ADAM17 protein
CTD
PMID:14753746
NCBI chr12:21,373,510...21,423,633
Ensembl chr12:21,373,510...21,423,633
G
Adam19
ADAM metallopeptidase domain 19
decreases expression
ISO
zoledronic acid results in decreased expression of ADAM19 mRNA
CTD
PMID:24714768
NCBI chr11:45,945,329...46,038,174
Ensembl chr11:45,946,819...46,038,170
G
Adam28
a disintegrin and metallopeptidase domain 28
increases expression
ISO
zoledronic acid results in increased expression of ADAM28 mRNA
CTD
PMID:24714768
NCBI chr14:68,842,447...68,893,338
Ensembl chr14:68,843,476...68,893,291
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif 1
increases expression
ISO
zoledronic acid results in increased expression of ADAMTS1 mRNA
CTD
PMID:24714768
NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
G
Adamts9
ADAM metallopeptidase with thrombospondin type 1 motif 9
increases expression
ISO
zoledronic acid results in increased expression of ADAMTS9 mRNA
CTD
PMID:24714768
NCBI chr 6:92,749,680...92,921,431
Ensembl chr 6:92,749,680...92,920,473
G
Adamtsl3
ADAMTS-like 3
decreases expression
ISO
zoledronic acid results in decreased expression of ADAMTSL3 mRNA
CTD
PMID:24714768
NCBI chr 7:81,984,612...82,263,658
Ensembl chr 7:81,984,902...82,263,658
G
Adgrf1
adhesion G protein-coupled receptor F1
increases expression
ISO
zoledronic acid results in increased expression of ADGRF1 mRNA
CTD
PMID:24714768
NCBI chr17:43,581,174...43,636,767
Ensembl chr17:43,581,220...43,635,628
G
Adgrg1
adhesion G protein-coupled receptor G1
decreases expression
ISO
zoledronic acid results in decreased expression of ADGRG1 mRNA
CTD
PMID:24714768
NCBI chr 8:95,701,321...95,740,836
Ensembl chr 8:95,701,379...95,740,845
G
Adgrl1
adhesion G protein-coupled receptor L1
decreases expression
ISO
zoledronic acid results in decreased expression of ADGRL1 mRNA
CTD
PMID:20977926
NCBI chr 8:84,626,598...84,668,583
Ensembl chr 8:84,626,734...84,668,583
G
Adgrv1
adhesion G protein-coupled receptor V1
increases expression
ISO
zoledronic acid results in increased expression of ADGRV1 mRNA
CTD
PMID:24714768
NCBI chr13:81,243,187...81,781,504
Ensembl chr13:81,243,187...81,781,273
G
Adh6b
alcohol dehydrogenase 6B (class V)
decreases expression
ISO
zoledronic acid results in decreased expression of ADH6 mRNA
CTD
PMID:24714768
NCBI chr 3:138,047,176...138,064,621
Ensembl chr 3:138,047,536...138,064,622
G
Adm2
adrenomedullin 2
decreases expression
ISO
zoledronic acid results in decreased expression of ADM2 mRNA
CTD
PMID:24714768
NCBI chr15:89,206,923...89,208,934
Ensembl chr15:89,206,923...89,208,934
G
Adsl
adenylosuccinate lyase
decreases expression
ISO
zoledronic acid results in decreased expression of ADSL mRNA
CTD
PMID:20977926
NCBI chr15:80,832,691...80,855,148
Ensembl chr15:80,832,691...80,855,147
G
Afp
alpha fetoprotein
increases expression
ISO
zoledronic acid results in increased expression of AFP protein
CTD
PMID:28871336
NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766
G
Agpat5
1-acylglycerol-3-phosphate O-acyltransferase 5
increases expression
ISO
zoledronic acid results in increased expression of AGPAT5 mRNA
CTD
PMID:24714768
NCBI chr 8:18,896,295...18,934,429
Ensembl chr 8:18,896,293...18,941,377
G
Agr2
anterior gradient 2
decreases expression
ISO
zoledronic acid results in decreased expression of AGR2 mRNA
CTD
PMID:24714768
NCBI chr12:36,042,924...36,054,080
Ensembl chr12:36,042,906...36,054,086
G
Agrn
agrin
increases expression
ISO
zoledronic acid results in increased expression of AGRN protein
CTD
PMID:28871336
NCBI chr 4:156,249,747...156,281,997
Ensembl chr 4:156,249,747...156,281,945
G
Ahnak2
AHNAK nucleoprotein 2
decreases expression
ISO
zoledronic acid results in decreased expression of AHNAK2 mRNA
CTD
PMID:24714768
NCBI chr12:112,738,631...112,766,278
Ensembl chr12:112,738,628...112,766,277
G
Ahr
aryl-hydrocarbon receptor
affects activity
ISO
zoledronic acid affects the activity of AHR protein
CTD
PMID:25596134
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Ahsg
alpha-2-HS-glycoprotein
increases expression
ISO
zoledronic acid results in increased expression of AHSG protein
CTD
PMID:28871336
NCBI chr16:22,710,793...22,718,193
Ensembl chr16:22,710,027...22,718,199
G
Ak3
adenylate kinase 3
decreases expression
ISO
zoledronic acid results in decreased expression of AK3 mRNA
CTD
PMID:25596134
NCBI chr19:28,968,715...29,026,122
Ensembl chr19:28,998,233...29,025,361
G
Ak5
adenylate kinase 5
decreases expression
ISO
zoledronic acid results in decreased expression of AK5 mRNA
CTD
PMID:24714768
NCBI chr 3:152,168,461...152,373,992
Ensembl chr 3:152,168,452...152,373,997
G
Akap7
A kinase anchor protein 7
decreases expression
ISO
zoledronic acid results in decreased expression of AKAP7 mRNA
CTD
PMID:24714768
NCBI chr10:25,044,988...25,175,115
Ensembl chr10:25,044,988...25,183,768
G
Akip1
A kinase interacting protein 1
increases expression
ISO
zoledronic acid results in increased expression of AKIP1 mRNA
CTD
PMID:24714768
NCBI chr 7:109,302,885...109,311,393
Ensembl chr 7:109,302,897...109,311,396
G
Akirin2
akirin 2
decreases expression
ISO
zoledronic acid results in decreased expression of AKIRIN2 mRNA
CTD
PMID:20977926
NCBI chr 4:34,550,615...34,566,930
Ensembl chr 4:34,550,937...34,566,908
G
Akr1a1
aldo-keto reductase family 1, member A1
increases expression
ISO
zoledronic acid results in increased expression of AKR1A1 mRNA
CTD
PMID:24714768
NCBI chr 4:116,493,707...116,508,871
Ensembl chr 4:116,493,707...116,508,877
G
Akr1b1
aldo-keto reductase family 1 member B
increases expression
ISO
zoledronic acid results in increased expression of AKR1B1 mRNA
CTD
PMID:24714768
NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413
G
Akr1c21
aldo-keto reductase family 1, member C21
decreases expression
ISO
zoledronic acid results in decreased expression of AKR1C2 mRNA
CTD
PMID:25596134
NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540
G
Akt1
thymoma viral proto-oncogene 1
multiple interactions
ISO
CCN1 protein affects the reaction [Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of AKT1 protein
CTD
PMID:19530242
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Akt1s1
AKT1 substrate 1
increases expression
ISO
zoledronic acid results in increased expression of AKT1S1 mRNA
CTD
PMID:20977926
NCBI chr 7:44,498,648...44,504,845
Ensembl chr 7:44,498,415...44,504,845
G
Alb
albumin
increases expression
ISO
zoledronic acid results in increased expression of ALB protein
CTD
PMID:28871336
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Aldh18a1
aldehyde dehydrogenase 18 family, member A1
decreases expression
ISO
zoledronic acid results in decreased expression of ALDH18A1 mRNA
CTD
PMID:25596134
NCBI chr19:40,538,701...40,576,907
Ensembl chr19:40,538,701...40,576,907
G
Aldh1a3
aldehyde dehydrogenase family 1, subfamily A3
increases expression
ISO
zoledronic acid results in increased expression of ALDH1A3 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 7:66,040,640...66,077,225
Ensembl chr 7:66,040,638...66,077,265
G
Aldh3a2
aldehyde dehydrogenase family 3, subfamily A2
decreases expression
ISO
zoledronic acid results in decreased expression of ALDH3A2 mRNA
CTD
PMID:24714768
NCBI chr11:61,114,240...61,158,267
Ensembl chr11:61,114,243...61,158,290
G
Aldh8a1
aldehyde dehydrogenase 8 family, member A1
increases expression
ISO
zoledronic acid results in increased expression of ALDH8A1 mRNA
CTD
PMID:24714768
NCBI chr10:21,253,199...21,272,477
Ensembl chr10:21,253,190...21,272,484
G
Alox5
arachidonate 5-lipoxygenase
increases expression
ISO
zoledronic acid results in increased expression of ALOX5 mRNA
CTD
PMID:24714768
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
increases expression
ISO
zoledronic acid results in increased expression of ALOX5AP mRNA
CTD
PMID:20977926 PMID:24714768
NCBI chr 5:149,201,814...149,224,963
Ensembl chr 5:149,201,577...149,224,963
G
Alpk2
alpha-kinase 2
increases expression
ISO
zoledronic acid results in increased expression of ALPK2 mRNA
CTD
PMID:24714768
NCBI chr18:65,398,600...65,526,959
Ensembl chr18:65,398,600...65,527,137
G
Alpl
alkaline phosphatase, liver/bone/kidney
decreases activity multiple interactions
EXP
zoledronic acid results in decreased activity of ALPL protein TNFRSF11B protein affects the reaction [zoledronic acid results in decreased activity of ALPL protein]
CTD
PMID:18496637
NCBI chr 4:137,469,042...137,523,695
Ensembl chr 4:137,469,044...137,523,695
G
Als2cl
ALS2 C-terminal like
increases expression
ISO
zoledronic acid results in increased expression of ALS2CL mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 9:110,709,203...110,729,598
Ensembl chr 9:110,708,938...110,729,598
G
Ank2
ankyrin 2, brain
decreases expression
ISO
zoledronic acid results in decreased expression of ANK2 mRNA
CTD
PMID:24714768
NCBI chr 3:126,715,256...127,293,996
Ensembl chr 3:126,715,261...127,292,999
G
Ankef1
ankyrin repeat and EF-hand domain containing 1
increases expression
ISO
zoledronic acid results in increased expression of ANKEF1 mRNA
CTD
PMID:20977926
NCBI chr 2:136,374,241...136,397,774
Ensembl chr 2:136,343,830...136,404,011
G
Ankra2
ankyrin repeat family A member 2
increases expression
ISO
zoledronic acid results in increased expression of ANKRA2 mRNA
CTD
PMID:25596134
NCBI chr13:98,399,584...98,411,262
Ensembl chr13:98,399,582...98,411,262
G
Ankrd10
ankyrin repeat domain 10
increases expression
ISO
zoledronic acid results in increased expression of ANKRD10 mRNA
CTD
PMID:20977926
NCBI chr 8:11,661,581...11,694,617
Ensembl chr 8:11,661,583...11,685,757
G
Ankrd22
ankyrin repeat domain 22
increases expression
ISO
zoledronic acid results in increased expression of ANKRD22 mRNA
CTD
PMID:24714768
NCBI chr19:34,099,949...34,143,441
Ensembl chr19:34,098,869...34,143,453
G
Anln
anillin, actin binding protein
decreases expression
ISO
zoledronic acid results in decreased expression of ANLN mRNA
CTD
PMID:24714768
NCBI chr 9:22,243,305...22,302,132
Ensembl chr 9:22,243,308...22,300,484
G
Anpep
alanyl aminopeptidase, membrane
increases expression
ISO
zoledronic acid results in increased expression of ANPEP mRNA
CTD
PMID:24714768
NCBI chr 7:79,471,551...79,497,958
Ensembl chr 7:79,471,551...79,510,807
G
Anxa2
annexin A2
decreases expression
ISO
zoledronic acid results in decreased expression of ANXA2 protein
CTD
PMID:28871336
NCBI chr 9:69,360,978...69,399,074
Ensembl chr 9:69,360,902...69,399,077
G
Ap1s2
adaptor-related protein complex 1, sigma 2 subunit
increases expression
ISO
zoledronic acid results in increased expression of AP1S2 mRNA
CTD
PMID:24714768
NCBI chr X:162,691,427...162,716,662
Ensembl chr X:162,692,013...162,716,662
G
Ap1s3
adaptor-related protein complex AP-1, sigma 3
increases expression
ISO
zoledronic acid results in increased expression of AP1S3 mRNA
CTD
PMID:20977926
NCBI chr 1:79,584,593...79,649,736
Ensembl chr 1:79,584,593...79,649,689
G
Ap4b1
adaptor-related protein complex AP-4, beta 1
increases expression
ISO
zoledronic acid results in increased expression of AP4B1 mRNA
CTD
PMID:24714768
NCBI chr 3:103,716,375...103,729,341
Ensembl chr 3:103,716,889...103,745,964 Ensembl chr 3:103,716,889...103,745,964
G
Apaf1
apoptotic peptidase activating factor 1
increases expression
ISO EXP
zoledronic acid results in increased expression of APAF1 mRNA
CTD
PMID:28871336
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
G
Apba3
amyloid beta precursor protein binding family A member 3
decreases expression
ISO
zoledronic acid results in decreased expression of APBA3 mRNA
CTD
PMID:20977926
NCBI chr10:81,102,799...81,109,081
Ensembl chr10:81,102,794...81,109,080
G
Aph1a
aph1 homolog A, gamma secretase subunit
increases expression
ISO
zoledronic acid results in increased expression of APH1A mRNA
CTD
PMID:20977926
NCBI chr 3:95,801,233...95,805,904
Ensembl chr 3:95,801,281...95,805,600
G
Api5
apoptosis inhibitor 5
increases expression
ISO
zoledronic acid results in increased expression of API5 mRNA
CTD
PMID:20977926
NCBI chr 2:94,242,073...94,268,490
Ensembl chr 2:94,242,027...94,268,481
G
Arap1
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
decreases expression
ISO
zoledronic acid results in decreased expression of ARAP1 mRNA
CTD
PMID:20977926
NCBI chr 7:100,997,296...101,061,793
Ensembl chr 7:100,997,274...101,061,793
G
Arhgap18
Rho GTPase activating protein 18
decreases expression
ISO
zoledronic acid results in decreased expression of ARHGAP18 mRNA
CTD
PMID:20977926
NCBI chr10:26,648,363...26,794,644
Ensembl chr10:26,629,417...26,794,644
G
Arhgap19
Rho GTPase activating protein 19
decreases expression
ISO
zoledronic acid results in decreased expression of ARHGAP19 mRNA
CTD
PMID:20977926
NCBI chr19:41,755,027...41,790,523
Ensembl chr19:41,755,027...41,790,486
G
Arhgap22
Rho GTPase activating protein 22
increases expression
ISO
zoledronic acid results in increased expression of ARHGAP22 mRNA
CTD
PMID:24714768
NCBI chr14:32,935,952...33,091,893
Ensembl chr14:32,935,983...33,091,891
G
Arhgap24
Rho GTPase activating protein 24
decreases expression
ISO
zoledronic acid results in decreased expression of ARHGAP24 mRNA
CTD
PMID:24714768
NCBI chr 5:102,355,043...103,053,743
Ensembl chr 5:102,629,257...103,045,803
G
Arhgap26
Rho GTPase activating protein 26
increases expression
ISO
zoledronic acid results in increased expression of ARHGAP26 mRNA
CTD
PMID:24714768
NCBI chr18:38,734,531...39,509,338
Ensembl chr18:39,126,198...39,509,337 Ensembl chr18:39,126,198...39,509,337
G
Arhgap29
Rho GTPase activating protein 29
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGAP29 mRNA
CTD
PMID:16996129
NCBI chr 3:121,746,752...121,810,326
Ensembl chr 3:121,746,190...121,810,402
G
Arhgdia
Rho GDP dissociation inhibitor alpha
decreases expression
ISO
zoledronic acid results in decreased expression of ARHGDIA protein
CTD
PMID:28871336
NCBI chr11:120,468,925...120,472,450
Ensembl chr11:120,468,930...120,472,450
G
Arhgef12
Rho guanine nucleotide exchange factor 12
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF12 mRNA
CTD
PMID:16996129
NCBI chr 9:42,875,138...43,017,069
Ensembl chr 9:42,875,138...43,018,534
G
Arhgef3
Rho guanine nucleotide exchange factor 3
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF3 mRNA
CTD
PMID:16996129
NCBI chr14:26,836,418...27,125,873
Ensembl chr14:26,836,856...27,125,868
G
Arhgef4
Rho guanine nucleotide exchange factor 4
decreases expression
ISO
zoledronic acid results in decreased expression of ARHGEF4 mRNA
CTD
PMID:24714768
NCBI chr 1:34,717,263...34,851,819
Ensembl chr 1:34,717,269...34,852,390
G
Arid2
AT-rich interaction domain 2
decreases expression
ISO
zoledronic acid results in decreased expression of ARID2 mRNA
CTD
PMID:20977926
NCBI chr15:96,185,403...96,303,344
Ensembl chr15:96,185,399...96,302,873
G
Arl14
ADP-ribosylation factor-like 14
decreases expression
ISO
zoledronic acid results in decreased expression of ARL14 mRNA
CTD
PMID:24714768
NCBI chr 3:69,129,752...69,130,951
Ensembl chr 3:69,129,752...69,130,951
G
Arl4c
ADP-ribosylation factor-like 4C
decreases expression
ISO
zoledronic acid results in decreased expression of ARL4C mRNA
CTD
PMID:24714768
NCBI chr 1:88,625,947...88,629,913
Ensembl chr 1:88,600,847...88,629,943
G
Arl5b
ADP-ribosylation factor-like 5B
increases expression
ISO
zoledronic acid results in increased expression of ARL5B mRNA
CTD
PMID:20977926
NCBI chr 2:15,060,066...15,087,267
Ensembl chr 2:15,054,206...15,087,267
G
Arnt2
aryl hydrocarbon receptor nuclear translocator 2
decreases expression
ISO
zoledronic acid results in decreased expression of ARNT2 mRNA
CTD
PMID:24714768
NCBI chr 7:83,895,486...84,059,201
Ensembl chr 7:83,895,486...84,059,384
G
Arrdc3
arrestin domain containing 3
increases expression
ISO
zoledronic acid results in increased expression of ARRDC3 mRNA
CTD
PMID:24714768
NCBI chr13:81,031,508...81,044,161
Ensembl chr13:81,031,503...81,044,161
G
Arrdc4
arrestin domain containing 4
increases expression
ISO
zoledronic acid results in increased expression of ARRDC4 mRNA
CTD
PMID:24714768
NCBI chr 7:68,386,742...68,398,986
Ensembl chr 7:68,386,743...68,398,989
G
Asic1
acid-sensing ion channel 1
multiple interactions decreases expression
EXP ISO
zoledronic acid inhibits the reaction [Freund's Adjuvant results in increased expression of ASIC1 mRNA] zoledronic acid results in decreased expression of ASIC1 mRNA
CTD
PMID:16769263 PMID:17323179
NCBI chr15:99,568,090...99,599,011
Ensembl chr15:99,568,249...99,599,011
G
Asns
asparagine synthetase
decreases expression
ISO
zoledronic acid results in decreased expression of ASNS mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254
G
Asphd2
aspartate beta-hydroxylase domain containing 2
decreases expression
ISO
zoledronic acid results in decreased expression of ASPHD2 mRNA
CTD
PMID:24714768
NCBI chr 5:112,532,220...112,543,236
Ensembl chr 5:112,532,220...112,542,732
G
Aspm
abnormal spindle microtubule assembly
decreases expression
ISO
zoledronic acid results in decreased expression of ASPM mRNA
CTD
PMID:24714768
NCBI chr 1:139,381,450...139,421,826
Ensembl chr 1:139,382,510...139,421,829
G
Atf4
activating transcription factor 4
decreases expression
ISO
zoledronic acid results in decreased expression of ATF4 mRNA
CTD
PMID:24714768
NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742
G
Atf5
activating transcription factor 5
increases expression
ISO
zoledronic acid results in increased expression of ATF5 mRNA
CTD
PMID:24714768
NCBI chr 7:44,461,680...44,466,082
Ensembl chr 7:44,461,680...44,466,082
G
Atg2a
autophagy related 2A
increases expression
ISO
zoledronic acid results in increased expression of ATG2A protein
CTD
PMID:28871336
NCBI chr19:6,291,508...6,312,332
Ensembl chr19:6,291,698...6,312,365
G
Atoh8
atonal bHLH transcription factor 8
increases expression
ISO
zoledronic acid results in increased expression of ATOH8 mRNA
CTD
PMID:24714768
NCBI chr 6:72,183,158...72,212,765
Ensembl chr 6:72,183,161...72,212,561
G
Atosa
atos homolog A
increases expression
ISO
Zoledronic Acid results in increased expression of ATOSA mRNA
CTD
PMID:25596134
NCBI chr 9:74,860,162...74,939,750
Ensembl chr 9:74,860,151...74,939,746
G
Atp10b
ATPase, class V, type 10B
increases expression
ISO
zoledronic acid results in increased expression of ATP10B mRNA
CTD
PMID:24714768
NCBI chr11:42,902,991...43,153,112
Ensembl chr11:43,040,704...43,153,112
G
Atp1a1
ATPase, Na+/K+ transporting, alpha 1 polypeptide
decreases expression
ISO
zoledronic acid results in decreased expression of ATP1A1 mRNA
CTD
PMID:24714768
NCBI chr 3:101,483,535...101,512,023
Ensembl chr 3:101,483,535...101,512,000
G
Atp6v0a4
ATPase, H+ transporting, lysosomal V0 subunit A4
decreases expression
ISO
zoledronic acid results in decreased expression of ATP6V0A4 mRNA
CTD
PMID:24714768
NCBI chr 6:38,025,418...38,101,521
Ensembl chr 6:38,025,418...38,101,521
G
Atp6v1b1
ATPase, H+ transporting, lysosomal V1 subunit B1
decreases expression
ISO
zoledronic acid results in decreased expression of ATP6V1B1 mRNA
CTD
PMID:24714768
NCBI chr 6:83,719,999...83,735,837
Ensembl chr 6:83,719,972...83,735,837
G
Atp7b
ATPase, copper transporting, beta polypeptide
decreases expression
ISO
zoledronic acid results in decreased expression of ATP7B mRNA
CTD
PMID:24714768
NCBI chr 8:22,482,799...22,550,347
Ensembl chr 8:22,482,801...22,550,321
G
Atrx
ATRX, chromatin remodeler
decreases expression
ISO
zoledronic acid results in decreased expression of ATRX mRNA
CTD
PMID:20977926
NCBI chr X:104,841,221...104,972,978
Ensembl chr X:104,841,221...104,973,009
G
Atxn1
ataxin 1
increases expression
ISO
zoledronic acid results in increased expression of ATXN1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr13:45,703,231...46,118,467
Ensembl chr13:45,703,231...46,118,484
G
Aurkb
aurora kinase B
decreases expression
ISO
zoledronic acid results in decreased expression of AURKB mRNA
CTD
PMID:25596134
NCBI chr11:68,936,477...68,942,490
Ensembl chr11:68,936,473...68,942,490
G
Avpi1
arginine vasopressin-induced 1
decreases expression
ISO
zoledronic acid results in decreased expression of AVPI1 mRNA
CTD
PMID:24714768
NCBI chr19:42,111,714...42,117,432
Ensembl chr19:42,111,712...42,117,498
G
Axl
AXL receptor tyrosine kinase
decreases expression
ISO
zoledronic acid results in decreased expression of AXL mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 7:25,455,925...25,488,502
Ensembl chr 7:25,456,698...25,488,130
G
B3galt5
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5
decreases expression
ISO
zoledronic acid results in decreased expression of B3GALT5 mRNA
CTD
PMID:24714768
NCBI chr16:96,037,001...96,121,059
Ensembl chr16:96,037,001...96,121,059
G
Baat
bile acid-Coenzyme A: amino acid N-acyltransferase
increases expression
ISO
zoledronic acid results in increased expression of BAAT mRNA
CTD
PMID:24714768
NCBI chr 4:49,489,416...49,507,915
Ensembl chr 4:49,489,422...49,506,557
G
Bad
BCL2-associated agonist of cell death
multiple interactions increases expression
ISO
[Tretinoin co-treated with zoledronic acid] results in increased expression of BAD protein zoledronic acid results in increased expression of BAD mRNA
CTD
PMID:19036117 PMID:20349282
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bag1
BCL2-associated athanogene 1
increases expression
ISO
zoledronic acid results in increased expression of BAG1 mRNA
CTD
PMID:19036117
NCBI chr 4:40,936,398...40,948,294
Ensembl chr 4:40,936,398...40,948,294
G
Bag3
BCL2-associated athanogene 3
increases expression
ISO
zoledronic acid results in increased expression of BAG3 mRNA
CTD
PMID:19036117
NCBI chr 7:128,125,307...128,148,705
Ensembl chr 7:128,125,340...128,148,705
G
Basp1
brain abundant, membrane attached signal protein 1
increases expression
ISO
zoledronic acid results in increased expression of BASP1 mRNA
CTD
PMID:24714768
NCBI chr15:25,363,363...25,413,850
Ensembl chr15:25,363,363...25,413,850
G
Bax
BCL2-associated X protein
decreases expression multiple interactions increases expression
ISO EXP
zoledronic acid results in decreased expression of BAX mRNA [Tretinoin co-treated with zoledronic acid] results in increased expression of BAX protein [zoledronic acid co-treated with Doxorubicin] results in increased expression of BAX protein Zoledronic Acid results in increased expression of BAX mRNA zoledronic acid results in increased expression of BAX mRNA
CTD
PMID:19036117 PMID:19789217 PMID:20349282 PMID:28871336 PMID:35587103
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bbln
bublin coiled coil protein
increases expression
ISO
Zoledronic Acid results in increased expression of BBLN mRNA
CTD
PMID:24714768
NCBI chr 2:32,269,120...32,271,877
Ensembl chr 2:32,267,109...32,271,950
G
Bbox1
gamma-butyrobetaine hydroxylase 1
decreases expression
ISO
zoledronic acid results in decreased expression of BBOX1 mRNA
CTD
PMID:24714768
NCBI chr 2:110,094,401...110,145,158
Ensembl chr 2:110,093,042...110,144,905
G
Bbx
bobby sox HMG box containing
decreases expression
ISO
zoledronic acid results in decreased expression of BBX mRNA
CTD
PMID:20977926
NCBI chr16:50,012,207...50,252,829
Ensembl chr16:50,012,207...50,252,753
G
BC004004
cDNA sequence BC004004
increases expression
ISO
zoledronic acid results in increased expression of C6ORF89 mRNA
CTD
PMID:20977926
NCBI chr17:29,487,762...29,521,862
Ensembl chr17:29,487,762...29,533,039
G
Bcap29
B cell receptor associated protein 29
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of BCAP29 mRNA
CTD
PMID:16996129
NCBI chr12:31,645,353...31,684,657
Ensembl chr12:31,640,966...31,684,657
G
Bcar3
breast cancer anti-estrogen resistance 3
decreases expression
ISO
Zoledronic Acid results in decreased expression of BCAR3 mRNA
CTD
PMID:25596134
NCBI chr 3:122,213,406...122,323,840
Ensembl chr 3:122,087,785...122,323,840
G
Bche
butyrylcholinesterase
decreases expression
ISO
zoledronic acid results in decreased expression of BCHE mRNA
CTD
PMID:24714768
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
G
Bcl2
B cell leukemia/lymphoma 2
decreases response to substance multiple interactions decreases expression affects expression increases expression
ISO EXP
BCL2 protein results in decreased susceptibility to zoledronic acid [Tretinoin co-treated with zoledronic acid] results in decreased expression of BCL2 protein; [zoledronic acid co-treated with docetaxel] results in decreased expression of BCL2 protein zoledronic acid results in decreased expression of BCL2 mRNA zoledronic acid affects the expression of BCL2 mRNA Zoledronic Acid results in increased expression of BCL2 mRNA [zoledronic acid co-treated with Doxorubicin] results in decreased expression of BCL2 protein
CTD
PMID:11986784 PMID:18225567 PMID:19036117 PMID:19103299 PMID:19789217 PMID:20349282 PMID:24714768 PMID:28871336 PMID:35587103 More...
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bcl2a1b
B cell leukemia/lymphoma 2 related protein A1b
decreases expression
ISO
zoledronic acid results in decreased expression of BCL2A1 mRNA
CTD
PMID:19036117
NCBI chr 9:89,081,326...89,089,891
Ensembl chr 9:89,081,262...89,089,880
G
Bcl2l1
BCL2-like 1
increases expression
ISO
zoledronic acid results in increased expression of BCL2L1 mRNA
CTD
PMID:19036117
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Bcl2l10
Bcl2-like 10
affects expression
ISO
zoledronic acid affects the expression of BCL2L10 mRNA
CTD
PMID:19036117
NCBI chr 9:75,255,040...75,258,922
Ensembl chr 9:75,255,040...75,258,931
G
Bcl2l11
BCL2 like 11
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of BCL2L11 mRNA
CTD
PMID:16996129
NCBI chr 2:127,967,958...128,004,467
Ensembl chr 2:127,967,958...128,004,467
G
Bcl2l15
BCLl2-like 15
increases expression
ISO
zoledronic acid results in increased expression of BCL2L15 mRNA
CTD
PMID:24714768
NCBI chr 3:103,738,331...103,761,934
Ensembl chr 3:103,739,917...103,761,934
G
Bcl2l2
BCL2-like 2
increases expression
ISO
zoledronic acid results in increased expression of BCL2L2 mRNA
CTD
PMID:19036117
NCBI chr14:55,120,900...55,125,691
Ensembl chr14:55,120,834...55,125,691
G
Becn1
beclin 1, autophagy related
decreases expression
ISO
zoledronic acid results in decreased expression of BECN1 protein
CTD
PMID:28871336
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
Bend5
BEN domain containing 5
decreases expression
ISO
zoledronic acid results in decreased expression of BEND5 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 4:111,271,993...111,317,495
Ensembl chr 4:111,272,203...111,317,495
G
Bfsp1
beaded filament structural protein 1, in lens-CP94
decreases expression
ISO
zoledronic acid results in decreased expression of BFSP1 mRNA
CTD
PMID:24714768
NCBI chr 2:143,668,448...143,757,320
Ensembl chr 2:143,668,448...143,705,093
G
Bglap
bone gamma carboxyglutamate protein
increases expression
ISO
zoledronic acid results in increased expression of BGLAP mRNA
CTD
PMID:14751568
NCBI chr 3:88,290,802...88,291,773
Ensembl chr 3:88,290,808...88,291,771
G
Bhlhe40
basic helix-loop-helix family, member e40
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of BHLHE40 mRNA
CTD
PMID:16996129
NCBI chr 6:108,637,590...108,643,886
Ensembl chr 6:108,637,590...108,643,886
G
Bicdl1
BICD family like cargo adaptor 1
increases expression
ISO
zoledronic acid results in increased expression of BICDL1 mRNA
CTD
PMID:20977926
NCBI chr 5:115,786,233...115,869,824
Ensembl chr 5:115,786,234...115,869,680
G
Bid
BH3 interacting domain death agonist
increases expression
ISO
zoledronic acid results in increased expression of BID mRNA
CTD
PMID:19036117
NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
G
Birc2
baculoviral IAP repeat-containing 2
multiple interactions decreases expression
ISO
[Tretinoin co-treated with zoledronic acid] results in decreased expression of BIRC2 mRNA zoledronic acid results in decreased expression of BIRC2 mRNA
CTD
PMID:19036117 PMID:20349282
NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065
G
Birc3
baculoviral IAP repeat-containing 3
increases expression
ISO
zoledronic acid results in increased expression of BIRC3 mRNA
CTD
PMID:24714768
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
G
Birc5
baculoviral IAP repeat-containing 5
multiple interactions decreases expression
ISO
[Tretinoin co-treated with zoledronic acid] results in decreased expression of BIRC5 mRNA; [Tretinoin co-treated with zoledronic acid] results in decreased expression of BIRC5 protein zoledronic acid results in decreased expression of BIRC5 mRNA; zoledronic acid results in decreased expression of BIRC5 protein
CTD
PMID:19036117 PMID:20349282 PMID:24714768
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
G
Birc6
baculoviral IAP repeat-containing 6
decreases expression
ISO
zoledronic acid results in decreased expression of BIRC6 mRNA
CTD
PMID:19036117
NCBI chr17:74,835,247...75,010,351
Ensembl chr17:74,835,290...75,010,351
G
Bivm
basic, immunoglobulin-like variable motif containing
decreases expression
ISO
zoledronic acid results in decreased expression of BIVM mRNA
CTD
PMID:24714768
NCBI chr 1:44,158,032...44,183,931
Ensembl chr 1:44,158,117...44,183,930
G
Bloc1s5
biogenesis of lysosomal organelles complex-1, subunit 5, muted
increases expression
ISO
zoledronic acid results in increased expression of BLOC1S5 mRNA
CTD
PMID:20977926
NCBI chr13:38,786,674...38,821,093
Ensembl chr13:38,776,818...38,819,085
G
Bmal1
basic helix-loop-helix ARNT like 1
increases expression
ISO
Zoledronic Acid results in increased expression of BMAL1 mRNA
CTD
PMID:20977926
NCBI chr 7:112,777,820...112,913,333
Ensembl chr 7:112,806,672...112,913,333
G
Bmf
BCL2 modifying factor
increases expression
ISO
zoledronic acid results in increased expression of BMF mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 2:118,359,238...118,385,240
Ensembl chr 2:118,359,238...118,380,168
G
Bmp1
bone morphogenetic protein 1
increases expression
ISO
zoledronic acid results in increased expression of BMP1 mRNA
CTD
PMID:20977926
NCBI chr14:70,711,998...70,758,280
Ensembl chr14:70,711,998...70,757,674
G
Bmp2
bone morphogenetic protein 2
increases expression
ISO
zoledronic acid results in increased expression of BMP2 mRNA
CTD
PMID:14751568 PMID:24714768
NCBI chr 2:133,394,079...133,404,816
Ensembl chr 2:133,394,079...133,404,805
G
Bmpr1a
bone morphogenetic protein receptor, type 1A
increases expression
ISO
zoledronic acid results in increased expression of BMPR1A mRNA
CTD
PMID:24714768
NCBI chr14:34,133,018...34,225,335
Ensembl chr14:34,132,691...34,225,298
G
Bmpr2
bone morphogenetic protein receptor type 2
increases expression
ISO
zoledronic acid results in increased expression of BMPR2 mRNA
CTD
PMID:20977926
NCBI chr 1:59,802,721...59,917,240
Ensembl chr 1:59,802,559...59,918,173
G
Bnip3
BCL2/adenovirus E1B interacting protein 3
decreases expression increases expression
ISO
zoledronic acid results in decreased expression of BNIP3 mRNA zoledronic acid results in increased expression of BNIP3 mRNA
CTD
PMID:19036117 PMID:25596134
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
G
Bnip5
BCL2 interacting protein 5
increases expression
ISO
Zoledronic Acid results in increased expression of BNIP5 mRNA
CTD
PMID:24714768
NCBI chr17:29,114,248...29,134,310
Ensembl chr17:29,115,366...29,134,298
G
Bola2
bolA family member 2
increases expression
ISO
zoledronic acid results in increased expression of BOLA2 mRNA
CTD
PMID:24714768
NCBI chr 7:126,295,172...126,295,865
Ensembl chr 7:126,294,573...126,298,970
G
Bpgm
2,3-bisphosphoglycerate mutase
increases expression
ISO
zoledronic acid results in increased expression of BPGM mRNA
CTD
PMID:24714768
NCBI chr 6:34,453,291...34,482,071
Ensembl chr 6:34,453,142...34,482,548
G
Brca2
breast cancer 2, early onset
increases expression
ISO
zoledronic acid results in increased expression of BRCA2 mRNA
CTD
PMID:20977926
NCBI chr 5:150,445,759...150,493,612
Ensembl chr 5:150,446,095...150,493,794
G
Brip1
BRCA1 interacting protein C-terminal helicase 1
increases expression
ISO
zoledronic acid results in increased expression of BRIP1 mRNA
CTD
PMID:20977926
NCBI chr11:85,948,957...86,092,041
Ensembl chr11:85,948,964...86,092,019
G
Btg2
BTG anti-proliferation factor 2
decreases expression increases expression
ISO
zoledronic acid results in decreased expression of BTG2 mRNA zoledronic acid results in increased expression of BTG2 mRNA
CTD
PMID:20977926 PMID:25596134
NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858
G
Bub1
BUB1, mitotic checkpoint serine/threonine kinase
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of BUB1 mRNA
CTD
PMID:16996129
NCBI chr 2:127,642,117...127,673,790
Ensembl chr 2:127,643,036...127,673,785
G
C1ql4
complement component 1, q subcomponent-like 4
decreases expression
ISO
zoledronic acid results in decreased expression of C1QL4 mRNA
CTD
PMID:24714768
NCBI chr15:98,981,967...98,988,555
Ensembl chr15:98,981,967...98,985,698
G
C1qtnf1
C1q and tumor necrosis factor related protein 1
increases expression
ISO
zoledronic acid results in increased expression of C1QTNF1 mRNA
CTD
PMID:24714768
NCBI chr11:118,319,187...118,342,608
Ensembl chr11:118,319,029...118,340,789
G
C1qtnf6
C1q and tumor necrosis factor related protein 6
decreases expression
ISO
zoledronic acid results in decreased expression of C1QTNF6 mRNA
CTD
PMID:24714768
NCBI chr15:78,407,546...78,416,370
Ensembl chr15:78,407,546...78,415,616
G
C1rb
complement component 1, r subcomponent B
increases expression
ISO
zoledronic acid results in increased expression of C1R mRNA
CTD
PMID:24714768
NCBI chr 6:124,547,389...124,558,003
Ensembl chr 6:124,547,253...124,558,130
G
C1s1
complement component 1, s subcomponent 1
increases expression
ISO
Zoledronic Acid results in increased expression of C1S mRNA
CTD
PMID:24714768
NCBI chr 6:124,507,303...124,519,340
Ensembl chr 6:124,507,304...124,519,318
G
C2cd4a
C2 calcium-dependent domain containing 4A
increases expression
ISO
zoledronic acid results in increased expression of C2CD4A mRNA
CTD
PMID:24714768
NCBI chr 9:67,737,814...67,739,612
Ensembl chr 9:67,737,771...67,739,612
G
C2cd4b
C2 calcium-dependent domain containing 4B
increases expression
ISO
zoledronic acid results in increased expression of NLF2 mRNA
CTD
PMID:24714768
NCBI chr 9:67,623,506...67,668,215
Ensembl chr 9:67,666,719...67,668,212
G
C3
complement component 3
increases expression
ISO
zoledronic acid results in increased expression of C3 mRNA
CTD
PMID:24714768
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Cacna2d3
calcium channel, voltage-dependent, alpha2/delta subunit 3
increases expression
ISO
zoledronic acid results in increased expression of CACNA2D3 mRNA
CTD
PMID:24714768
NCBI chr14:28,626,900...29,444,732
Ensembl chr14:28,626,900...29,443,821
G
Cactin
cactin, spliceosome C complex subunit
decreases expression
ISO
zoledronic acid results in decreased expression of CACTIN protein
CTD
PMID:28871336
NCBI chr10:81,156,937...81,162,085
Ensembl chr10:81,156,937...81,162,076
G
Calm1
calmodulin 1
decreases expression
ISO
zoledronic acid results in decreased expression of CALM1 protein
CTD
PMID:28871336
NCBI chr12:100,165,694...100,176,083
Ensembl chr12:100,165,694...100,176,073
G
Calml4
calmodulin-like 4
decreases expression
ISO
zoledronic acid results in decreased expression of CALML4 mRNA
CTD
PMID:20977926
NCBI chr 9:62,765,068...62,783,203
Ensembl chr 9:62,765,362...62,783,203
G
Camk1d
calcium/calmodulin-dependent protein kinase ID
increases expression
ISO
zoledronic acid results in increased expression of CAMK1D mRNA
CTD
PMID:24714768
NCBI chr 2:5,298,268...5,719,665
Ensembl chr 2:5,298,268...5,719,326
G
Camk2d
calcium/calmodulin-dependent protein kinase II, delta
decreases expression
ISO
zoledronic acid results in decreased expression of CAMK2D mRNA
CTD
PMID:24714768
NCBI chr 3:126,389,136...126,639,975
Ensembl chr 3:126,389,951...126,639,975
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
decreases expression
ISO
zoledronic acid results in decreased expression of CAMK2N1 mRNA
CTD
PMID:24714768
NCBI chr 4:138,182,459...138,187,437
Ensembl chr 4:138,181,625...138,187,434
G
Camk4
calcium/calmodulin-dependent protein kinase IV
decreases expression
ISO
zoledronic acid results in decreased expression of CAMK4 protein
CTD
PMID:28871336
NCBI chr18:33,067,995...33,328,820
Ensembl chr18:33,067,984...33,324,281
G
Camsap1
calmodulin regulated spectrin-associated protein 1
decreases expression
ISO
zoledronic acid results in decreased expression of CAMSAP1 protein
CTD
PMID:28871336
NCBI chr 2:25,816,850...25,873,574
Ensembl chr 2:25,816,850...25,873,294
G
Cant1
calcium activated nucleotidase 1
increases expression
ISO
zoledronic acid results in increased expression of CANT1 mRNA
CTD
PMID:20977926
NCBI chr11:118,297,115...118,309,971
Ensembl chr11:118,297,115...118,309,912
G
Cap2
cyclase associated actin cytoskeleton regulatory protein 2
decreases expression
ISO
zoledronic acid results in decreased expression of CAP2 mRNA
CTD
PMID:24714768
NCBI chr13:46,655,379...46,803,757
Ensembl chr13:46,655,324...46,803,757
G
Capn13
calpain 13
increases expression
ISO
zoledronic acid results in increased expression of CAPN13 mRNA
CTD
PMID:24714768
NCBI chr17:73,613,451...73,706,376
Ensembl chr17:73,613,459...73,707,861
G
Capn6
calpain 6
decreases expression
ISO
zoledronic acid results in decreased expression of CAPN6 mRNA
CTD
PMID:24714768
NCBI chr X:142,585,232...142,610,408
Ensembl chr X:142,585,227...142,610,410
G
Caprin1
cell cycle associated protein 1
increases expression
ISO
zoledronic acid results in increased expression of CAPRIN1 mRNA
CTD
PMID:20977926
NCBI chr 2:103,593,292...103,627,946
Ensembl chr 2:103,593,286...103,627,994
G
Card10
caspase recruitment domain family, member 10
decreases expression
ISO
zoledronic acid results in decreased expression of CARD10 mRNA
CTD
PMID:24714768
NCBI chr15:78,659,323...78,687,261
Ensembl chr15:78,659,338...78,687,242
G
Cars1
cysteinyl-tRNA synthetase 1
increases expression
ISO
Zoledronic Acid results in increased expression of CARS1 mRNA
CTD
PMID:20977926
NCBI chr 7:143,110,967...143,153,827
Ensembl chr 7:143,110,967...143,153,827
G
Casp1
caspase 1
affects expression multiple interactions increases expression
ISO
zoledronic acid affects the expression of CASP1 mRNA [zoledronic acid co-treated with fluvastatin] results in increased expression of CASP1 mRNA zoledronic acid results in increased expression of CASP1 mRNA
CTD
PMID:16996129 PMID:19036117 PMID:24714768
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
G
Casp14
caspase 14
decreases expression
ISO
zoledronic acid results in decreased expression of CASP14 mRNA
CTD
PMID:19036117
NCBI chr10:78,547,829...78,554,181
Ensembl chr10:78,547,825...78,554,128
G
Casp2
caspase 2
affects expression
ISO
zoledronic acid affects the expression of CASP2 mRNA
CTD
PMID:19036117
NCBI chr 6:42,241,942...42,259,442
Ensembl chr 6:42,241,919...42,259,442
G
Casp3
caspase 3
multiple interactions decreases expression increases activity increases cleavage increases expression
ISO EXP
[Tretinoin co-treated with zoledronic acid] results in increased activity of CASP3 protein; [vorinostat co-treated with zoledronic acid] results in increased activity of CASP3 protein; [zoledronic acid co-treated with arsenic trioxide] results in increased cleavage of CASP3 protein; [zoledronic acid co-treated with docetaxel] results in decreased expression of CASP3 protein; [zoledronic acid co-treated with Doxorubicin] results in increased expression of CASP3 protein; [zoledronic acid co-treated with Gossypol] results in increased activity of CASP3 protein; vorinostat promotes the reaction [zoledronic acid results in increased activity of CASP3 protein]; zoledronic acid results in increased cleavage of and results in increased activity of CASP3 protein; zoledronic acid results in increased expression of and results in increased activity of CASP3 protein zoledronic acid results in decreased expression of CASP3 protein [zoledronic acid co-treated with Doxorubicin] results in increased activity of CASP3 protein zoledronic acid results in increased cleavage of CASP3 protein Zoledronic Acid results in increased expression of CASP3 mRNA
CTD
PMID:11986784 PMID:12796698 PMID:17070308 PMID:17562444 PMID:18025282 PMID:18695136 PMID:19036117 PMID:19789217 PMID:19825521 PMID:19915386 PMID:20349282 PMID:20977926 PMID:24714768 PMID:35587103 More...
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp4
caspase 4, apoptosis-related cysteine peptidase
increases expression
ISO
Zoledronic Acid results in increased expression of CASP4 mRNA
CTD
PMID:35587103
NCBI chr 9:5,308,816...5,336,791
Ensembl chr 9:5,308,828...5,336,783
G
Casp6
caspase 6
increases activity
ISO
zoledronic acid results in increased activity of CASP6 protein
CTD
PMID:17070308
NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752
G
Casp7
caspase 7
multiple interactions increases activity
ISO
[Tretinoin co-treated with zoledronic acid] results in increased activity of CASP7 protein; [zoledronic acid co-treated with Gossypol] results in increased activity of CASP7 protein zoledronic acid results in increased activity of CASP7 protein
CTD
PMID:19825521 PMID:20349282
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
G
Casp8
caspase 8
increases expression multiple interactions
ISO EXP
zoledronic acid results in increased expression of CASP8 mRNA [zoledronic acid co-treated with Doxorubicin] results in increased activity of CASP8 protein
CTD
PMID:19036117 PMID:19789217 PMID:20977926
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Casp9
caspase 9
increases activity multiple interactions affects expression
ISO EXP
zoledronic acid results in increased activity of CASP9 protein [zoledronic acid co-treated with Doxorubicin] results in increased activity of CASP9 protein zoledronic acid results in increased cleavage of and results in increased activity of CASP9 protein Zoledronic Acid affects the expression of CASP9 mRNA
CTD
PMID:12799645 PMID:19036117 PMID:19789217 PMID:35587103
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Casr
calcium-sensing receptor
decreases expression
ISO
zoledronic acid results in decreased expression of CASR mRNA
CTD
PMID:24714768
NCBI chr16:36,310,947...36,382,605
Ensembl chr16:36,314,058...36,382,503
G
Castor1
cytosolic arginine sensor for mTORC1 subunit 1
increases expression
ISO
zoledronic acid results in increased expression of CASTOR1 mRNA
CTD
PMID:24714768
NCBI chr11:4,167,401...4,172,409
Ensembl chr11:4,168,225...4,172,409
G
Cavin2
caveolae associated 2
decreases expression
ISO
zoledronic acid results in decreased expression of CAVIN2 mRNA
CTD
PMID:24714768
NCBI chr 1:51,328,285...51,342,119
Ensembl chr 1:51,328,285...51,342,119
G
Cbr1
carbonyl reductase 1
decreases expression
ISO
zoledronic acid results in decreased expression of CBR1 mRNA
CTD
PMID:24714768
NCBI chr16:93,404,752...93,407,226
Ensembl chr16:93,402,741...93,407,393
G
Cbs
cystathionine beta-synthase
decreases expression
ISO
zoledronic acid results in decreased expression of CBS mRNA
CTD
PMID:24714768
NCBI chr17:31,831,602...31,856,170
Ensembl chr17:31,827,868...31,856,212
G
Cbx5
chromobox 5
increases expression
ISO
zoledronic acid results in increased expression of CBX5 mRNA
CTD
PMID:20977926
NCBI chr15:103,099,973...103,148,337
Ensembl chr15:103,099,971...103,148,243
G
Cc2d2a
coiled-coil and C2 domain containing 2A
decreases expression
ISO
zoledronic acid results in decreased expression of CC2D2A mRNA
CTD
PMID:24714768
NCBI chr 5:43,819,715...43,898,317
Ensembl chr 5:43,819,688...43,898,314
G
Ccdc138
coiled-coil domain containing 138
increases expression
ISO
zoledronic acid results in increased expression of CCDC138 mRNA
CTD
PMID:20977926
NCBI chr10:58,333,523...58,412,066
Ensembl chr10:58,333,770...58,412,066
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions increases expression
ISO
zoledronic acid promotes the reaction [Gossypol results in decreased expression of CCL2 mRNA] zoledronic acid results in increased expression of CCL2 mRNA
CTD
PMID:19825521 PMID:24714768
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl20
C-C motif chemokine ligand 20
increases expression
ISO
zoledronic acid results in increased expression of CCL20 mRNA
CTD
PMID:20977926 PMID:24714768
NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
G
Ccl28
C-C motif chemokine ligand 28
increases expression
ISO
zoledronic acid results in increased expression of CCL28 mRNA
CTD
PMID:24714768
NCBI chr13:120,085,355...120,115,895
Ensembl chr13:120,085,355...120,115,895
G
Ccl8
C-C motif chemokine ligand 8
increases expression
ISO
Zoledronic Acid results in increased expression of CCL8 mRNA
CTD
PMID:24714768
NCBI chr11:82,006,011...82,007,625
Ensembl chr11:82,006,011...82,007,625
G
Ccl9
C-C motif chemokine ligand 9
increases expression
ISO
Zoledronic Acid results in increased expression of CCL23 mRNA
CTD
PMID:24714768
NCBI chr11:83,463,743...83,469,462
Ensembl chr11:83,463,745...83,469,462
G
Ccn1
cellular communication network factor 1
multiple interactions decreases expression
ISO
CCN1 protein affects the reaction [Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; CCN1 protein affects the reaction [Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of MAPK1 protein]; CCN1 protein affects the reaction [Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of MAPK3 protein]; CCN1 protein affects the reaction [Zoledronic Acid results in increased expression of CDKN1A protein]; geranylgeraniol inhibits the reaction [Zoledronic Acid results in decreased expression of CCN1 protein]; Zoledronic Acid promotes the reaction [CCN1 protein affects the expression of CDKN1B protein] Zoledronic Acid results in decreased expression of CCN1 mRNA; Zoledronic Acid results in decreased expression of CCN1 protein
CTD
PMID:19530242
NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
G
Ccna2
cyclin A2
decreases expression
ISO
zoledronic acid results in decreased expression of CCNA2 mRNA
CTD
PMID:24714768
NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
G
Ccnb1
cyclin B1
multiple interactions decreases expression
EXP ISO
[zoledronic acid co-treated with Doxorubicin] results in decreased expression of CCNB1 protein zoledronic acid results in decreased expression of CCNB1 mRNA
CTD
PMID:19789217 PMID:20977926
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
G
Ccnb2
cyclin B2
decreases expression
ISO
zoledronic acid results in decreased expression of CCNB2 mRNA
CTD
PMID:24714768
NCBI chr 9:70,314,971...70,328,836
Ensembl chr 9:70,314,974...70,328,829
G
Ccnd1
cyclin D1
decreases expression multiple interactions
ISO EXP
zoledronic acid results in decreased expression of CCND1 mRNA [zoledronic acid co-treated with Doxorubicin] results in decreased expression of CCND1 protein zoledronic acid results in decreased expression of CCND1 protein
CTD
PMID:16621245 PMID:19789217 PMID:24714768
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Ccnd3
cyclin D3
multiple interactions decreases expression
EXP
[zoledronic acid co-treated with Doxorubicin] results in decreased expression of CCND3 protein zoledronic acid results in decreased expression of CCND3 protein
CTD
PMID:19789217
NCBI chr17:47,815,976...47,910,614
Ensembl chr17:47,815,976...47,910,616
G
Ccne1
cyclin E1
multiple interactions
EXP
[zoledronic acid co-treated with Doxorubicin] results in decreased expression of CCNE1 protein
CTD
PMID:19789217
NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959
G
Ccne2
cyclin E2
decreases expression increases expression
ISO
zoledronic acid results in decreased expression of CCNE2 mRNA zoledronic acid results in increased expression of CCNE2 mRNA
CTD
PMID:20977926 PMID:25596134
NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779
G
Cd14
CD14 antigen
increases expression
ISO
zoledronic acid results in increased expression of CD14 mRNA; zoledronic acid results in increased expression of CD14 protein
CTD
PMID:24714768 PMID:28871336
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
G
Cd27
CD27 antigen
affects expression
ISO
zoledronic acid affects the expression of CD27 mRNA
CTD
PMID:19036117
NCBI chr 6:125,209,583...125,214,014
Ensembl chr 6:125,209,585...125,213,973
G
Cd34
CD34 antigen
increases expression
ISO
zoledronic acid results in increased expression of CD34 mRNA
CTD
PMID:24714768
NCBI chr 1:194,621,239...194,643,587
Ensembl chr 1:194,621,127...194,643,587
G
Cd40
CD40 antigen
increases expression
ISO
zoledronic acid results in increased expression of CD40 mRNA
CTD
PMID:24714768
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cd40lg
CD40 ligand
decreases expression
ISO
zoledronic acid results in decreased expression of CD40LG mRNA
CTD
PMID:19036117
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
G
Cd44
CD44 antigen
increases expression
ISO
zoledronic acid results in increased expression of CD44 mRNA
CTD
PMID:24714768
NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
G
Cd55
CD55 molecule, decay accelerating factor for complement
increases expression
ISO
zoledronic acid results in increased expression of CD55 mRNA; zoledronic acid results in increased expression of CD55 protein
CTD
PMID:20977926 PMID:24714768 PMID:28871336
NCBI chr 1:130,357,526...130,390,513
Ensembl chr 1:130,366,764...130,390,481
G
Cd59b
CD59b antigen
increases expression
ISO
zoledronic acid results in increased expression of CD59 mRNA
CTD
PMID:24714768
NCBI chr 2:103,900,127...103,920,619
Ensembl chr 2:103,896,142...103,921,534
G
Cd68
CD68 antigen
increases expression
ISO
zoledronic acid results in increased expression of CD68 mRNA
CTD
PMID:24714768
NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979
G
Cd69
CD69 antigen
increases expression
ISO
zoledronic acid results in increased expression of CD69 mRNA
CTD
PMID:24714768
NCBI chr 6:129,244,287...129,252,332
Ensembl chr 6:129,244,288...129,252,399
G
Cd74
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)
increases expression
ISO
zoledronic acid results in increased expression of CD74 mRNA
CTD
PMID:24714768
NCBI chr18:60,936,921...60,945,724
Ensembl chr18:60,936,920...60,945,724
G
Cd80
CD80 antigen
increases expression
ISO
zoledronic acid results in increased expression of CD80 protein
CTD
PMID:19446661
NCBI chr16:38,277,793...38,316,682
Ensembl chr16:38,275,923...38,316,697
G
Cd83
CD83 antigen
increases expression
ISO
zoledronic acid results in increased expression of CD83 mRNA
CTD
PMID:24714768
NCBI chr13:43,938,661...43,956,608
Ensembl chr13:43,938,251...43,956,608
G
Cd86
CD86 antigen
increases expression
ISO
zoledronic acid results in increased expression of CD86 protein
CTD
PMID:19446661
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
G
Cdc14a
CDC14 cell division cycle 14A
increases expression
ISO
zoledronic acid results in increased expression of CDC14A mRNA
CTD
PMID:24714768
NCBI chr 3:116,066,202...116,222,390
Ensembl chr 3:116,066,202...116,222,394
G
Cdc20
cell division cycle 20
decreases expression
ISO
zoledronic acid results in decreased expression of CDC20 mRNA
CTD
PMID:20977926 PMID:24714768
NCBI chr 4:118,290,098...118,294,540
Ensembl chr 4:118,290,098...118,294,549
G
Cdc25c
cell division cycle 25C
increases expression
ISO
zoledronic acid results in increased expression of CDC25C mRNA
CTD
PMID:20977926
NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586
G
Cdc26
cell division cycle 26
decreases expression
ISO
zoledronic acid results in decreased expression of CDC26 protein
CTD
PMID:28871336
NCBI chr 4:62,310,581...62,326,862
Ensembl chr 4:62,301,891...62,326,879
G
Cdc42
cell division cycle 42
multiple interactions
EXP ISO
zoledronic acid results in increased abundance of [Guanosine Triphosphate binds to CDC42 protein] zoledronic acid results in increased expression of [CDC42 protein binds to Guanosine Triphosphate]; zoledronic acid results in increased expression of and affects the localization of CDC42 protein
CTD
PMID:16734383 PMID:28871336
NCBI chr 4:137,047,011...137,085,007
Ensembl chr 4:137,047,007...137,085,031
G
Cdc42ep2
CDC42 effector protein 2
increases expression
ISO
zoledronic acid results in increased expression of CDC42EP2 mRNA
CTD
PMID:24714768
NCBI chr19:5,967,584...5,974,844
Ensembl chr19:5,965,664...5,974,844
G
Cdc42ep5
CDC42 effector protein 5
increases expression
ISO
zoledronic acid results in increased expression of CDC42EP5 mRNA
CTD
PMID:24714768
NCBI chr 7:4,154,259...4,167,830
Ensembl chr 7:4,154,259...4,167,859
G
Cdc45
cell division cycle 45
decreases expression
ISO
Zoledronic Acid results in decreased expression of CDC45 mRNA
CTD
PMID:24714768
NCBI chr16:18,599,202...18,632,371
Ensembl chr16:18,599,197...18,630,737
G
Cdca5
cell division cycle associated 5
increases expression
ISO
zoledronic acid results in increased expression of CDCA5 protein
CTD
PMID:28871336
NCBI chr19:6,135,127...6,141,803
Ensembl chr19:6,135,013...6,141,807
G
Cdca7
cell division cycle associated 7
decreases expression
ISO
zoledronic acid results in decreased expression of CDCA7 mRNA
CTD
PMID:24714768
NCBI chr 2:72,306,540...72,317,237
Ensembl chr 2:72,306,503...72,317,237
G
Cdca8
cell division cycle associated 8
decreases expression
ISO
zoledronic acid results in decreased expression of CDCA8 mRNA
CTD
PMID:24714768
NCBI chr 4:124,812,258...124,830,710
Ensembl chr 4:124,812,258...124,833,104
G
Cdh4
cadherin 4
increases expression
ISO
zoledronic acid results in increased expression of CDH4 mRNA
CTD
PMID:24714768
NCBI chr 2:179,084,228...179,541,166
Ensembl chr 2:179,084,224...179,541,166
G
Cdk1
cyclin dependent kinase 1
decreases expression
ISO
zoledronic acid results in decreased expression of CDK1 mRNA
CTD
PMID:24714768
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
G
Cdk2
cyclin dependent kinase 2
multiple interactions
EXP
[zoledronic acid co-treated with Doxorubicin] results in decreased expression of CDK2 protein
CTD
PMID:19789217
NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
G
Cdk2ap2
cyclin dependent kinase 2 associated protein 2
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of CDK2AP2 mRNA
CTD
PMID:16996129
NCBI chr19:4,146,204...4,149,019
Ensembl chr19:4,147,182...4,149,019
G
Cdk4
cyclin dependent kinase 4
multiple interactions
EXP
[zoledronic acid co-treated with Doxorubicin] results in decreased expression of CDK4 protein
CTD
PMID:19789217
NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
multiple interactions increases expression
ISO
CCN1 protein affects the reaction [Zoledronic Acid results in increased expression of CDKN1A protein] zoledronic acid results in increased expression of CDKN1A protein
CTD
PMID:19530242
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cdkn1b
cyclin dependent kinase inhibitor 1B
multiple interactions
ISO
[Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein; Gefitinib promotes the reaction [[Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein]; Zoledronic Acid promotes the reaction [CCN1 protein affects the expression of CDKN1B protein]
CTD
PMID:16322342 PMID:19530242
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
G
Cdkn1c
cyclin dependent kinase inhibitor 1C
increases expression
ISO
zoledronic acid results in increased expression of CDKN1C mRNA
CTD
PMID:20977926
NCBI chr 7:143,012,076...143,014,735
Ensembl chr 7:143,012,076...143,014,787
G
Cdkn2aip
CDKN2A interacting protein
decreases expression
ISO
zoledronic acid results in decreased expression of CDKN2AIP mRNA
CTD
PMID:24714768
NCBI chr 8:48,162,379...48,166,966
Ensembl chr 8:48,162,379...48,166,967
G
Cdkn2b
cyclin dependent kinase inhibitor 2B
increases expression
ISO
zoledronic acid results in increased expression of CDKN2B mRNA
CTD
PMID:24714768
NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276
G
Cdkn3
cyclin dependent kinase inhibitor 3
decreases expression
ISO
zoledronic acid results in decreased expression of CDKN3 mRNA
CTD
PMID:24714768
NCBI chr14:46,997,912...47,008,987
Ensembl chr14:46,997,998...47,009,126
G
Cdt1
chromatin licensing and DNA replication factor 1
decreases expression
ISO
zoledronic acid results in decreased expression of CDT1 mRNA
CTD
PMID:24714768
NCBI chr 8:123,294,754...123,299,869
Ensembl chr 8:123,294,754...123,300,293
G
Cdv3
carnitine deficiency-associated gene expressed in ventricle 3
increases expression
ISO
zoledronic acid results in increased expression of CDV3 mRNA
CTD
PMID:20977926
NCBI chr 9:103,230,301...103,243,034
Ensembl chr 9:103,230,293...103,243,039
G
Cebpa
CCAAT/enhancer binding protein alpha
increases expression
ISO
zoledronic acid results in increased expression of CEBPA mRNA
CTD
PMID:20977926
NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO
zoledronic acid results in increased expression of CEBPB mRNA
CTD
PMID:24714768
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
G
Cebpd
CCAAT/enhancer binding protein delta
increases expression
ISO
zoledronic acid results in increased expression of CEBPD mRNA
CTD
PMID:24714768
NCBI chr16:15,705,150...15,707,409
Ensembl chr16:15,705,150...15,708,895
G
Cenpa
centromere protein A
decreases expression
ISO
zoledronic acid results in decreased expression of CENPA mRNA
CTD
PMID:24714768
NCBI chr 5:30,824,214...30,832,181
Ensembl chr 5:30,824,121...30,832,174
G
Cenpf
centromere protein F
decreases expression decreases farnesylation
ISO
zoledronic acid results in decreased expression of CENPF mRNA zoledronic acid results in decreased farnesylation of CENPF protein
CTD
PMID:20015195 PMID:24714768
NCBI chr 1:189,372,803...189,420,302
Ensembl chr 1:189,372,803...189,420,283
G
Cenpi
centromere protein I
increases expression
ISO
zoledronic acid results in increased expression of CENPI mRNA
CTD
PMID:20977926
NCBI chr X:133,206,777...133,263,853
Ensembl chr X:133,208,833...133,263,388
G
Cenpm
centromere protein M
decreases expression
ISO
zoledronic acid results in decreased expression of CENPM mRNA
CTD
PMID:24714768
NCBI chr15:82,115,694...82,128,974
Ensembl chr15:82,117,980...82,128,949
G
Cep120
centrosomal protein 120
increases expression
ISO
zoledronic acid results in increased expression of CEP120 mRNA
CTD
PMID:20977926
NCBI chr18:53,814,795...53,877,825
Ensembl chr18:53,814,795...53,877,680
G
Cep20
centrosomal protein 20
increases expression
ISO
Zoledronic Acid results in increased expression of CEP20 mRNA
CTD
PMID:20977926
NCBI chr16:14,117,105...14,136,093
Ensembl chr16:14,117,108...14,135,269
G
Cep295
centrosomal protein 295
increases expression
ISO
zoledronic acid results in increased expression of CEP295 mRNA
CTD
PMID:20977926
NCBI chr 9:15,228,210...15,269,145
Ensembl chr 9:15,228,211...15,269,084
G
Cep55
centrosomal protein 55
decreases expression
ISO
zoledronic acid results in decreased expression of CEP55 mRNA
CTD
PMID:24714768
NCBI chr19:38,043,423...38,062,873
Ensembl chr19:38,043,459...38,062,871
G
Cep57
centrosomal protein 57
increases expression
ISO
zoledronic acid results in increased expression of CEP57 mRNA
CTD
PMID:20977926
NCBI chr 9:13,717,979...13,738,698
Ensembl chr 9:13,719,088...13,738,403
G
Cept1
choline/ethanolaminephosphotransferase 1
increases expression
ISO
zoledronic acid results in increased expression of CEPT1 mRNA
CTD
PMID:24714768
NCBI chr 3:106,409,576...106,455,118
Ensembl chr 3:106,409,576...106,455,118
G
Cfb
complement factor B
increases expression
ISO
zoledronic acid results in increased expression of CFB mRNA
CTD
PMID:24714768
NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494
G
Cfl1
cofilin 1, non-muscle
increases expression
ISO
zoledronic acid results in increased expression of CFL1 protein
CTD
PMID:28871336
NCBI chr19:5,540,483...5,544,059
Ensembl chr19:5,540,483...5,545,229
G
Cflar
CASP8 and FADD-like apoptosis regulator
increases expression
ISO
zoledronic acid results in increased expression of CFLAR mRNA
CTD
PMID:24714768
NCBI chr 1:58,750,353...58,798,043
Ensembl chr 1:58,750,667...58,798,043
G
Cgn
cingulin
decreases expression
ISO
zoledronic acid results in decreased expression of CGN mRNA
CTD
PMID:24714768
NCBI chr 3:94,667,376...94,695,036
Ensembl chr 3:94,667,376...94,693,826
G
Cgnl1
cingulin-like 1
decreases expression
ISO
zoledronic acid results in decreased expression of CGNL1 mRNA
CTD
PMID:24714768
NCBI chr 9:71,533,789...71,716,582
Ensembl chr 9:71,533,791...71,678,884
G
Chac1
ChaC, cation transport regulator 1
increases expression
ISO
zoledronic acid results in increased expression of CHAC1 mRNA
CTD
PMID:20977926
NCBI chr 2:119,181,723...119,184,807
Ensembl chr 2:119,181,710...119,184,862
G
Chmp4b
charged multivesicular body protein 4B
increases expression
ISO
zoledronic acid results in increased expression of CHMP4B mRNA
CTD
PMID:20977926
NCBI chr 2:154,498,949...154,536,703
Ensembl chr 2:154,493,625...154,536,705
G
Chmp6
charged multivesicular body protein 6
increases expression
ISO
zoledronic acid results in increased expression of CHMP6 protein
CTD
PMID:28871336
NCBI chr11:119,803,874...119,810,378
Ensembl chr11:119,804,267...119,810,374
G
Chst4
carbohydrate sulfotransferase 4
increases expression
ISO
zoledronic acid results in increased expression of CHST4 mRNA
CTD
PMID:24714768
NCBI chr 8:110,755,776...110,766,033
Ensembl chr 8:110,755,785...110,766,372
G
Ciita
class II transactivator
increases expression
ISO
zoledronic acid results in increased expression of CIITA mRNA
CTD
PMID:24714768
NCBI chr16:10,297,877...10,348,928
Ensembl chr16:10,297,923...10,346,282
G
Cimip2c
ciliary microtubule inner protein 2C
decreases expression
ISO
Zoledronic Acid results in decreased expression of CIMIP2C mRNA
CTD
PMID:24714768
NCBI chr 5:30,623,395...30,641,433
Ensembl chr 5:30,623,391...30,641,432
G
Cks2
CDC28 protein kinase regulatory subunit 2
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of CKS2 mRNA
CTD
PMID:16996129
NCBI chr13:51,799,268...51,804,698
Ensembl chr13:51,799,268...51,804,696
G
Clca4c-ps
chloride channel accessory 4C, pseudogene
decreases expression
ISO
zoledronic acid results in decreased expression of CLCA3 mRNA
CTD
PMID:24714768
NCBI chr 3:144,585,083...144,601,772
Ensembl chr 3:144,585,078...144,601,772
G
Clcn5
chloride channel, voltage-sensitive 5
decreases expression
ISO
zoledronic acid results in decreased expression of CLCN5 mRNA
CTD
PMID:24714768
NCBI chr X:7,020,049...7,185,597
Ensembl chr X:7,020,049...7,185,597
G
Clcnka
chloride channel, voltage-sensitive Ka
decreases expression
ISO
zoledronic acid results in decreased expression of CLCNKA mRNA
CTD
PMID:24714768
NCBI chr 4:141,111,922...141,126,017
Ensembl chr 4:141,111,921...141,126,035
G
Clcnkb
chloride channel, voltage-sensitive Kb
decreases expression
ISO
zoledronic acid results in decreased expression of CLCNKB mRNA
CTD
PMID:24714768
NCBI chr 4:141,131,668...141,143,440
Ensembl chr 4:141,131,664...141,143,325
G
Cldn14
claudin 14
increases expression
ISO
zoledronic acid results in increased expression of CLDN14 mRNA
CTD
PMID:24714768
NCBI chr16:93,715,919...93,809,733
Ensembl chr16:93,715,919...93,809,696
G
Cldn16
claudin 16
decreases expression
ISO
zoledronic acid results in decreased expression of CLDN16 mRNA
CTD
PMID:24714768
NCBI chr16:26,281,885...26,301,515
Ensembl chr16:26,281,885...26,301,515
G
Cldn2
claudin 2
decreases expression
ISO
zoledronic acid results in decreased expression of CLDN2 mRNA
CTD
PMID:24714768
NCBI chr X:138,701,552...138,712,135
Ensembl chr X:138,701,577...138,712,135
G
Cldn3
claudin 3
increases expression
ISO
zoledronic acid results in increased expression of CLDN3 mRNA
CTD
PMID:20977926
NCBI chr 5:135,015,068...135,016,330
Ensembl chr 5:135,015,068...135,016,326
G
Clec4e
C-type lectin domain family 4, member e
increases expression
ISO
zoledronic acid results in increased expression of CLEC4E mRNA
CTD
PMID:24714768
NCBI chr 6:123,258,748...123,266,830
Ensembl chr 6:123,258,748...123,266,829
G
Cln3
CLN3 lysosomal/endosomal transmembrane protein, battenin
increases expression
ISO
zoledronic acid results in increased expression of CLN3 mRNA
CTD
PMID:24714768
NCBI chr 7:126,170,571...126,184,991
Ensembl chr 7:126,170,379...126,184,989
G
Cngb1
cyclic nucleotide gated channel beta 1
increases expression
ISO
zoledronic acid results in increased expression of CNGB1 mRNA
CTD
PMID:24714768
NCBI chr 8:95,965,671...96,033,213
Ensembl chr 8:95,965,673...96,033,213
G
Cntnap1
contactin associated protein-like 1
increases expression
ISO
zoledronic acid results in increased expression of CNTNAP1 mRNA
CTD
PMID:24714768
NCBI chr11:101,065,429...101,081,550
Ensembl chr11:101,061,349...101,081,550
G
Col16a1
collagen, type XVI, alpha 1
increases expression
ISO
zoledronic acid results in increased expression of COL16A1 mRNA
CTD
PMID:24714768
NCBI chr 4:129,941,638...129,993,070
Ensembl chr 4:129,941,633...129,993,076
G
Col18a1
collagen, type XVIII, alpha 1
decreases expression
ISO
zoledronic acid results in decreased expression of COL18A1 mRNA
CTD
PMID:24714768
NCBI chr10:76,888,013...77,002,351
Ensembl chr10:76,888,012...77,002,382
G
Col1a1
collagen, type I, alpha 1
decreases expression increases expression multiple interactions
ISO EXP
zoledronic acid results in decreased expression of COL1A1 mRNA; zoledronic acid results in decreased expression of COL1A1 protein zoledronic acid results in increased expression of COL1A1 mRNA Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of COL1A1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of COL1A1 mRNA]
CTD
PMID:19597852 PMID:28871336
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Col3a1
collagen, type III, alpha 1
increases expression multiple interactions
EXP
zoledronic acid results in increased expression of COL3A1 mRNA Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of COL3A1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of COL3A1 mRNA]
CTD
PMID:28871336
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
G
Col4a1
collagen, type IV, alpha 1
increases expression multiple interactions
EXP
zoledronic acid results in increased expression of COL4A1 mRNA Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of COL4A1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of COL4A1 mRNA]
CTD
PMID:28871336
NCBI chr 8:11,248,423...11,362,889
Ensembl chr 8:11,248,423...11,362,826
G
Col4a3
collagen, type IV, alpha 3
decreases expression
ISO
zoledronic acid results in decreased expression of COL4A3 mRNA
CTD
PMID:24714768
NCBI chr 1:82,564,647...82,699,778
Ensembl chr 1:82,564,642...82,699,780
G
Col4a5
collagen, type IV, alpha 5
decreases expression
ISO
zoledronic acid results in decreased expression of COL4A5 mRNA
CTD
PMID:24714768
NCBI chr X:140,258,367...140,472,232
Ensembl chr X:140,258,381...140,472,230
G
Col5a1
collagen, type V, alpha 1
increases expression
ISO
zoledronic acid results in increased expression of COL5A1 protein
CTD
PMID:28871336
NCBI chr 2:27,776,393...27,929,522
Ensembl chr 2:27,776,437...27,929,526
G
Col9a2
collagen, type IX, alpha 2
increases expression
ISO
zoledronic acid results in increased expression of COL9A2 mRNA
CTD
PMID:24714768
NCBI chr 4:120,896,763...120,912,522
Ensembl chr 4:120,896,582...120,912,519
G
Comp
cartilage oligomeric matrix protein
increases expression
ISO
zoledronic acid results in increased expression of COMP protein
CTD
PMID:28871336
NCBI chr 8:70,826,186...70,834,721
Ensembl chr 8:70,826,208...70,834,716
G
Coq3
coenzyme Q3 methyltransferase
decreases expression
ISO
zoledronic acid results in decreased expression of COQ3 mRNA
CTD
PMID:24714768
NCBI chr 4:21,879,646...21,912,163
Ensembl chr 4:21,879,673...21,912,162
G
Coq4
coenzyme Q4
decreases expression
ISO
zoledronic acid results in decreased expression of COQ4 mRNA
CTD
PMID:20977926
NCBI chr 2:29,677,505...29,687,947
Ensembl chr 2:29,677,505...29,687,947
G
Cox17
cytochrome c oxidase assembly protein 17, copper chaperone
decreases expression
ISO
zoledronic acid results in decreased expression of COX17 mRNA
CTD
PMID:20977926
NCBI chr16:38,167,332...38,173,125
Ensembl chr16:38,167,353...38,182,659
G
Cp
ceruloplasmin
increases expression
ISO
zoledronic acid results in increased expression of CP mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309
G
Cpa4
carboxypeptidase A4
decreases expression
ISO
zoledronic acid results in decreased expression of CPA4 mRNA
CTD
PMID:24714768
NCBI chr 6:30,568,368...30,592,417
Ensembl chr 6:30,568,368...30,592,417
G
Cpd
carboxypeptidase D
increases expression
ISO
zoledronic acid results in increased expression of CPD mRNA
CTD
PMID:20977926
NCBI chr11:76,668,034...76,737,834
Ensembl chr11:76,669,250...76,737,844
G
Cpeb2
cytoplasmic polyadenylation element binding protein 2
decreases expression
ISO
zoledronic acid results in decreased expression of CPEB2 mRNA
CTD
PMID:24714768
NCBI chr 5:43,382,692...43,447,067
Ensembl chr 5:43,390,513...43,447,067
G
Cpne3
copine III
increases expression
ISO
zoledronic acid results in increased expression of CPNE3 mRNA
CTD
PMID:20977926
NCBI chr 4:19,519,252...19,570,108
Ensembl chr 4:19,519,254...19,570,108
G
Cpne8
copine VIII
decreases expression
ISO
zoledronic acid results in decreased expression of CPNE8 mRNA
CTD
PMID:24714768
NCBI chr15:90,371,684...90,563,591
Ensembl chr15:90,371,685...90,563,635
G
Cpq
carboxypeptidase Q
decreases expression
ISO
zoledronic acid results in decreased expression of PGCP mRNA
CTD
PMID:24714768
NCBI chr15:33,083,275...33,594,698
Ensembl chr15:33,083,275...33,594,698
G
Cpt1a
carnitine palmitoyltransferase 1a, liver
multiple interactions decreases expression
EXP ISO
Fenofibrate inhibits the reaction [zoledronic acid results in decreased expression of CPT1A mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of CPT1A mRNA] zoledronic acid results in decreased expression of CPT1A mRNA; zoledronic acid results in decreased expression of CPT1A protein
CTD
PMID:28871336
NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
G
Cpt2
carnitine palmitoyltransferase 2
decreases expression multiple interactions
EXP
zoledronic acid results in decreased expression of CPT2 mRNA Fenofibrate inhibits the reaction [zoledronic acid results in decreased expression of CPT2 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of CPT2 mRNA]
CTD
PMID:28871336
NCBI chr 4:107,761,179...107,780,786
Ensembl chr 4:107,761,178...107,780,807
G
Cpvl
carboxypeptidase, vitellogenic-like
decreases expression
ISO
zoledronic acid results in decreased expression of CPVL mRNA
CTD
PMID:24714768
NCBI chr 6:53,850,106...53,955,658
Ensembl chr 6:53,850,264...53,955,656
G
Crat
carnitine acetyltransferase
decreases expression
EXP
zoledronic acid results in decreased expression of CRAT mRNA
CTD
PMID:28871336
NCBI chr 2:30,290,483...30,305,602
Ensembl chr 2:30,290,483...30,305,825
G
Creb5
cAMP responsive element binding protein 5
decreases expression
ISO
zoledronic acid results in decreased expression of CREB5 mRNA
CTD
PMID:24714768
NCBI chr 6:53,264,154...53,677,349
Ensembl chr 6:53,264,255...53,677,361
G
Crls1
cardiolipin synthase 1
decreases expression
ISO
zoledronic acid results in decreased expression of CRLS1 mRNA
CTD
PMID:20977926
NCBI chr 2:132,688,557...132,708,706
Ensembl chr 2:132,688,586...132,708,705
G
Cryab
crystallin, alpha B
increases expression
ISO
zoledronic acid results in increased expression of CRYAB mRNA
CTD
PMID:24714768
NCBI chr 9:50,657,251...50,667,936
Ensembl chr 9:50,662,625...50,667,936
G
Csf1
colony stimulating factor 1 (macrophage)
increases expression decreases expression
ISO
zoledronic acid results in increased expression of CSF1 mRNA zoledronic acid results in decreased expression of CSF1 mRNA
CTD
PMID:20977926 PMID:24714768
NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
G
Csf2
colony stimulating factor 2 (granulocyte-macrophage)
increases expression
ISO
zoledronic acid results in increased expression of CSF2 mRNA
CTD
PMID:24714768
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
G
Csrp2
cysteine and glycine-rich protein 2
decreases expression
ISO
zoledronic acid results in decreased expression of CSRP2 mRNA
CTD
PMID:24714768
NCBI chr10:110,756,037...110,775,375
Ensembl chr10:110,755,650...110,775,483
G
Cst3
cystatin C
increases expression
ISO
zoledronic acid results in increased expression of CST3 protein
CTD
PMID:28871336
NCBI chr 2:148,713,642...148,717,432
Ensembl chr 2:148,713,642...148,717,612
G
Ctbs
chitobiase
increases expression
ISO
zoledronic acid results in increased expression of CTBS mRNA
CTD
PMID:20977926
NCBI chr 3:146,156,204...146,171,604
Ensembl chr 3:146,155,550...146,171,604
G
Cth
cystathionine gamma lyase
decreases expression
ISO
zoledronic acid results in decreased expression of CTH mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 3:157,599,885...157,630,718
Ensembl chr 3:157,599,885...157,630,714
G
Ctsb
cathepsin B
decreases expression
ISO
zoledronic acid results in decreased expression of CTSB protein
CTD
PMID:16475674
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
G
Ctsc
cathepsin C
increases expression
ISO
zoledronic acid results in increased expression of CTSC mRNA
CTD
PMID:25596134
NCBI chr 7:87,927,233...87,960,083
Ensembl chr 7:87,927,293...87,960,096
G
Ctse
cathepsin E
increases expression
ISO
zoledronic acid results in increased expression of CTSE mRNA
CTD
PMID:24714768
NCBI chr 1:131,566,052...131,603,245
Ensembl chr 1:131,566,044...131,603,243
G
Ctss
cathepsin S
increases expression
ISO
zoledronic acid results in increased expression of CTSS mRNA
CTD
PMID:24714768
NCBI chr 3:95,434,097...95,463,716
Ensembl chr 3:95,434,097...95,463,714
G
Cttn
cortactin
decreases expression
ISO
zoledronic acid results in decreased expression of CTTN mRNA
CTD
PMID:25596134
NCBI chr 7:143,989,468...144,024,743
Ensembl chr 7:143,989,470...144,024,746
G
Ctu2
cytosolic thiouridylase subunit 2
decreases expression
ISO
zoledronic acid results in decreased expression of CTU2 mRNA
CTD
PMID:20977926
NCBI chr 8:123,202,882...123,209,831
Ensembl chr 8:123,202,882...123,210,877
G
Cubn
cubilin
increases expression
ISO
zoledronic acid results in increased expression of CUBN mRNA
CTD
PMID:24714768
NCBI chr 2:13,281,149...13,496,687
Ensembl chr 2:13,281,149...13,496,624
G
Cul4a
cullin 4A
increases expression
ISO
zoledronic acid results in increased expression of CUL4A mRNA
CTD
PMID:24714768
NCBI chr 8:13,155,623...13,197,940
Ensembl chr 8:13,155,621...13,197,940
G
Cx3cl1
C-X3-C motif chemokine ligand 1
increases expression
ISO
zoledronic acid results in increased expression of CX3CL1 mRNA
CTD
PMID:24714768
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
G
Cxcl1
C-X-C motif chemokine ligand 1
multiple interactions increases expression
ISO
[zoledronic acid co-treated with Gossypol] results in decreased expression of CXCL1 mRNA zoledronic acid results in increased expression of CXCL1 mRNA
CTD
PMID:19825521 PMID:24714768
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
ISO
zoledronic acid results in increased expression of CXCL10 mRNA
CTD
PMID:24714768
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
G
Cxcl12
C-X-C motif chemokine ligand 12
decreases expression
ISO
zoledronic acid results in decreased expression of CXCL12 mRNA
CTD
PMID:24714768
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
G
Cxcl14
C-X-C motif chemokine ligand 14
decreases expression
ISO
zoledronic acid results in decreased expression of CXCL14 mRNA
CTD
PMID:24714768
NCBI chr13:56,436,456...56,444,624
Ensembl chr13:56,436,456...56,444,364
G
Cxcl15
C-X-C motif chemokine ligand 15
increases expression
ISO
zoledronic acid results in increased expression of CXCL8 mRNA
CTD
PMID:24714768
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cxcl16
C-X-C motif chemokine ligand 16
increases expression
ISO
zoledronic acid results in increased expression of CXCL16 mRNA
CTD
PMID:24714768
NCBI chr11:70,345,215...70,350,810
Ensembl chr11:70,344,809...70,350,810
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression
ISO
zoledronic acid results in increased expression of CXCL2 mRNA
CTD
PMID:24714768
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions increases expression
ISO
[zoledronic acid co-treated with Gossypol] results in decreased expression of CXCL1 mRNA zoledronic acid results in increased expression of CXCL1 mRNA
CTD
PMID:19825521 PMID:24714768
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
G
Cxcr4
C-X-C motif chemokine receptor 4
increases expression
ISO
zoledronic acid results in increased expression of CXCR4 mRNA
CTD
PMID:24714768
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
G
Cyb5r3
cytochrome b5 reductase 3
increases expression
ISO
zoledronic acid results in increased expression of CYB5R3 mRNA
CTD
PMID:20977926
NCBI chr15:83,037,696...83,060,641
Ensembl chr15:83,037,695...83,056,793
G
Cycs
cytochrome c, somatic
increases expression
ISO
Zoledronic Acid results in increased expression of CYCS mRNA
CTD
PMID:35587103
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
G
Cyfip2
cytoplasmic FMR1 interacting protein 2
decreases expression
ISO
zoledronic acid results in decreased expression of CYFIP2 mRNA
CTD
PMID:24714768
NCBI chr11:46,084,676...46,203,686
Ensembl chr11:46,084,677...46,203,686
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
zoledronic acid results in increased expression of CYP1A1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
ISO
zoledronic acid results in increased expression of CYP1A2 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
ISO
zoledronic acid results in increased expression of CYP1B1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
G
Cyp2c65
cytochrome P450, family 2, subfamily c, polypeptide 65
increases expression
ISO
zoledronic acid results in increased expression of CYP2C9 mRNA
CTD
PMID:24714768
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
G
Cyp3a13
cytochrome P450, family 3, subfamily a, polypeptide 13
increases expression
ISO
Zoledronic Acid results in increased expression of CYP3A5 mRNA
CTD
PMID:24714768
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
increases expression
ISO
zoledronic acid results in increased expression of CYP4B1 mRNA
CTD
PMID:24714768
NCBI chr 4:115,481,895...115,504,918
Ensembl chr 4:115,481,922...115,504,920
G
Cyp51
cytochrome P450, family 51
increases expression
ISO
zoledronic acid results in increased expression of CYP51A1 mRNA
CTD
PMID:24714768
NCBI chr 5:4,130,674...4,154,697
Ensembl chr 5:4,131,145...4,154,746
G
Cys1
cystin 1
decreases expression
ISO
zoledronic acid results in decreased expression of CYS1 mRNA
CTD
PMID:24714768
NCBI chr12:24,715,832...24,731,794
Ensembl chr12:24,715,832...24,731,812
G
Cytip
cytohesin 1 interacting protein
increases expression
ISO
zoledronic acid results in increased expression of CYTIP mRNA
CTD
PMID:24714768
NCBI chr 2:58,019,151...58,085,559
Ensembl chr 2:58,019,149...58,085,544
G
D430019H16Rik
RIKEN cDNA D430019H16 gene
decreases expression
ISO
zoledronic acid results in decreased expression of C14ORF132 mRNA
CTD
PMID:24714768
NCBI chr12:105,420,115...105,459,354
Ensembl chr12:105,420,115...105,459,354
G
Dapk1
death associated protein kinase 1
decreases expression
ISO
zoledronic acid results in decreased expression of DAPK1 mRNA
CTD
PMID:19036117
NCBI chr13:60,749,506...60,911,005
Ensembl chr13:60,749,761...60,911,005
G
Dapp1
dual adaptor for phosphotyrosine and 3-phosphoinositides 1
increases expression
ISO
zoledronic acid results in increased expression of DAPP1 mRNA
CTD
PMID:20977926 PMID:24714768
NCBI chr 3:137,636,768...137,687,331
Ensembl chr 3:137,636,768...137,687,306
G
Dcaf15
DDB1 and CUL4 associated factor 15
increases expression
ISO
zoledronic acid results in increased expression of DCAF15 mRNA
CTD
PMID:20977926
NCBI chr 8:84,823,698...84,831,426
Ensembl chr 8:84,823,701...84,831,397
G
Dcdc2a
doublecortin domain containing 2a
decreases expression
ISO
zoledronic acid results in decreased expression of DCDC2 mRNA
CTD
PMID:24714768
NCBI chr13:25,239,126...25,394,689
Ensembl chr13:25,239,987...25,394,689
G
Dcun1d4
defective in cullin neddylation 1 domain containing 4
increases expression
ISO
zoledronic acid results in increased expression of DCUN1D4 mRNA
CTD
PMID:20977926
NCBI chr 5:73,638,353...73,718,137
Ensembl chr 5:73,638,343...73,718,137
G
Ddah1
dimethylarginine dimethylaminohydrolase 1
decreases expression
ISO
zoledronic acid results in decreased expression of DDAH1 mRNA
CTD
PMID:24714768
NCBI chr 3:145,464,447...145,600,032
Ensembl chr 3:145,464,430...145,600,032
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
Zoledronic Acid results in increased expression of DDIT3 mRNA
CTD
PMID:35587103
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
G
Ddit4
DNA-damage-inducible transcript 4
decreases expression
ISO
zoledronic acid results in decreased expression of DDIT4 mRNA
CTD
PMID:25596134
NCBI chr10:59,785,497...59,787,592
Ensembl chr10:59,785,491...59,787,656
G
Ddit4l
DNA-damage-inducible transcript 4-like
increases expression
ISO
zoledronic acid results in increased expression of DDIT4L mRNA
CTD
PMID:24714768
NCBI chr 3:137,329,433...137,334,093
Ensembl chr 3:137,327,373...137,334,094
G
Ddr1
discoidin domain receptor family, member 1
increases expression decreases expression
ISO
zoledronic acid results in increased expression of DDR1 mRNA zoledronic acid monohydrate decreases expression of DDR1 mRNA and protein in human PC3 cancer cell line
CTD RGD
PMID:24714768 PMID:26366216
RGD:151347692
NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513
G
Ddx10
DEAD box helicase 10
decreases expression
ISO
zoledronic acid results in decreased expression of DDX10 mRNA
CTD
PMID:24714768
NCBI chr 9:53,009,754...53,159,423
Ensembl chr 9:53,009,935...53,159,353
G
Ddx42
DEAD box helicase 42
increases expression
ISO
zoledronic acid results in increased expression of DDX42 mRNA
CTD
PMID:20977926
NCBI chr11:106,107,715...106,139,966
Ensembl chr11:106,107,752...106,139,965
G
Defb1
defensin beta 1
increases expression
ISO
zoledronic acid results in increased expression of DEFB1 mRNA
CTD
PMID:24714768
NCBI chr 8:22,266,571...22,285,201
Ensembl chr 8:22,266,615...22,285,201
G
Defb3
defensin beta 3
increases expression
ISO
Zoledronic Acid results in increased expression of DEFB4 mRNA
CTD
PMID:24714768
NCBI chr 8:19,343,377...19,345,355
Ensembl chr 8:19,343,376...19,345,307
G
Dennd2a
DENN domain containing 2A
decreases expression
ISO
zoledronic acid results in decreased expression of DENND2A mRNA
CTD
PMID:24714768
NCBI chr 6:39,439,308...39,535,067
Ensembl chr 6:39,439,312...39,534,801
G
Dennd2b
DENN domain containing 2B
increases expression
ISO
Zoledronic Acid results in increased expression of DENND2B mRNA
CTD
PMID:24714768
NCBI chr 7:109,123,118...109,302,828
Ensembl chr 7:109,123,118...109,302,812
G
Dennd2d
DENN domain containing 2D
increases expression
ISO
zoledronic acid results in increased expression of DENND2D mRNA
CTD
PMID:24714768
NCBI chr 3:106,389,745...106,410,346
Ensembl chr 3:106,389,721...106,410,346
G
Depdc1a
DEP domain containing 1a
decreases expression
ISO
zoledronic acid results in decreased expression of DEPDC1 mRNA
CTD
PMID:24714768
NCBI chr 3:159,201,042...159,235,690
Ensembl chr 3:159,201,070...159,235,592
G
Depp1
DEPP1 autophagy regulator
increases expression
ISO
zoledronic acid results in increased expression of DEPP1 mRNA
CTD
PMID:24714768
NCBI chr 6:116,627,645...116,629,808
Ensembl chr 6:116,627,570...116,629,755
G
Deptor
DEP domain containing MTOR-interacting protein
decreases expression
ISO
Zoledronic Acid results in decreased expression of DEPTOR mRNA
CTD
PMID:24714768
NCBI chr15:54,975,824...55,122,667
Ensembl chr15:54,975,713...55,122,667
G
Dffa
DNA fragmentation factor, alpha subunit
decreases expression
ISO
zoledronic acid results in decreased expression of DFFA mRNA
CTD
PMID:20977926
NCBI chr 4:149,188,599...149,205,110
Ensembl chr 4:149,188,603...149,205,104
G
Dhcr7
7-dehydrocholesterol reductase
increases expression
ISO
zoledronic acid results in increased expression of DHCR7 mRNA
CTD
PMID:24714768
NCBI chr 7:143,376,827...143,402,147
Ensembl chr 7:143,376,882...143,402,147
G
Dhrs11
dehydrogenase/reductase 11
decreases expression
ISO
zoledronic acid results in decreased expression of DHRS11 mRNA
CTD
PMID:24714768
NCBI chr11:84,711,547...84,719,880
Ensembl chr11:84,711,682...84,719,820
G
Dhrs3
dehydrogenase/reductase 3
decreases expression
ISO
zoledronic acid results in decreased expression of DHRS3 mRNA
CTD
PMID:24714768
NCBI chr 4:144,618,712...144,654,214
Ensembl chr 4:144,619,397...144,654,779
G
Dhx35
DEAH-box helicase 35
increases expression
ISO
zoledronic acid results in increased expression of DHX35 mRNA
CTD
PMID:20977926
NCBI chr 2:158,636,674...158,700,141
Ensembl chr 2:158,636,727...158,700,134
G
Diablo
diablo, IAP-binding mitochondrial protein
multiple interactions
ISO
[Tretinoin co-treated with zoledronic acid] results in decreased expression of DIABLO protein
CTD
PMID:20349282
NCBI chr 5:123,649,393...123,664,825
Ensembl chr 5:123,647,828...123,662,239
G
Diaph3
diaphanous related formin 3
decreases expression
ISO
zoledronic acid results in decreased expression of DIAPH3 mRNA
CTD
PMID:24714768
NCBI chr14:86,892,793...87,378,683
Ensembl chr14:86,892,803...87,378,671
G
Dio2
deiodinase, iodothyronine, type II
decreases expression
ISO
zoledronic acid results in decreased expression of DIO2 mRNA
CTD
PMID:24714768
NCBI chr12:90,691,326...90,705,812
Ensembl chr12:90,691,326...90,705,812
G
Dkk1
dickkopf WNT signaling pathway inhibitor 1
decreases expression
ISO
zoledronic acid results in decreased expression of DKK1 mRNA
CTD
PMID:24714768
NCBI chr19:30,523,276...30,526,896
Ensembl chr19:30,523,263...30,527,065
G
Dlc1
deleted in liver cancer 1
decreases expression
ISO
zoledronic acid results in decreased expression of DLC1 mRNA
CTD
PMID:24714768
NCBI chr 8:37,034,893...37,420,343
Ensembl chr 8:37,034,905...37,420,297
G
Dlg1
discs large MAGUK scaffold protein 1
increases expression
ISO
zoledronic acid results in increased expression of DLG1 mRNA
CTD
PMID:20977926
NCBI chr16:31,482,261...31,692,174
Ensembl chr16:31,482,261...31,693,947
G
Dlgap4
DLG associated protein 4
decreases expression
ISO
zoledronic acid results in decreased expression of DLGAP4 mRNA
CTD
PMID:20977926
NCBI chr 2:156,455,431...156,606,283
Ensembl chr 2:156,455,625...156,606,283
G
Dlgap5
DLG associated protein 5
decreases expression
ISO
zoledronic acid results in decreased expression of DLGAP5 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr14:47,625,238...47,655,657
Ensembl chr14:47,625,236...47,655,864
G
Dlx1
distal-less homeobox 1
decreases expression
ISO
zoledronic acid results in decreased expression of DLX1 mRNA
CTD
PMID:25596134
NCBI chr 2:71,358,457...71,364,325
Ensembl chr 2:71,358,457...71,364,325
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
increases expression
ISO
zoledronic acid results in increased expression of DNAJB9 mRNA
CTD
PMID:20977926
NCBI chr12:44,252,680...44,256,851
Ensembl chr12:44,252,342...44,257,109
G
Dnase1l1
deoxyribonuclease 1-like 1
increases expression
ISO
zoledronic acid results in increased expression of DNASE1L1 mRNA
CTD
PMID:20977926
NCBI chr X:73,316,823...73,325,939
Ensembl chr X:73,316,823...73,325,943
G
Dner
delta/notch-like EGF repeat containing
increases expression
ISO
zoledronic acid results in increased expression of DNER mRNA
CTD
PMID:24714768
NCBI chr 1:84,347,560...84,673,942
Ensembl chr 1:84,347,560...84,673,942
G
Dock10
dedicator of cytokinesis 10
increases expression
ISO
zoledronic acid results in increased expression of DOCK10 mRNA
CTD
PMID:24714768
NCBI chr 1:80,478,785...80,736,482
Ensembl chr 1:80,478,790...80,736,244
G
Dpp9
dipeptidylpeptidase 9
increases expression
ISO
zoledronic acid results in increased expression of DPP9 mRNA
CTD
PMID:20977926
NCBI chr17:56,493,674...56,525,927
Ensembl chr17:56,493,807...56,525,905
G
Dse
dermatan sulfate epimerase
increases expression
ISO
zoledronic acid results in increased expression of DSE mRNA
CTD
PMID:24714768
NCBI chr10:34,027,385...34,084,267
Ensembl chr10:34,027,389...34,083,711
G
Dsel
dermatan sulfate epimerase-like
decreases expression
ISO
zoledronic acid results in decreased expression of DSEL mRNA
CTD
PMID:24714768
NCBI chr 1:111,786,431...111,792,782
Ensembl chr 1:111,786,432...111,792,648
G
Dtwd2
DTW domain containing 2
decreases expression
ISO
zoledronic acid results in decreased expression of DTWD2 mRNA
CTD
PMID:20977926
NCBI chr18:49,829,212...49,890,255
Ensembl chr18:49,829,212...49,888,668
G
Dtx3
deltex 3, E3 ubiquitin ligase
increases expression
ISO
zoledronic acid results in increased expression of DTX3 mRNA
CTD
PMID:20977926
NCBI chr10:127,026,242...127,032,367
Ensembl chr10:127,026,247...127,031,597
G
Dusp18
dual specificity phosphatase 18
increases expression
ISO
zoledronic acid results in increased expression of DUSP18 mRNA
CTD
PMID:20977926
NCBI chr11:3,844,940...3,851,299
Ensembl chr11:3,845,240...3,851,296
G
Dusp4
dual specificity phosphatase 4
decreases expression
ISO
zoledronic acid results in decreased expression of DUSP4 mRNA
CTD
PMID:24714768
NCBI chr 8:35,274,448...35,289,106
Ensembl chr 8:35,274,451...35,287,048
G
Dusp5
dual specificity phosphatase 5
decreases expression
ISO
zoledronic acid results in decreased expression of DUSP5 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr19:53,517,576...53,530,240
Ensembl chr19:53,517,540...53,530,862
G
Dusp6
dual specificity phosphatase 6
decreases expression
ISO
zoledronic acid results in decreased expression of DUSP6 mRNA
CTD
PMID:24714768
NCBI chr10:99,098,676...99,103,351
Ensembl chr10:99,099,093...99,103,351
G
Dync2li1
dynein cytoplasmic 2 light intermediate chain 1
decreases expression
ISO
zoledronic acid results in decreased expression of DYNC2LI1 mRNA
CTD
PMID:24714768
NCBI chr17:84,933,903...84,962,996
Ensembl chr17:84,933,924...84,963,016
G
E2f2
E2F transcription factor 2
increases expression
ISO
zoledronic acid results in increased expression of E2F2 mRNA
CTD
PMID:20977926
NCBI chr 4:135,899,585...135,923,368
Ensembl chr 4:135,899,705...135,923,368
G
Ebi3
Epstein-Barr virus induced gene 3
increases expression
ISO
zoledronic acid results in increased expression of EBI3 mRNA
CTD
PMID:24714768
NCBI chr17:56,259,623...56,264,022
Ensembl chr17:56,259,640...56,264,022
G
Ebp
EBP cholestenol delta-isomerase
increases expression
ISO
zoledronic acid results in increased expression of EBP mRNA
CTD
PMID:24714768
NCBI chr X:8,051,568...8,059,751
Ensembl chr X:8,051,568...8,059,751
G
Ece1
endothelin converting enzyme 1
increases expression
ISO
zoledronic acid results in increased expression of ECE1 mRNA
CTD
PMID:24714768
NCBI chr 4:137,589,548...137,692,540
Ensembl chr 4:137,589,548...137,692,540
G
Ech1
enoyl coenzyme A hydratase 1, peroxisomal
decreases expression
EXP
zoledronic acid results in decreased expression of ECH1 mRNA
CTD
PMID:28871336
NCBI chr 7:28,524,763...28,531,664
Ensembl chr 7:28,524,642...28,531,672
G
Ecm1
extracellular matrix protein 1
increases expression
ISO
zoledronic acid results in increased expression of ECM1 mRNA
CTD
PMID:24714768
NCBI chr 3:95,641,459...95,646,880
Ensembl chr 3:95,641,459...95,646,881
G
Edn1
endothelin 1
increases expression
ISO
zoledronic acid results in increased expression of EDN1 mRNA
CTD
PMID:24714768
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Efhd1
EF hand domain containing 1
decreases expression
ISO
zoledronic acid results in decreased expression of EFHD1 mRNA
CTD
PMID:24714768
NCBI chr 1:87,192,075...87,238,563
Ensembl chr 1:87,192,085...87,238,561
G
Efna1
ephrin A1
increases expression
ISO
zoledronic acid results in increased expression of EFNA1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 3:89,179,037...89,188,258
Ensembl chr 3:89,179,040...89,188,449
G
Efnb2
ephrin B2
decreases expression
ISO
zoledronic acid results in decreased expression of EFNB2 mRNA
CTD
PMID:24714768
NCBI chr 8:8,667,235...8,711,242
Ensembl chr 8:8,667,434...8,711,242
G
Egfl6
EGF-like-domain, multiple 6
decreases expression
ISO
zoledronic acid results in decreased expression of EGFL6 mRNA
CTD
PMID:24714768
NCBI chr X:165,306,003...165,368,712
Ensembl chr X:165,306,003...165,368,716
G
Egln2
egl-9 family hypoxia-inducible factor 2
increases expression
ISO
zoledronic acid results in increased expression of EGLN2 mRNA
CTD
PMID:20977926
NCBI chr 7:26,858,083...26,866,227
Ensembl chr 7:26,858,083...26,866,227
G
Egr1
early growth response 1
increases expression decreases expression
ISO
zoledronic acid results in increased expression of EGR1 mRNA zoledronic acid results in decreased expression of EGR1 mRNA
CTD
PMID:20977926 PMID:24714768
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
G
Egr2
early growth response 2
increases expression
ISO
zoledronic acid results in increased expression of EGR2 mRNA
CTD
PMID:20977926
NCBI chr10:67,370,334...67,383,354
Ensembl chr10:67,371,305...67,378,018
G
Egr4
early growth response 4
increases expression
ISO
zoledronic acid results in increased expression of EGR4 mRNA
CTD
PMID:20977926
NCBI chr 6:85,488,103...85,490,571
Ensembl chr 6:85,488,103...85,490,571
G
Ehhadh
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase
decreases expression
EXP
zoledronic acid results in decreased expression of EHHADH mRNA
CTD
PMID:28871336
NCBI chr16:21,580,035...21,606,589
Ensembl chr16:21,580,037...21,606,557
G
Elk1
ELK1, member of ETS oncogene family
increases expression
ISO
zoledronic acid results in increased expression of ELK1 mRNA
CTD
PMID:20977926
NCBI chr X:20,799,634...20,816,847
Ensembl chr X:20,799,634...20,816,847
G
Ell2
elongation factor for RNA polymerase II 2
increases expression
ISO
zoledronic acid results in increased expression of ELL2 mRNA
CTD
PMID:20977926
NCBI chr13:75,855,603...75,920,480
Ensembl chr13:75,854,876...75,920,483
G
Elob
elongin B
decreases expression
ISO
zoledronic acid results in decreased expression of ELOB mRNA
CTD
PMID:24714768
NCBI chr17:24,043,714...24,048,083
Ensembl chr17:24,043,712...24,048,110
G
Elovl6
ELOVL fatty acid elongase 6
increases expression
ISO
zoledronic acid results in increased expression of ELOVL6 mRNA
CTD
PMID:24714768
NCBI chr 3:129,326,035...129,432,144
Ensembl chr 3:129,326,004...129,432,144
G
Eml4
echinoderm microtubule associated protein like 4
increases expression
ISO
zoledronic acid results in increased expression of EML4 mRNA
CTD
PMID:20977926
NCBI chr17:83,658,341...83,787,790
Ensembl chr17:83,658,360...83,787,790
G
Emp3
epithelial membrane protein 3
multiple interactions increases expression
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of EMP3 mRNA zoledronic acid results in increased expression of EMP3 mRNA
CTD
PMID:16996129 PMID:20977926
NCBI chr 7:45,567,447...45,570,850
Ensembl chr 7:45,567,447...45,570,828
G
Enpp6
ectonucleotide pyrophosphatase/phosphodiesterase 6
increases expression
ISO
zoledronic acid results in increased expression of ENPP6 mRNA
CTD
PMID:24714768
NCBI chr 8:47,439,920...47,549,797
Ensembl chr 8:47,439,922...47,549,797
G
Ep400
E1A binding protein p400
decreases expression
ISO
zoledronic acid results in decreased expression of EP400 mRNA
CTD
PMID:25596134
NCBI chr 5:110,812,239...110,918,583
Ensembl chr 5:110,812,239...110,918,583
G
Epha4
Eph receptor A4
increases expression
ISO
zoledronic acid results in increased expression of EPHA4 mRNA
CTD
PMID:24714768
NCBI chr 1:77,343,819...77,491,763
Ensembl chr 1:77,343,822...77,491,725
G
Ephb3
Eph receptor B3
decreases expression
ISO
zoledronic acid results in decreased expression of EPHB3 mRNA
CTD
PMID:24714768
NCBI chr16:21,023,530...21,042,054
Ensembl chr16:21,023,505...21,042,055
G
Ephb4
Eph receptor B4
multiple interactions
ISO
[zoledronic acid co-treated with Gossypol] results in decreased expression of EPHB4 mRNA
CTD
PMID:19825521
NCBI chr 5:137,348,371...137,372,784
Ensembl chr 5:137,348,371...137,376,931
G
Ephx2
epoxide hydrolase 2, cytoplasmic
decreases expression increases expression
ISO
zoledronic acid results in decreased expression of EPHX2 mRNA zoledronic acid results in increased expression of EPHX2 protein
CTD
PMID:24714768 PMID:28871336
NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
G
Eprs1
glutamyl-prolyl-tRNA synthetase 1
decreases expression
ISO
Zoledronic Acid results in decreased expression of EPRS1 mRNA
CTD
PMID:25596134
NCBI chr 1:185,093,614...185,160,557
Ensembl chr 1:185,095,241...185,160,557
G
Epsti1
epithelial stromal interaction 1
increases expression
ISO
zoledronic acid results in increased expression of EPSTI1 mRNA
CTD
PMID:24714768
NCBI chr14:78,141,679...78,240,096
Ensembl chr14:78,141,679...78,240,097
G
Ercc5
excision repair cross-complementing rodent repair deficiency, complementation group 5
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of ERCC5 mRNA
CTD
PMID:16996129
NCBI chr 1:44,184,084...44,220,399
Ensembl chr 1:44,186,904...44,220,420
G
Erg
ETS transcription factor
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of ERG mRNA
CTD
PMID:16996129
NCBI chr16:95,160,028...95,387,452
Ensembl chr16:95,160,028...95,387,452
G
Ergic2
ERGIC and golgi 2
decreases expression
ISO
zoledronic acid results in decreased expression of ERGIC2 mRNA
CTD
PMID:20977926
NCBI chr 6:148,080,816...148,113,886
Ensembl chr 6:148,080,577...148,113,872
G
Erlin1
ER lipid raft associated 1
increases expression
ISO
zoledronic acid results in increased expression of ERLIN1 mRNA
CTD
PMID:20977926
NCBI chr19:44,023,382...44,058,580
Ensembl chr19:44,023,383...44,058,224
G
Ern1
endoplasmic reticulum to nucleus signalling 1
increases expression
ISO
Zoledronic Acid results in increased expression of ERN1 mRNA; Zoledronic Acid results in increased expression of ERN1 protein
CTD
PMID:35587103
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
G
Ero1a
endoplasmic reticulum oxidoreductase 1 alpha
increases expression
ISO
Zoledronic Acid results in increased expression of ERO1A mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr14:45,520,544...45,556,029
Ensembl chr14:45,520,544...45,556,228
G
Erp27
endoplasmic reticulum protein 27
increases expression
ISO
zoledronic acid results in increased expression of ERP27 mRNA
CTD
PMID:24714768
NCBI chr 6:136,884,312...136,899,465
Ensembl chr 6:136,884,309...136,899,178
G
Esco2
establishment of sister chromatid cohesion N-acetyltransferase 2
increases expression
ISO
zoledronic acid results in increased expression of ESCO2 mRNA
CTD
PMID:20977926
NCBI chr14:66,056,476...66,071,418
Ensembl chr14:66,056,487...66,071,443
G
Esrrg
estrogen-related receptor gamma
decreases expression
ISO
zoledronic acid results in decreased expression of ESRRG mRNA
CTD
PMID:24714768
NCBI chr 1:187,340,707...187,947,082
Ensembl chr 1:187,340,988...187,947,082
G
Ets1
E26 avian leukemia oncogene 1, 5' domain
increases expression
ISO
zoledronic acid results in increased expression of ETS1 mRNA
CTD
PMID:24714768
NCBI chr 9:32,547,501...32,669,116
Ensembl chr 9:32,547,517...32,669,116
G
Ets2
E26 avian leukemia oncogene 2, 3' domain
decreases expression
ISO
zoledronic acid results in decreased expression of ETS2 mRNA
CTD
PMID:24714768
NCBI chr16:95,503,274...95,522,093
Ensembl chr16:95,502,942...95,522,095
G
Etv4
ets variant 4
decreases expression
ISO
zoledronic acid results in decreased expression of ETV4 mRNA
CTD
PMID:24714768
NCBI chr11:101,660,573...101,677,963
Ensembl chr11:101,660,568...101,676,197
G
Eva1a
eva-1 homolog A, regulator of programmed cell death
decreases expression
ISO
zoledronic acid results in decreased expression of EVA1A mRNA
CTD
PMID:24714768
NCBI chr 6:82,018,058...82,070,079
Ensembl chr 6:82,018,024...82,070,080
G
Exoc5
exocyst complex component 5
increases expression
ISO
zoledronic acid results in increased expression of EXOC5 mRNA
CTD
PMID:20977926
NCBI chr14:49,249,379...49,304,124
Ensembl chr14:49,241,547...49,304,110
G
Ezr
ezrin
increases expression
ISO
zoledronic acid results in increased expression of EZR mRNA
CTD
PMID:20977926
NCBI chr17:7,005,530...7,050,179
Ensembl chr17:7,005,440...7,050,183
G
F3
coagulation factor III, tissue factor
decreases expression
ISO
zoledronic acid results in decreased expression of F3 mRNA
CTD
PMID:24714768
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
Fabp1
fatty acid binding protein 1, liver
increases expression
ISO
Zoledronic Acid results in increased expression of FABP1 mRNA
CTD
PMID:35587103
NCBI chr 6:71,176,863...71,182,018
Ensembl chr 6:71,176,811...71,182,007
G
Fadd
Fas associated via death domain
multiple interactions
ISO
[Tretinoin co-treated with zoledronic acid] results in increased expression of FADD protein
CTD
PMID:20349282
NCBI chr 7:144,132,060...144,136,178
Ensembl chr 7:144,131,055...144,136,200
G
Fads2
fatty acid desaturase 2
increases expression
ISO
zoledronic acid results in increased expression of FADS2 mRNA
CTD
PMID:24714768
NCBI chr19:10,040,129...10,078,867
Ensembl chr19:10,040,129...10,079,110
G
Fads3
fatty acid desaturase 3
increases expression
ISO
zoledronic acid results in increased expression of FADS3 mRNA
CTD
PMID:20977926
NCBI chr19:10,018,189...10,037,477
Ensembl chr19:10,018,933...10,037,474
G
Fam107a
family with sequence similarity 107, member A
increases expression
ISO
zoledronic acid results in increased expression of FAM107A mRNA
CTD
PMID:24714768
NCBI chr14:14,152,166...14,173,503
Ensembl chr14:14,151,750...14,173,499
G
Fam167a
family with sequence similarity 167, member A
decreases expression
ISO
zoledronic acid results in decreased expression of FAM167A mRNA
CTD
PMID:25596134
NCBI chr14:63,673,843...63,702,951
Ensembl chr14:63,673,843...63,702,947
G
Fam171b
family with sequence similarity 171, member B
decreases expression
ISO
zoledronic acid results in decreased expression of FAM171B mRNA
CTD
PMID:24714768
NCBI chr 2:83,642,889...83,713,878
Ensembl chr 2:83,642,980...83,713,830
G
Fam20a
FAM20A, golgi associated secretory pathway pseudokinase
increases expression
ISO
zoledronic acid results in increased expression of FAM20A mRNA
CTD
PMID:24714768
NCBI chr11:109,563,752...109,613,989
Ensembl chr11:109,560,575...109,613,105
G
Fam222b
family with sequence similarity 222, member B
decreases expression
ISO
zoledronic acid results in decreased expression of FAM222B mRNA
CTD
PMID:20977926
NCBI chr11:77,985,516...78,048,165
Ensembl chr11:77,985,486...78,047,526
G
Fam43a
family with sequence similarity 43, member A
decreases expression
ISO
zoledronic acid results in decreased expression of FAM43A mRNA
CTD
PMID:24714768
NCBI chr16:30,418,541...30,421,615
Ensembl chr16:30,418,541...30,421,615
G
Fas
Fas cell surface death receptor
increases expression multiple interactions
ISO
zoledronic acid results in increased expression of FAS mRNA [Tretinoin co-treated with zoledronic acid] results in increased expression of FAS protein
CTD
PMID:19036117 PMID:20349282 PMID:25596134
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fasl
Fas ligand
affects expression
ISO
zoledronic acid affects the expression of FASLG mRNA
CTD
PMID:19036117
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
G
Fblim1
filamin binding LIM protein 1
decreases expression
ISO
zoledronic acid results in decreased expression of FBLIM1 protein
CTD
PMID:28871336
NCBI chr 4:141,303,373...141,333,351
Ensembl chr 4:141,303,373...141,333,407
G
Fbln1
fibulin 1
increases expression
ISO
zoledronic acid results in increased expression of FBLN1 mRNA; zoledronic acid results in increased expression of FBLN1 protein
CTD
PMID:24714768 PMID:28871336
NCBI chr15:85,090,150...85,170,495
Ensembl chr15:85,090,150...85,170,736
G
Fbln5
fibulin 5
increases expression
ISO
zoledronic acid results in increased expression of FBLN5 mRNA
CTD
PMID:24714768
NCBI chr12:101,712,820...101,785,541
Ensembl chr12:101,712,824...101,785,314
G
Fbn1
fibrillin 1
increases expression
ISO
zoledronic acid results in increased expression of FBN1 mRNA
CTD
PMID:20977926 PMID:24714768
NCBI chr 2:125,142,514...125,348,417
Ensembl chr 2:125,142,514...125,349,913
G
Fcgbp
Fc fragment of IgG binding protein
increases expression
ISO
zoledronic acid results in increased expression of FCGBP mRNA
CTD
PMID:24714768
NCBI chr 7:27,770,661...27,820,289
Ensembl chr 7:27,770,661...27,820,287
G
Fcgrt
Fc fragment of IgG receptor and transporter
decreases expression
ISO
zoledronic acid results in decreased expression of FCGRT mRNA
CTD
PMID:24714768
NCBI chr 7:44,742,417...44,753,246
Ensembl chr 7:44,742,414...44,753,275
G
Fcmr
Fc fragment of IgM receptor
increases expression
ISO
zoledronic acid results in increased expression of FCMR mRNA
CTD
PMID:24714768
NCBI chr 1:130,793,514...130,808,528
Ensembl chr 1:130,793,406...130,808,528
G
Fcrl2
Fc receptor like 2
increases expression
ISO
zoledronic acid results in increased expression of FCRL2 mRNA
CTD
PMID:24714768
NCBI chr 3:87,158,318...87,171,046
Ensembl chr 3:87,158,065...87,171,045
G
Fcrla
Fc receptor-like A
increases expression
ISO
zoledronic acid results in increased expression of FCRLA mRNA
CTD
PMID:24714768
NCBI chr 1:170,745,163...170,755,169
Ensembl chr 1:170,745,145...170,755,152
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
multiple interactions increases expression
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of FDFT1 mRNA zoledronic acid results in increased expression of FDFT1 mRNA
CTD
PMID:16996129 PMID:18325729
NCBI chr14:63,382,599...63,419,136
Ensembl chr14:63,382,599...63,417,027
G
Fdps
farnesyl diphosphate synthetase
affects binding decreases activity multiple interactions increases activity increases expression
ISO
zoledronic acid binds to FDPS protein zoledronic acid results in decreased activity of FDPS protein [zoledronic acid results in decreased activity of FDPS protein] which results in increased abundance of isopentenyl pyrophosphate zoledronic acid results in increased activity of FDPS protein zoledronic acid results in increased expression of FDPS mRNA
CTD
PMID:11160603 PMID:12846887 PMID:16684881 PMID:17208200 PMID:18325729 PMID:19621390 PMID:19699819 PMID:24714768 More...
NCBI chr 3:89,000,895...89,009,274
Ensembl chr 3:89,000,895...89,009,266
G
Fech
ferrochelatase
decreases expression
ISO
zoledronic acid results in decreased expression of FECH mRNA
CTD
PMID:24714768
NCBI chr18:64,589,613...64,622,169
Ensembl chr18:64,585,985...64,623,322
G
Fem1b
fem 1 homolog b
increases expression
ISO
zoledronic acid results in increased expression of FEM1B mRNA
CTD
PMID:20977926
NCBI chr 9:62,699,106...62,718,930
Ensembl chr 9:62,699,103...62,719,216
G
Fez1
fasciculation and elongation protein zeta 1
increases expression
ISO
zoledronic acid results in increased expression of FEZ1 mRNA
CTD
PMID:24714768
NCBI chr 9:36,732,694...36,790,220
Ensembl chr 9:36,733,160...36,790,220
G
Fgf18
fibroblast growth factor 18
increases expression
ISO
zoledronic acid results in increased expression of FGF18 mRNA
CTD
PMID:24714768
NCBI chr11:33,066,970...33,097,400
Ensembl chr11:33,067,430...33,097,400
G
Fgf2
fibroblast growth factor 2
decreases expression multiple interactions
ISO
zoledronic acid results in decreased expression of FGF2 mRNA zoledronic acid promotes the reaction [Gossypol results in decreased expression of FGF2 mRNA]
CTD
PMID:19825521 PMID:24714768
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
G
Fgf9
fibroblast growth factor 9
decreases expression
ISO
zoledronic acid results in decreased expression of FGF9 mRNA
CTD
PMID:24714768
NCBI chr14:58,308,543...58,350,311
Ensembl chr14:58,308,004...58,350,177
G
Fgfbp1
fibroblast growth factor binding protein 1
increases expression
ISO
zoledronic acid results in increased expression of FGFBP1 mRNA
CTD
PMID:24714768
NCBI chr 5:44,136,200...44,139,173
Ensembl chr 5:44,136,200...44,139,121
G
Fgfr3
fibroblast growth factor receptor 3
multiple interactions decreases expression
ISO
zoledronic acid promotes the reaction [Gossypol results in decreased expression of FGFR3 mRNA] zoledronic acid results in decreased expression of FGFR3 mRNA
CTD
PMID:19825521 PMID:24714768
NCBI chr 5:33,879,068...33,894,412
Ensembl chr 5:33,879,018...33,894,412
G
Fgfr4
fibroblast growth factor receptor 4
decreases expression
ISO
zoledronic acid results in decreased expression of FGFR4 mRNA
CTD
PMID:24714768
NCBI chr13:55,300,631...55,316,572
Ensembl chr13:55,300,453...55,316,572
G
Fgl2
fibrinogen-like protein 2
decreases expression
ISO
zoledronic acid results in decreased expression of FGL2 mRNA
CTD
PMID:24714768
NCBI chr 5:21,577,671...21,583,384
Ensembl chr 5:21,577,640...21,583,372
G
Fhl1
four and a half LIM domains 1
increases expression
ISO
zoledronic acid results in increased expression of FHL1 mRNA
CTD
PMID:20977926
NCBI chr X:55,776,569...55,838,704
Ensembl chr X:55,777,147...55,838,706
G
Fhl2
four and a half LIM domains 2
decreases expression
ISO
zoledronic acid results in decreased expression of FHL2 mRNA
CTD
PMID:24714768
NCBI chr 1:43,162,233...43,237,501
Ensembl chr 1:43,162,234...43,236,144
G
Fignl1
fidgetin-like 1
increases expression
ISO
zoledronic acid results in increased expression of FIGNL1 mRNA
CTD
PMID:20977926
NCBI chr11:11,737,429...11,758,962
Ensembl chr11:11,737,431...11,758,962
G
Filip1l
filamin A interacting protein 1-like
decreases expression
ISO
zoledronic acid results in decreased expression of FILIP1L mRNA
CTD
PMID:24714768
NCBI chr16:57,173,376...57,393,167
Ensembl chr16:57,173,456...57,393,489
G
Fjx1
four jointed box 1
decreases expression
ISO
zoledronic acid results in decreased expression of FJX1 mRNA
CTD
PMID:24714768
NCBI chr 2:102,279,711...102,282,137
Ensembl chr 2:102,279,711...102,282,844
G
Fkbp1a
FK506 binding protein 1a
increases expression
ISO
zoledronic acid results in increased expression of FKBP1A mRNA
CTD
PMID:24714768
NCBI chr 2:151,384,403...151,403,611
Ensembl chr 2:151,384,403...151,403,612
G
Fmnl3
formin-like 3
increases expression
ISO
zoledronic acid results in increased expression of FMNL3 mRNA
CTD
PMID:24714768
NCBI chr15:99,215,091...99,268,375
Ensembl chr15:99,215,106...99,268,363
G
Fn1
fibronectin 1
multiple interactions increases expression
ISO EXP
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [zoledronic acid results in increased expression of FN1 protein] zoledronic acid results in increased expression of FN1 mRNA; zoledronic acid results in increased expression of FN1 protein Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of FN1 protein]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of FN1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of FN1 protein]
CTD
PMID:28871336
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
G
Fnbp1
formin binding protein 1
increases expression
ISO
zoledronic acid results in increased expression of FNBP1 mRNA
CTD
PMID:24714768
NCBI chr 2:30,916,218...31,032,046
Ensembl chr 2:30,916,218...31,032,020
G
Fnta
farnesyltransferase, CAAX box, alpha
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of FNTA mRNA
CTD
PMID:16996129
NCBI chr 8:26,488,716...26,505,638
Ensembl chr 8:26,488,750...26,505,678
G
Folr1
folate receptor alpha
decreases expression
ISO
zoledronic acid results in decreased expression of FOLR1 mRNA
CTD
PMID:24714768
NCBI chr 7:101,507,551...101,519,974
Ensembl chr 7:101,507,538...101,519,995
G
Fos
FBJ osteosarcoma oncogene
decreases expression multiple interactions
ISO EXP
zoledronic acid results in decreased expression of FOS mRNA zoledronic acid results in decreased expression of FOS protein zoledronic acid inhibits the reaction [Freund's Adjuvant results in increased expression of FOS protein]
CTD
PMID:16769263 PMID:17323179 PMID:24714768
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Foxj1
forkhead box J1
decreases expression
ISO
zoledronic acid results in decreased expression of FOXJ1 mRNA
CTD
PMID:24714768
NCBI chr11:116,221,530...116,226,331
Ensembl chr11:116,221,530...116,226,225
G
Foxo1
forkhead box O1
decreases expression
ISO
zoledronic acid results in decreased expression of FOXO1 mRNA
CTD
PMID:24714768
NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642
G
Frem2
Fras1 related extracellular matrix protein 2
decreases expression
ISO
zoledronic acid results in decreased expression of FREM2 mRNA
CTD
PMID:25596134
NCBI chr 3:53,421,359...53,566,014
Ensembl chr 3:53,421,359...53,564,776
G
Frk
fyn-related kinase
increases expression
ISO
zoledronic acid results in increased expression of FRK mRNA
CTD
PMID:24714768
NCBI chr10:34,359,396...34,487,530
Ensembl chr10:34,359,395...34,487,274
G
Fscn1
fascin actin-bundling protein 1
increases expression
ISO
zoledronic acid results in increased expression of FSCN1 mRNA
CTD
PMID:20977926
NCBI chr 5:142,946,110...142,958,944
Ensembl chr 5:142,946,098...142,958,940
G
Fsd1l
fibronectin type III and SPRY domain containing 1-like
increases expression
ISO
zoledronic acid results in increased expression of FSD1L mRNA
CTD
PMID:24714768
NCBI chr 4:53,631,383...53,707,009
Ensembl chr 4:53,631,471...53,707,009
G
Fstl1
follistatin-like 1
increases expression
ISO
zoledronic acid results in increased expression of FSTL1 mRNA
CTD
PMID:24714768
NCBI chr16:37,597,417...37,656,878
Ensembl chr16:37,597,235...37,656,876
G
Fstl3
follistatin-like 3
decreases expression
ISO
zoledronic acid results in decreased expression of FSTL3 mRNA
CTD
PMID:24714768
NCBI chr10:79,613,108...79,618,464
Ensembl chr10:79,613,106...79,618,464
G
Fth1
ferritin heavy polypeptide 1
increases expression
ISO
zoledronic acid results in increased expression of FTH1 mRNA
CTD
PMID:25596134
NCBI chr19:9,957,964...9,962,475
Ensembl chr19:9,957,962...9,962,462
G
Fuca1
fucosidase, alpha-L- 1, tissue
increases expression
ISO
zoledronic acid results in increased expression of FUCA1 mRNA
CTD
PMID:24714768
NCBI chr 4:135,648,037...135,667,611
Ensembl chr 4:135,648,046...135,667,622
G
Fut8
fucosyltransferase 8
increases expression
ISO
zoledronic acid results in increased expression of FUT8 mRNA
CTD
PMID:24714768
NCBI chr12:77,284,878...77,522,770
Ensembl chr12:77,284,899...77,523,112
G
Fxyd2
FXYD domain-containing ion transport regulator 2
decreases expression
ISO
zoledronic acid results in decreased expression of FXYD2 mRNA
CTD
PMID:24714768
NCBI chr 9:45,311,007...45,321,576
Ensembl chr 9:45,310,967...45,321,576
G
Fyb1
FYN binding protein 1
decreases expression
ISO
zoledronic acid results in decreased expression of FYB1 mRNA
CTD
PMID:24714768
NCBI chr15:6,552,280...6,695,089
Ensembl chr15:6,552,334...6,692,794
G
Fzd5
frizzled class receptor 5
increases expression
ISO
zoledronic acid results in increased expression of FZD5 mRNA
CTD
PMID:24714768
NCBI chr 1:64,769,717...64,776,907
Ensembl chr 1:64,769,717...64,776,910
G
Gabarapl1
GABA type A receptor associated protein like 1
decreases expression
ISO
zoledronic acid results in decreased expression of GABARAPL1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 6:129,510,155...129,519,294
Ensembl chr 6:129,510,123...129,519,309
G
Gabrp
gamma-aminobutyric acid type A receptor subunit pi
decreases expression
ISO
zoledronic acid results in decreased expression of GABRP mRNA
CTD
PMID:24714768
NCBI chr11:33,500,781...33,528,978
Ensembl chr11:33,500,781...33,528,959
G
Gadd45a
growth arrest and DNA-damage-inducible 45 alpha
decreases expression
ISO
zoledronic acid results in decreased expression of GADD45A mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
G
Gadd45b
growth arrest and DNA-damage-inducible 45 beta
multiple interactions increases expression
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of GADD45B mRNA zoledronic acid results in increased expression of GADD45B mRNA
CTD
PMID:16996129 PMID:20977926
NCBI chr10:80,765,925...80,768,038
Ensembl chr10:80,765,907...80,768,038
G
Gadd45g
growth arrest and DNA-damage-inducible 45 gamma
increases expression
ISO
zoledronic acid results in increased expression of GADD45G mRNA
CTD
PMID:24714768
NCBI chr13:52,000,711...52,002,511
Ensembl chr13:52,000,714...52,002,504
G
Galnt10
polypeptide N-acetylgalactosaminyltransferase 10
decreases expression
ISO
zoledronic acid results in decreased expression of GALNT10 mRNA
CTD
PMID:24714768
NCBI chr11:57,536,268...57,678,327
Ensembl chr11:57,536,268...57,678,340
G
Galnt11
polypeptide N-acetylgalactosaminyltransferase 11
decreases expression
ISO
zoledronic acid results in decreased expression of GALNT11 mRNA
CTD
PMID:24714768
NCBI chr 5:25,427,732...25,470,916
Ensembl chr 5:25,426,902...25,470,916
G
Galnt16
polypeptide N-acetylgalactosaminyltransferase 16
decreases expression
ISO
zoledronic acid results in decreased expression of GALNT16 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr12:80,565,245...80,650,672
Ensembl chr12:80,565,051...80,677,746
G
Galnt18
polypeptide N-acetylgalactosaminyltransferase 18
increases expression
ISO
Zoledronic Acid results in increased expression of GALNT18 mRNA
CTD
PMID:24714768
NCBI chr 7:111,070,863...111,379,274
Ensembl chr 7:111,070,868...111,379,184
G
Gbp2
guanylate binding protein 2
increases expression
ISO
zoledronic acid results in increased expression of GBP2 mRNA
CTD
PMID:24714768
NCBI chr 3:142,326,424...142,343,769
Ensembl chr 3:142,326,363...142,343,769
G
Gbp3
guanylate binding protein 3
increases expression
ISO
zoledronic acid results in increased expression of GBP4 mRNA
CTD
PMID:24714768
NCBI chr 3:142,265,781...142,278,974
Ensembl chr 3:142,265,787...142,278,970
G
Gbp5
guanylate binding protein 5
increases expression
ISO
zoledronic acid results in increased expression of GBP5 mRNA
CTD
PMID:24714768
NCBI chr 3:142,202,695...142,228,105
Ensembl chr 3:142,199,739...142,228,105
G
Gc
vitamin D binding protein
increases expression
ISO
zoledronic acid results in increased expression of GC protein
CTD
PMID:28871336
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
G
Gcnt1
glucosaminyl (N-acetyl) transferase 1, core 2
decreases expression
ISO
zoledronic acid results in decreased expression of GCNT1 mRNA
CTD
PMID:24714768
NCBI chr19:17,303,505...17,350,208
Ensembl chr19:17,303,505...17,350,208
G
Gcnt3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
ISO
zoledronic acid results in increased expression of GCNT3 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 9:69,938,777...69,947,172
Ensembl chr 9:69,938,778...69,945,370
G
Gdf15
growth differentiation factor 15
decreases expression
ISO
zoledronic acid results in decreased expression of GDF15 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106
G
Gdi2
GDP dissociation inhibitor 2
increases expression
ISO
zoledronic acid results in increased expression of GDI2 protein
CTD
PMID:28871336
NCBI chr13:3,588,075...3,616,261
Ensembl chr13:3,588,063...3,617,871
G
Gem
GTP binding protein overexpressed in skeletal muscle
decreases expression
ISO
zoledronic acid results in decreased expression of GEM mRNA
CTD
PMID:24714768
NCBI chr 4:11,702,379...11,714,993
Ensembl chr 4:11,704,457...11,714,752
G
Ggps1
geranylgeranyl diphosphate synthase 1
decreases activity
ISO
zoledronic acid results in decreased activity of GGPS1 protein
CTD
PMID:17208200
NCBI chr13:14,224,375...14,238,319
Ensembl chr13:14,225,244...14,238,073
G
Ggt1
gamma-glutamyltransferase 1
decreases expression
ISO
zoledronic acid results in decreased expression of GGT1 mRNA
CTD
PMID:24714768
NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
G
Gins2
GINS complex subunit 2
decreases expression
ISO
zoledronic acid results in decreased expression of GINS2 mRNA
CTD
PMID:24714768
NCBI chr 8:121,308,005...121,315,814
Ensembl chr 8:121,305,372...121,316,043
G
Gjb1
gap junction protein, beta 1
decreases expression
ISO
zoledronic acid results in decreased expression of GJB1 mRNA
CTD
PMID:24714768
NCBI chr X:100,419,982...100,429,235
Ensembl chr X:100,419,984...100,429,235
G
Gjb2
gap junction protein, beta 2
increases expression
ISO
zoledronic acid results in increased expression of GJB2 mRNA
CTD
PMID:24714768
NCBI chr14:57,336,059...57,342,159
Ensembl chr14:57,336,057...57,342,159
G
Gk
glycerol kinase
increases expression
ISO
zoledronic acid results in increased expression of GK mRNA
CTD
PMID:20977926
NCBI chr X:84,745,543...84,820,425
Ensembl chr X:84,745,543...84,820,425
G
Gla
galactosidase, alpha
decreases expression
ISO
zoledronic acid results in decreased expression of GLA protein
CTD
PMID:28871336
NCBI chr X:133,488,912...133,501,707
Ensembl chr X:133,488,898...133,501,874
G
Glce
glucuronyl C5-epimerase
increases expression
ISO
zoledronic acid results in increased expression of GLCE mRNA
CTD
PMID:24714768
NCBI chr 9:61,964,526...62,029,891
Ensembl chr 9:61,964,530...62,029,937
G
Glg1
golgi apparatus protein 1
decreases expression
ISO
zoledronic acid results in decreased expression of GLG1 mRNA
CTD
PMID:20977926
NCBI chr 8:111,879,916...111,985,842
Ensembl chr 8:111,881,053...111,985,848
G
Glipr1
GLI pathogenesis related 1
decreases expression
ISO
zoledronic acid results in decreased expression of GLIPR1 mRNA
CTD
PMID:20977926
NCBI chr10:111,821,353...111,838,539
Ensembl chr10:111,821,353...111,838,536
G
Glrx3
glutaredoxin 3
decreases expression
ISO
zoledronic acid results in decreased expression of GLRX3 mRNA
CTD
PMID:20977926
NCBI chr 7:137,039,302...137,071,360
Ensembl chr 7:137,039,343...137,070,323
G
Gm11992
predicted gene 11992
decreases expression
ISO
zoledronic acid results in decreased expression of C7ORF57 mRNA
CTD
PMID:24714768
NCBI chr11:8,998,592...9,019,354
Ensembl chr11:8,998,594...9,019,356
G
Gm13377
predicted gene 13377
decreases expression
ISO
zoledronic acid results in decreased expression of PRTFDC1 mRNA
CTD
PMID:24714768
NCBI chr 2:21,049,620...21,144,493
Ensembl chr 2:21,049,619...21,146,765
G
Gm14137
predicted gene 14137
increases expression
ISO
zoledronic acid results in increased expression of C15ORF62 mRNA
CTD
PMID:24714768
NCBI chr 2:119,004,990...119,008,049
Ensembl chr 2:119,004,990...119,008,056
G
Gm14305
predicted gene 14305
increases expression
ISO
Zoledronic Acid results in increased expression of ZNF74 mRNA
CTD
PMID:20977926
NCBI chr 2:176,400,146...176,413,606
Ensembl chr 2:176,400,121...176,413,606
G
Gm35938
predicted gene, 35938
increases expression
ISO
zoledronic acid results in increased expression of HHLA2 mRNA
CTD
PMID:24714768
NCBI chr16:49,384,216...49,387,359
G
Gm38656
predicted gene, 38656
increases expression
ISO
Zoledronic Acid results in increased expression of SCGB1D2 mRNA
CTD
PMID:24714768
NCBI chr19:9,162,589...9,164,383
G
Gm40318
predicted gene, 40318
decreases expression
ISO
Zoledronic Acid results in decreased expression of S100P protein
CTD
PMID:28871336
NCBI chr 5:36,919,848...36,924,763
Ensembl chr 5:36,919,961...36,924,039
G
Gm49817
predicted gene, 49817
increases expression
ISO
Zoledronic Acid results in increased expression of PLEKHG7 mRNA
CTD
PMID:24714768
NCBI chr10:95,888,057...95,962,580
G
Gm7030
predicted gene 7030
increases expression
ISO
Zoledronic Acid results in increased expression of HLA-F mRNA
CTD
PMID:24714768
NCBI chr17:36,438,501...36,440,317
Ensembl chr17:36,420,611...36,440,317
G
Gnb2
guanine nucleotide binding protein (G protein), beta 2
increases expression
ISO
zoledronic acid results in increased expression of GNB2 protein
CTD
PMID:28871336
NCBI chr 5:137,526,389...137,533,085
Ensembl chr 5:137,526,389...137,531,772
G
Gnb4
guanine nucleotide binding protein (G protein), beta 4
increases expression
ISO
zoledronic acid results in increased expression of GNB4 mRNA
CTD
PMID:20977926
NCBI chr 3:32,632,736...32,670,813
Ensembl chr 3:32,634,481...32,670,734
G
Gng10
guanine nucleotide binding protein (G protein), gamma 10
increases expression
ISO
zoledronic acid results in increased expression of GNG10 protein
CTD
PMID:28871336
NCBI chr 4:59,035,156...59,041,899
Ensembl chr 4:59,035,088...59,041,903
G
Gng7
guanine nucleotide binding protein (G protein), gamma 7
decreases expression
ISO
zoledronic acid results in decreased expression of GNG7 mRNA
CTD
PMID:24714768
NCBI chr10:80,784,463...80,850,742
Ensembl chr10:80,784,458...80,850,779
G
Golt1a
golgi transport 1A
decreases expression
ISO
zoledronic acid results in decreased expression of GOLT1A mRNA
CTD
PMID:24714768
NCBI chr 1:133,237,561...133,250,764
Ensembl chr 1:133,237,538...133,250,764 Ensembl chr 1:133,237,538...133,250,764
G
Got1
glutamic-oxaloacetic transaminase 1, soluble
increases expression
ISO
zoledronic acid results in increased expression of GOT1 mRNA
CTD
PMID:25596134
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
G
Gpc3
glypican 3
decreases expression
ISO
zoledronic acid results in decreased expression of GPC3 mRNA
CTD
PMID:24714768
NCBI chr X:51,361,303...51,702,851
Ensembl chr X:51,361,303...51,702,827
G
Gpc4
glypican 4
decreases expression
ISO
zoledronic acid results in decreased expression of GPC4 mRNA
CTD
PMID:24714768
NCBI chr X:51,139,884...51,253,800
Ensembl chr X:51,141,898...51,254,129
G
Gpnmb
glycoprotein (transmembrane) nmb
decreases expression
ISO
zoledronic acid results in decreased expression of GPNMB mRNA
CTD
PMID:24714768
NCBI chr 6:49,013,449...49,044,413
Ensembl chr 6:49,013,480...49,047,863
G
Gpr141
G protein-coupled receptor 141
increases expression
ISO
zoledronic acid results in increased expression of GPR141 mRNA
CTD
PMID:24714768
NCBI chr13:19,933,850...20,008,499
Ensembl chr13:19,933,852...20,008,427
G
Gpr37l1
G protein-coupled receptor 37-like 1
increases expression
ISO
zoledronic acid results in increased expression of GPR37L1 mRNA
CTD
PMID:24714768
NCBI chr 1:135,087,988...135,095,419
Ensembl chr 1:135,087,972...135,095,419
G
Gprc5a
G protein-coupled receptor, family C, group 5, member A
decreases expression
ISO
zoledronic acid results in decreased expression of GPRC5A mRNA
CTD
PMID:24714768
NCBI chr 6:135,042,660...135,061,707
Ensembl chr 6:135,042,649...135,061,707
G
Grb14
growth factor receptor bound protein 14
decreases expression
ISO
zoledronic acid results in decreased expression of GRB14 mRNA
CTD
PMID:24714768
NCBI chr 2:64,742,820...64,853,143
Ensembl chr 2:64,742,820...64,855,331
G
Grip2
glutamate receptor interacting protein 2
increases expression
ISO
zoledronic acid results in increased expression of GRIP2 mRNA
CTD
PMID:24714768
NCBI chr 6:91,738,433...91,820,884
Ensembl chr 6:91,738,490...91,804,231
G
Grk5
G protein-coupled receptor kinase 5
increases expression
ISO
zoledronic acid results in increased expression of GRK5 mRNA
CTD
PMID:24714768
NCBI chr19:60,877,995...61,084,406
Ensembl chr19:60,878,187...61,084,406
G
Grm8
glutamate receptor, metabotropic 8
decreases expression
ISO
zoledronic acid results in decreased expression of GRM8 mRNA
CTD
PMID:24714768
NCBI chr 6:27,275,120...28,135,094
Ensembl chr 6:27,275,118...28,135,177
G
Gtf2i
general transcription factor II I
increases expression
ISO
zoledronic acid results in increased expression of GTF2I mRNA
CTD
PMID:20977926
NCBI chr 5:134,266,686...134,346,571
Ensembl chr 5:134,266,688...134,343,614
G
Gtf2ird1
general transcription factor II I repeat domain-containing 1
decreases expression
ISO
zoledronic acid results in decreased expression of GTF2IRD1 mRNA
CTD
PMID:24714768
NCBI chr 5:134,386,515...134,485,628
Ensembl chr 5:134,386,510...134,485,570
G
Gtf3c4
general transcription factor IIIC, polypeptide 4
increases expression
ISO
zoledronic acid results in increased expression of GTF3C4 mRNA
CTD
PMID:20977926
NCBI chr 2:28,712,311...28,730,628
Ensembl chr 2:28,712,311...28,730,372
G
Gtpbp2
GTP binding protein 2
increases expression
ISO
zoledronic acid results in increased expression of GTPBP2 mRNA
CTD
PMID:20977926
NCBI chr17:46,470,153...46,480,294
Ensembl chr17:46,471,958...46,480,296
G
Gzmb
granzyme B
affects expression multiple interactions
ISO
zoledronic acid affects the expression of GZMB mRNA IL2 protein affects the reaction [zoledronic acid affects the expression of GZMB mRNA]
CTD
PMID:19446661
NCBI chr14:56,496,293...56,499,791
Ensembl chr14:56,496,295...56,499,717
G
H1f2
H1.2 linker histone, cluster member
increases expression
ISO
Zoledronic Acid results in increased expression of H1-2 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr13:23,922,790...23,923,514
Ensembl chr13:23,922,791...23,924,350
G
H2-DMa
histocompatibility 2, class II, locus DMa
increases expression
ISO
zoledronic acid results in increased expression of HLA-DMA mRNA
CTD
PMID:24714768
NCBI chr17:34,338,667...34,358,075
Ensembl chr17:34,338,515...34,358,075
G
H2-DMb1
histocompatibility 2, class II, locus Mb1
increases expression
ISO
Zoledronic Acid results in increased expression of HLA-DMB mRNA
CTD
PMID:24714768
NCBI chr17:34,372,165...34,379,203
Ensembl chr17:34,372,046...34,379,204
G
H2-Ea
histocompatibility 2, class II antigen E alpha
increases expression
ISO
zoledronic acid results in increased expression of HLA-DRA mRNA
CTD
PMID:24714768
NCBI chr17:34,560,926...34,563,619
Ensembl chr17:34,560,926...34,563,618
G
H2-Eb1
histocompatibility 2, class II antigen E beta
increases expression
ISO
zoledronic acid results in increased expression of HLA-DRB1 mRNA
CTD
PMID:24714768
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
G
H2-Q1
histocompatibility 2, Q region locus 1
increases expression
ISO
zoledronic acid results in increased expression of HLA-A mRNA
CTD
PMID:24714768
NCBI chr17:35,539,503...35,547,118
Ensembl chr17:35,539,381...35,544,075
G
H2-T23
histocompatibility 2, T region locus 23
increases expression
ISO
zoledronic acid results in increased expression of HLA-E mRNA
CTD
PMID:24714768
NCBI chr17:36,340,869...36,343,593
Ensembl chr17:36,340,665...36,343,747
G
H2ac18
H2A clustered histone 18
increases expression
ISO
Zoledronic Acid results in increased expression of H2AC18 mRNA
CTD
PMID:24714768
NCBI chr 3:96,152,853...96,153,439
Ensembl chr 3:96,152,813...96,153,398
G
H2ac20
H2A clustered histone 20
increases expression
ISO
Zoledronic Acid results in increased expression of H2AC20 mRNA
CTD
PMID:24714768
NCBI chr 3:96,127,728...96,128,209
Ensembl chr 3:96,127,677...96,128,196
G
H2ax
H2A.X variant histone
increases expression
ISO
Zoledronic Acid results in increased expression of H2AX mRNA
CTD
PMID:20977926
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
G
H2bc12
H2B clustered histone 12
increases expression
ISO
Zoledronic Acid results in increased expression of H2BC12 mRNA
CTD
PMID:24714768
NCBI chr13:22,219,991...22,220,490
Ensembl chr13:22,220,040...22,220,515
G
H2bc14
H2B clustered histone 14
increases expression
ISO
Zoledronic Acid results in increased expression of H2BC5 mRNA
CTD
PMID:24714768
NCBI chr13:21,906,214...21,906,696
Ensembl chr13:21,906,214...21,906,737
G
H4c12
H4 clustered histone 12
increases expression
ISO
Zoledronic Acid results in increased expression of H4C8 mRNA
CTD
PMID:24714768
NCBI chr13:21,934,315...21,934,723
Ensembl chr13:21,934,364...21,934,675
G
H4c14
H4 clustered histone 14
decreases expression
ISO
Zoledronic Acid results in decreased expression of H4C3 mRNA
CTD
PMID:20977926
NCBI chr 3:96,170,250...96,170,633
Ensembl chr 3:96,168,998...96,170,627
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
decreases expression
EXP
zoledronic acid results in decreased expression of HADHA mRNA
CTD
PMID:28871336
NCBI chr 5:30,324,421...30,359,978
Ensembl chr 5:30,323,302...30,360,160
G
Hapln3
hyaluronan and proteoglycan link protein 3
increases expression
ISO
zoledronic acid results in increased expression of HAPLN3 mRNA
CTD
PMID:24714768
NCBI chr 7:78,766,775...78,783,100
Ensembl chr 7:78,764,850...78,780,766
G
Havcr1
hepatitis A virus cellular receptor 1
increases expression
ISO EXP
zoledronic acid results in increased expression of HAVCR1 mRNA
CTD
PMID:28871336
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
G
Hdac9
histone deacetylase 9
increases expression
ISO
zoledronic acid results in increased expression of HDAC9 mRNA
CTD
PMID:24714768
NCBI chr12:34,097,579...34,967,094
Ensembl chr12:34,097,579...34,967,094
G
Hdgf
heparin binding growth factor
increases expression
ISO
zoledronic acid results in increased expression of HDGF mRNA
CTD
PMID:24714768
NCBI chr 3:87,813,844...87,823,439
Ensembl chr 3:87,813,628...87,823,439
G
Heg1
heart development protein with EGF-like domains 1
increases expression
ISO
zoledronic acid results in increased expression of HEG1 mRNA
CTD
PMID:24714768
NCBI chr16:33,504,754...33,591,946
Ensembl chr16:33,504,740...33,591,946
G
Herc4
hect domain and RLD 4
decreases expression
ISO
zoledronic acid results in decreased expression of HERC4 mRNA
CTD
PMID:20977926
NCBI chr10:63,079,122...63,153,660
Ensembl chr10:63,079,589...63,153,657
G
Hes1
hes family bHLH transcription factor 1
decreases expression
ISO
zoledronic acid results in decreased expression of HES1 mRNA
CTD
PMID:24714768
NCBI chr16:29,883,259...29,886,614
Ensembl chr16:29,883,202...29,886,614
G
Hes2
hes family bHLH transcription factor 2
decreases expression
ISO
zoledronic acid results in decreased expression of HES2 mRNA
CTD
PMID:24714768
NCBI chr 4:152,243,324...152,246,926
Ensembl chr 4:152,243,324...152,246,926
G
Hgd
homogentisate 1, 2-dioxygenase
decreases expression
ISO
zoledronic acid results in decreased expression of HGD mRNA
CTD
PMID:24714768
NCBI chr16:37,400,104...37,452,388
Ensembl chr16:37,400,515...37,452,382
G
Hif1a
hypoxia inducible factor 1, alpha subunit
multiple interactions
ISO
zoledronic acid inhibits the reaction [Dopamine results in decreased expression of HIF1A protein]
CTD
PMID:25818600
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Hint2
histidine triad nucleotide binding protein 2
increases expression
ISO
zoledronic acid results in increased expression of HINT2 protein
CTD
PMID:28871336
NCBI chr 4:43,654,227...43,656,445
Ensembl chr 4:43,654,227...43,656,466
G
Hlf
hepatic leukemia factor
decreases expression
ISO
zoledronic acid results in decreased expression of HLF mRNA
CTD
PMID:24714768
NCBI chr11:90,227,361...90,281,745
Ensembl chr11:90,227,362...90,281,721
G
Hmcn1
hemicentin 1
decreases expression
ISO
zoledronic acid results in decreased expression of HMCN1 mRNA
CTD
PMID:24714768
NCBI chr 1:150,438,251...150,869,568
Ensembl chr 1:150,438,275...150,869,186
G
Hmgb3
high mobility group box 3
increases expression
ISO
zoledronic acid results in increased expression of HMGB3 mRNA
CTD
PMID:24714768
NCBI chr X:70,599,523...70,604,261
Ensembl chr X:70,599,524...70,604,282
G
Hmgcs1
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
increases expression
ISO
zoledronic acid results in increased expression of HMGCS1 mRNA
CTD
PMID:24714768
NCBI chr13:120,151,887...120,169,796
Ensembl chr13:120,151,915...120,169,796
G
Hmmr
hyaluronan mediated motility receptor (RHAMM)
decreases expression
ISO
zoledronic acid results in decreased expression of HMMR mRNA
CTD
PMID:24714768
NCBI chr11:40,592,215...40,624,290
Ensembl chr11:40,592,222...40,624,249
G
Hmox1
heme oxygenase 1
decreases expression increases expression
ISO
zoledronic acid results in decreased expression of HMOX1 mRNA Zoledronic Acid results in increased expression of HMOX1 mRNA
CTD
PMID:24714768 PMID:25596134 PMID:35587103
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hmox2
heme oxygenase 2
multiple interactions
ISO
[Tretinoin co-treated with zoledronic acid] results in increased expression of HMOX2 protein
CTD
PMID:20349282
NCBI chr16:4,544,225...4,584,606
Ensembl chr16:4,544,225...4,584,606
G
Hp1bp3
heterochromatin protein 1, binding protein 3
increases expression
ISO
zoledronic acid results in increased expression of HP1BP3 mRNA
CTD
PMID:20977926
NCBI chr 4:137,943,781...137,971,994
Ensembl chr 4:137,943,607...137,971,994
G
Hpcal4
hippocalcin-like 4
decreases expression
ISO
zoledronic acid results in decreased expression of HPCAL4 mRNA
CTD
PMID:24714768
NCBI chr 4:123,077,297...123,088,492
Ensembl chr 4:123,077,020...123,088,494
G
Hpgd
hydroxyprostaglandin dehydrogenase 15 (NAD)
decreases expression
ISO
zoledronic acid results in decreased expression of HPGD mRNA
CTD
PMID:24714768
NCBI chr 8:56,747,587...56,774,081
Ensembl chr 8:56,747,620...56,774,078
G
Hras
Harvey rat sarcoma virus oncogene
decreases localization increases expression
ISO
zoledronic acid results in decreased localization of HRAS protein zoledronic acid results in increased expression of HRAS protein
CTD
PMID:11986784 PMID:28871336
NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918
G
Hs3st1
heparan sulfate (glucosamine) 3-O-sulfotransferase 1
increases expression
ISO
zoledronic acid results in increased expression of HS3ST1 mRNA
CTD
PMID:24714768
NCBI chr 5:39,771,278...39,802,791
Ensembl chr 5:39,771,278...39,912,818
G
Hs3st3a1
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1
increases expression
ISO
zoledronic acid results in increased expression of HS3ST3A1 mRNA
CTD
PMID:24714768
NCBI chr11:64,326,158...64,413,667
Ensembl chr11:64,326,158...64,413,667
G
Hs3st3b1
heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1
decreases expression
ISO
zoledronic acid results in decreased expression of HS3ST3B1 mRNA
CTD
PMID:20977926
NCBI chr11:63,775,519...63,813,110
Ensembl chr11:63,776,618...63,813,116
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
increases expression
ISO
zoledronic acid results in increased expression of HSD11B1 mRNA
CTD
PMID:24714768
NCBI chr 1:192,903,917...192,946,345
Ensembl chr 1:192,903,942...192,946,383
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
decreases expression
ISO
zoledronic acid results in decreased expression of HSD11B2 mRNA
CTD
PMID:24714768
NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
increases expression
ISO
zoledronic acid results in increased expression of HSD17B2 mRNA
CTD
PMID:24714768
NCBI chr 8:118,427,752...118,485,767
Ensembl chr 8:118,428,643...118,485,766
G
Hsd17b4
hydroxysteroid (17-beta) dehydrogenase 4
decreases expression
EXP
zoledronic acid results in decreased expression of HSD17B4 mRNA
CTD
PMID:28871336
NCBI chr18:50,261,268...50,329,337
Ensembl chr18:50,261,268...50,329,336
G
Hspa12a
heat shock protein 12A
decreases expression
ISO
zoledronic acid results in decreased expression of HSPA12A mRNA
CTD
PMID:24714768
NCBI chr19:58,784,182...58,932,104
Ensembl chr19:58,784,182...58,932,086
G
Hspa2
heat shock protein 2
increases expression
ISO
zoledronic acid results in increased expression of HSPA2 protein
CTD
PMID:28871336
NCBI chr12:76,450,688...76,453,712
Ensembl chr12:76,450,950...76,453,712
G
Hspa5
heat shock protein 5
increases expression decreases expression
ISO
zoledronic acid results in increased expression of HSPA5 mRNA Zoledronic Acid results in decreased expression of HSPA5 mRNA; Zoledronic Acid results in decreased expression of HSPA5 protein
CTD
PMID:25596134 PMID:35587103
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
G
Hspb8
heat shock protein 8
increases expression
ISO
zoledronic acid results in increased expression of HSPB8 mRNA
CTD
PMID:24714768
NCBI chr 5:116,546,550...116,560,923
Ensembl chr 5:116,546,550...116,560,923
G
Htr4
5 hydroxytryptamine (serotonin) receptor 4
increases expression
ISO
zoledronic acid results in increased expression of HTR4 mRNA
CTD
PMID:20977926
NCBI chr18:62,456,618...62,636,098
Ensembl chr18:62,457,275...62,629,648
G
Htra1
HtrA serine peptidase 1
decreases expression
ISO
zoledronic acid results in decreased expression of HTRA1 mRNA
CTD
PMID:24714768
NCBI chr 7:130,537,933...130,587,388
Ensembl chr 7:130,537,841...130,587,390
G
Ibsp
integrin binding sialoprotein
multiple interactions increases expression
ISO
[zoledronic acid results in decreased geranoylation of RHOA protein] which results in increased expression of IBSP mRNA; geranylgeraniol inhibits the reaction [zoledronic acid results in increased expression of IBSP mRNA]; zoledronic acid inhibits the reaction [RHOA protein results in decreased expression of IBSP mRNA]; zoledronic acid results in increased expression of and results in decreased degradation of IBSP mRNA zoledronic acid results in increased expression of IBSP protein
CTD
PMID:15324309
NCBI chr 5:104,447,153...104,459,338
Ensembl chr 5:104,447,037...104,459,335
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO
zoledronic acid results in increased expression of ICAM1 protein
CTD
PMID:19446661
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Icosl
icos ligand
increases expression
ISO
zoledronic acid results in increased expression of ICOSLG mRNA
CTD
PMID:24714768
NCBI chr10:77,904,921...77,915,359
Ensembl chr10:77,905,136...77,919,747
G
Id1
inhibitor of DNA binding 1, HLH protein
multiple interactions
ISO
zoledronic acid promotes the reaction [Gossypol results in decreased expression of ID1 mRNA]
CTD
PMID:19825521
NCBI chr 2:152,578,171...152,579,330
Ensembl chr 2:152,578,171...152,579,330
G
Id3
inhibitor of DNA binding 3
increases expression
ISO
zoledronic acid results in increased expression of ID3 mRNA
CTD
PMID:24714768
NCBI chr 4:135,871,133...135,872,703
Ensembl chr 4:135,870,808...135,873,066
G
Id4
inhibitor of DNA binding 4
increases expression
ISO
zoledronic acid results in increased expression of ID4 mRNA
CTD
PMID:24714768
NCBI chr13:48,414,592...48,419,504
Ensembl chr13:48,414,704...48,419,502
G
Idh2
isocitrate dehydrogenase 2 (NADP+), mitochondrial
decreases expression increases expression
ISO
zoledronic acid results in decreased expression of IDH2 mRNA zoledronic acid results in increased expression of IDH2 protein
CTD
PMID:24714768 PMID:28871336
NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
G
Idi1
isopentenyl-diphosphate delta isomerase
increases expression
ISO
zoledronic acid results in increased expression of IDI1 mRNA
CTD
PMID:18325729 PMID:24714768
NCBI chr13:8,935,642...8,942,432
Ensembl chr13:8,935,537...8,942,487
G
Ido1
indoleamine 2,3-dioxygenase 1
increases expression
ISO
zoledronic acid results in increased expression of IDO1 mRNA; zoledronic acid results in increased expression of INDO mRNA
CTD
PMID:24714768
NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
G
Ier5
immediate early response 5
increases expression
ISO
zoledronic acid results in increased expression of IER5 mRNA
CTD
PMID:24714768
NCBI chr 1:154,972,113...154,975,382
Ensembl chr 1:154,972,107...154,975,382
G
Iffo2
intermediate filament family orphan 2
increases expression
ISO
zoledronic acid results in increased expression of IFFO2 mRNA
CTD
PMID:24714768
NCBI chr 4:139,257,859...139,347,693
Ensembl chr 4:139,257,859...139,347,693
G
Ifi27
interferon, alpha-inducible protein 27
increases expression
ISO
zoledronic acid results in increased expression of IFI27 mRNA
CTD
PMID:24714768
NCBI chr12:103,400,448...103,406,504
Ensembl chr12:103,400,470...103,406,498
G
Ifng
interferon gamma
multiple interactions increases expression
ISO EXP
zoledronic acid promotes the reaction [IL2 protein affects the expression of IFNG protein] zoledronic acid results in increased expression of IFNG protein
CTD
PMID:19400555 PMID:19818098
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Ifngr1
interferon gamma receptor 1
increases expression
ISO
zoledronic acid results in increased expression of IFNGR1 mRNA
CTD
PMID:24714768
NCBI chr10:19,467,697...19,485,977
Ensembl chr10:19,467,697...19,485,977
G
Ift81
intraflagellar transport 81
decreases expression
ISO
zoledronic acid results in decreased expression of IFT81 mRNA
CTD
PMID:20977926
NCBI chr 5:122,678,328...122,752,614
Ensembl chr 5:122,688,267...122,752,581
G
Igf1
insulin-like growth factor 1
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of IGF1 mRNA
CTD
PMID:16996129
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igfbp5
insulin-like growth factor binding protein 5
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of IGFBP5 mRNA
CTD
PMID:16996129
NCBI chr 1:72,897,224...72,914,024
Ensembl chr 1:72,897,091...72,914,043
G
Ikbke
inhibitor of kappaB kinase epsilon
increases expression
ISO
zoledronic acid results in increased expression of IKBKE mRNA
CTD
PMID:24714768
NCBI chr 1:131,182,337...131,207,339
Ensembl chr 1:131,182,080...131,207,344
G
Ikzf5
IKAROS family zinc finger 5
decreases expression
ISO
zoledronic acid results in decreased expression of IKZF5 mRNA
CTD
PMID:20977926
NCBI chr 7:130,990,378...131,012,243
Ensembl chr 7:130,990,381...131,012,250
G
Il10
interleukin 10
decreases expression
EXP
zoledronic acid results in decreased expression of IL10 protein
CTD
PMID:19818098
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il10ra
interleukin 10 receptor, alpha
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of IL10RA mRNA
CTD
PMID:16996129
NCBI chr 9:45,165,135...45,180,447
Ensembl chr 9:45,165,135...45,180,447
G
Il13ra2
interleukin 13 receptor, alpha 2
increases expression
ISO
zoledronic acid results in increased expression of IL13RA2 mRNA
CTD
PMID:24714768
NCBI chr X:146,166,474...146,214,982
Ensembl chr X:146,166,472...146,212,188
G
Il17rb
interleukin 17 receptor B
decreases expression
ISO
zoledronic acid results in decreased expression of IL17RB mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr14:29,718,125...29,730,853
Ensembl chr14:29,718,092...29,730,853
G
Il18r1
interleukin 18 receptor 1
increases expression
ISO
zoledronic acid results in increased expression of IL18R1 mRNA
CTD
PMID:24714768
NCBI chr 1:40,504,712...40,540,014
Ensembl chr 1:40,504,712...40,540,014
G
Il19
interleukin 19
increases expression increases secretion
ISO
zoledronic acid results in increased expression of IL19 mRNA zoledronic acid results in increased secretion of IL19 protein
CTD
PMID:24714768
NCBI chr 1:130,860,393...130,873,194
Ensembl chr 1:130,860,393...130,867,852
G
Il1b
interleukin 1 beta
increases expression
ISO EXP
zoledronic acid results in increased expression of IL1B mRNA
CTD
PMID:24714768 PMID:28871336
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1r1
interleukin 1 receptor, type I
increases expression
ISO
zoledronic acid results in increased expression of IL1R1 mRNA
CTD
PMID:24714768
NCBI chr 1:40,261,651...40,355,361
Ensembl chr 1:40,264,240...40,356,417
G
Il1r2
interleukin 1 receptor, type II
decreases expression
ISO
zoledronic acid results in decreased expression of IL1R2 mRNA
CTD
PMID:24714768
NCBI chr 1:40,123,872...40,164,390
Ensembl chr 1:40,113,239...40,164,391
G
Il2
interleukin 2
multiple interactions
ISO
IL2 protein affects the reaction [zoledronic acid affects the expression of GZMB mRNA]; zoledronic acid promotes the reaction [IL2 protein affects the expression of IFNG protein]
CTD
PMID:19400555 PMID:19446661
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Il23a
interleukin 23, alpha subunit p19
increases expression
ISO
zoledronic acid results in increased expression of IL23A mRNA
CTD
PMID:20977926
NCBI chr10:128,132,009...128,133,953
Ensembl chr10:128,132,008...128,134,621
G
Il2rg
interleukin 2 receptor, gamma chain
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of IL2RG mRNA
CTD
PMID:16996129
NCBI chr X:100,307,991...100,311,861
Ensembl chr X:100,307,984...100,311,861
G
Il36g
interleukin 36G
increases expression
ISO
Zoledronic Acid results in increased expression of IL36G mRNA
CTD
PMID:24714768
NCBI chr 2:24,076,488...24,083,579
Ensembl chr 2:24,076,488...24,083,580
G
Il4i1
interleukin 4 induced 1
increases expression
ISO
zoledronic acid results in increased expression of IL4I1 mRNA
CTD
PMID:24714768
NCBI chr 7:44,485,712...44,490,233
Ensembl chr 7:44,465,811...44,490,233
G
Il6
interleukin 6
decreases expression increases expression multiple interactions
ISO EXP
zoledronic acid results in decreased expression of IL6 mRNA; zoledronic acid results in decreased expression of IL6 protein zoledronic acid results in increased expression of IL6 mRNA; zoledronic acid results in increased expression of IL6 protein SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of IL6 mRNA]
CTD
PMID:9351880 PMID:18601766 PMID:28871336
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Il7
interleukin 7
decreases expression
ISO
zoledronic acid results in decreased expression of IL7 mRNA
CTD
PMID:24714768
NCBI chr 3:7,637,088...7,678,820
Ensembl chr 3:7,635,054...7,678,820
G
Inhbe
inhibin beta-E
increases expression
ISO
zoledronic acid results in increased expression of INHBE mRNA
CTD
PMID:20977926
NCBI chr10:127,185,271...127,187,717
Ensembl chr10:127,184,726...127,190,280
G
Insig1
insulin induced gene 1
increases expression
ISO
zoledronic acid results in increased expression of INSIG1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 5:28,276,410...28,283,660
Ensembl chr 5:28,276,361...28,283,660
G
Iqcd
IQ motif containing D
increases expression
ISO
zoledronic acid results in increased expression of IQCD mRNA
CTD
PMID:24714768
NCBI chr 5:120,724,829...120,745,185
Ensembl chr 5:120,727,081...120,745,183
G
Irak2
interleukin-1 receptor-associated kinase 2
increases expression
ISO
zoledronic acid results in increased expression of IRAK2 mRNA
CTD
PMID:24714768
NCBI chr 6:113,615,428...113,671,987
Ensembl chr 6:113,615,428...113,671,987
G
Ireb2
iron responsive element binding protein 2
increases expression
ISO
zoledronic acid results in increased expression of IREB2 mRNA
CTD
PMID:20977926
NCBI chr 9:54,769,942...54,819,812
Ensembl chr 9:54,771,073...54,819,814
G
Irf2
interferon regulatory factor 2
increases expression
ISO
zoledronic acid results in increased expression of IRF2 mRNA
CTD
PMID:24714768
NCBI chr 8:47,192,751...47,300,493
Ensembl chr 8:47,192,767...47,300,493
G
Irf2bp1
interferon regulatory factor 2 binding protein 1
decreases expression
ISO
zoledronic acid results in decreased expression of IRF2BP1 mRNA
CTD
PMID:20977926
NCBI chr 7:18,737,983...18,740,688
Ensembl chr 7:18,737,969...18,740,702
G
Irf2bpl
interferon regulatory factor 2 binding protein-like
decreases expression
ISO
zoledronic acid results in decreased expression of IRF2BPL mRNA
CTD
PMID:24714768
NCBI chr12:86,927,477...86,931,588
Ensembl chr12:86,927,475...86,931,572
G
Irf8
interferon regulatory factor 8
decreases expression
ISO
zoledronic acid results in decreased expression of IRF8 mRNA
CTD
PMID:24714768
NCBI chr 8:121,463,097...121,483,433
Ensembl chr 8:121,463,097...121,483,433
G
Irx3
Iroquois related homeobox 3
decreases expression
ISO
zoledronic acid results in decreased expression of IRX3 mRNA
CTD
PMID:24714768
NCBI chr 8:92,525,139...92,528,282
Ensembl chr 8:92,525,153...92,528,695
G
Ism1
isthmin 1, angiogenesis inhibitor
increases expression
ISO
zoledronic acid results in increased expression of ISM1 mRNA
CTD
PMID:24714768
NCBI chr 2:139,515,169...139,600,500
Ensembl chr 2:139,520,098...139,600,501
G
Ism2
isthmin 2
decreases expression
ISO
zoledronic acid results in decreased expression of ISM2 mRNA
CTD
PMID:24714768
NCBI chr12:87,325,412...87,346,624
Ensembl chr12:87,325,412...87,346,479
G
Itfg2
integrin alpha FG-GAP repeat containing 2
decreases expression
ISO
zoledronic acid results in decreased expression of ITFG2 mRNA
CTD
PMID:25596134
NCBI chr 6:128,386,407...128,401,873
Ensembl chr 6:128,386,407...128,401,894
G
Itga1
integrin alpha 1
increases expression
ISO
zoledronic acid results in increased expression of ITGA1 mRNA
CTD
PMID:24714768
NCBI chr13:115,094,615...115,238,500
Ensembl chr13:115,089,632...115,238,500
G
Itgb2
integrin beta 2
increases expression
ISO
zoledronic acid results in increased expression of ITGB2 mRNA
CTD
PMID:24714768
NCBI chr10:77,366,164...77,401,542
Ensembl chr10:77,366,086...77,401,542
G
Itgb5
integrin beta 5
decreases expression
ISO
zoledronic acid results in decreased expression of ITGB5 mRNA
CTD
PMID:24714768
NCBI chr16:33,650,021...33,769,708
Ensembl chr16:33,650,035...33,769,708
G
Itih3
inter-alpha trypsin inhibitor, heavy chain 3
increases expression
ISO
zoledronic acid results in increased expression of ITIH3 protein
CTD
PMID:28871336
NCBI chr14:30,630,529...30,645,748
Ensembl chr14:30,630,529...30,645,717
G
Itprid2
ITPR interacting domain containing 2
decreases expression
ISO
zoledronic acid results in decreased expression of ITPRID2 mRNA
CTD
PMID:24714768
NCBI chr 2:79,419,207...79,503,310
Ensembl chr 2:79,465,696...79,503,310
G
Ivns1abp
influenza virus NS1A binding protein
decreases expression
ISO
zoledronic acid results in decreased expression of IVNS1ABP mRNA
CTD
PMID:24714768
NCBI chr 1:151,220,237...151,240,196
Ensembl chr 1:151,220,228...151,240,173
G
Iyd
iodotyrosine deiodinase
decreases expression
ISO
zoledronic acid results in decreased expression of IYD mRNA
CTD
PMID:24714768
NCBI chr10:3,490,274...3,504,880
Ensembl chr10:3,490,240...3,504,877
G
Izumo4
IZUMO family member 4
increases expression
ISO
zoledronic acid results in increased expression of IZUMO4 mRNA
CTD
PMID:24714768
NCBI chr10:80,537,858...80,541,216
Ensembl chr10:80,538,018...80,541,207
G
Jak1
Janus kinase 1
increases expression
ISO
zoledronic acid results in increased expression of JAK1 mRNA
CTD
PMID:24714768
NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479
G
Jak2
Janus kinase 2
increases expression
ISO
zoledronic acid results in increased expression of JAK2 mRNA
CTD
PMID:24714768
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Jak3
Janus kinase 3
increases expression
ISO
zoledronic acid results in increased expression of JAK3 mRNA
CTD
PMID:20977926
NCBI chr 8:72,129,027...72,143,221
Ensembl chr 8:72,128,940...72,143,219
G
Josd1
Josephin domain containing 1
increases expression
ISO
zoledronic acid results in increased expression of JOSD1 mRNA
CTD
PMID:20977926
NCBI chr15:79,558,451...79,572,073
Ensembl chr15:79,558,452...79,572,120
G
Kat2b
K(lysine) acetyltransferase 2B
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of KAT2B mRNA
CTD
PMID:16996129
NCBI chr17:53,873,802...53,979,749
Ensembl chr17:53,873,889...53,979,748
G
Kbtbd2
kelch repeat and BTB (POZ) domain containing 2
increases expression
ISO
zoledronic acid results in increased expression of KBTBD2 mRNA
CTD
PMID:20977926
NCBI chr 6:56,754,510...56,774,798
Ensembl chr 6:56,754,509...56,774,798
G
Kcnh1
potassium voltage-gated channel, subfamily H (eag-related), member 1
decreases expression
ISO
zoledronic acid results in decreased expression of KCNH1 mRNA
CTD
PMID:24714768
NCBI chr 1:191,871,759...192,192,467
Ensembl chr 1:191,873,082...192,192,467
G
Kcnh3
potassium voltage-gated channel, subfamily H (eag-related), member 3
decreases expression
ISO
zoledronic acid results in decreased expression of KCNH3 mRNA
CTD
PMID:24714768
NCBI chr15:99,122,396...99,140,699
Ensembl chr15:99,122,742...99,140,698
G
Kcnip3
Kv channel interacting protein 3, calsenilin
increases expression
ISO
zoledronic acid results in increased expression of KCNIP3 mRNA
CTD
PMID:24714768
NCBI chr 2:127,298,418...127,364,014
Ensembl chr 2:127,298,418...127,364,014
G
Kcnip4
Kv channel interacting protein 4
decreases expression
ISO
zoledronic acid results in decreased expression of KCNIP4 mRNA
CTD
PMID:24714768
NCBI chr 5:48,546,845...49,682,464
Ensembl chr 5:48,546,844...49,682,249
G
Kcnj1
potassium inwardly-rectifying channel, subfamily J, member 1
decreases expression
ISO
zoledronic acid results in decreased expression of KCNJ1 mRNA
CTD
PMID:24714768
NCBI chr 9:32,283,714...32,310,493
Ensembl chr 9:32,283,789...32,310,493
G
Kcns3
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3
increases expression
ISO
zoledronic acid results in increased expression of KCNS3 mRNA
CTD
PMID:24714768
NCBI chr12:11,140,738...11,201,186
Ensembl chr12:11,140,203...11,201,057
G
Kctd5
potassium channel tetramerisation domain containing 5
increases expression
ISO
zoledronic acid results in increased expression of KCTD5 mRNA
CTD
PMID:20977926
NCBI chr17:24,266,694...24,292,459
Ensembl chr17:24,266,708...24,292,459
G
Kdm3a
lysine (K)-specific demethylase 3A
increases expression
ISO
zoledronic acid results in increased expression of KDM3A mRNA
CTD
PMID:25596134
NCBI chr 6:71,565,954...71,609,963
Ensembl chr 6:71,565,956...71,609,974
G
Kif13a
kinesin family member 13A
decreases expression
ISO
zoledronic acid results in decreased expression of KIF13A protein
CTD
PMID:28871336
NCBI chr13:46,902,563...47,083,871
Ensembl chr13:46,902,563...47,083,343
G
Kif20a
kinesin family member 20A
decreases expression
ISO
zoledronic acid results in decreased expression of KIF20A mRNA
CTD
PMID:20977926 PMID:24714768
NCBI chr18:34,757,677...34,766,330
Ensembl chr18:34,757,666...34,766,330
G
Kif4
kinesin family member 4
decreases expression
ISO
zoledronic acid results in decreased expression of KIF4A mRNA
CTD
PMID:24714768
NCBI chr X:99,669,693...99,770,878
Ensembl chr X:99,669,343...99,770,820
G
Kifc1
kinesin family member C1
decreases expression
ISO
Zoledronic Acid results in decreased expression of KIFC1 mRNA
CTD
PMID:24714768
NCBI chr17:34,094,640...34,109,607
Ensembl chr17:34,094,633...34,109,635
G
Kit
KIT proto-oncogene receptor tyrosine kinase
increases expression
ISO
zoledronic acid results in increased expression of KIT mRNA
CTD
PMID:24714768
NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382
G
Kitl
kit ligand
decreases expression
ISO
zoledronic acid results in decreased expression of KITLG mRNA
CTD
PMID:24714768
NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278
G
Klf11
Kruppel-like transcription factor 11
increases expression
ISO
zoledronic acid results in increased expression of KLF11 mRNA
CTD
PMID:20977926 PMID:24714768
NCBI chr12:24,701,370...24,712,781
Ensembl chr12:24,701,273...24,712,788
G
Klf7
Kruppel-like transcription factor 7 (ubiquitous)
increases expression
ISO
zoledronic acid results in increased expression of KLF7 mRNA
CTD
PMID:20977926
NCBI chr 1:64,068,607...64,161,504
Ensembl chr 1:64,068,606...64,161,441
G
Klhl13
kelch-like 13
decreases expression
ISO
zoledronic acid results in decreased expression of KLHL13 mRNA
CTD
PMID:24714768
NCBI chr X:23,085,510...23,231,340
Ensembl chr X:23,085,510...23,231,321
G
Klk10
kallikrein related-peptidase 10
increases expression
ISO
zoledronic acid results in increased expression of KLK10 mRNA
CTD
PMID:24714768
NCBI chr 7:43,430,478...43,434,834
Ensembl chr 7:43,430,459...43,434,834
G
Klk6
kallikrein related-peptidase 6
decreases expression
ISO
zoledronic acid results in decreased expression of KLK6 mRNA
CTD
PMID:24714768
NCBI chr 7:43,473,967...43,481,219
Ensembl chr 7:43,473,923...43,481,454
G
Klrg2
killer cell lectin-like receptor subfamily G, member 2
increases expression
ISO
zoledronic acid results in increased expression of KLRG2 mRNA
CTD
PMID:24714768
NCBI chr 6:38,593,264...38,615,750
Ensembl chr 6:38,602,628...38,614,177
G
Kras
Kirsten rat sarcoma viral oncogene homolog
increases expression
ISO
zoledronic acid results in increased expression of KRAS protein
CTD
PMID:28871336
NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
G
Krcc1
lysine-rich coiled-coil 1
increases expression
ISO
zoledronic acid results in increased expression of KRCC1 mRNA
CTD
PMID:20977926
NCBI chr 6:71,248,661...71,263,809
Ensembl chr 6:71,248,661...71,262,303
G
Krt15
keratin 15
increases expression
ISO
zoledronic acid results in increased expression of KRT15 mRNA
CTD
PMID:25596134
NCBI chr11:100,022,585...100,026,775
Ensembl chr11:100,022,584...100,026,754
G
Krt8
keratin 8
decreases expression
ISO
zoledronic acid results in decreased expression of KRT8 mRNA
CTD
PMID:24714768
NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917
G
Krt80
keratin 80
decreases expression
ISO
zoledronic acid results in decreased expression of KRT80 mRNA
CTD
PMID:24714768
NCBI chr15:101,246,196...101,268,043
Ensembl chr15:101,245,325...101,268,043
G
Krt81
keratin 81
decreases expression
ISO
zoledronic acid results in decreased expression of KRT81 mRNA
CTD
PMID:24714768
NCBI chr15:101,356,942...101,361,646
Ensembl chr15:101,356,942...101,361,632
G
Kynu
kynureninase
increases expression
ISO
zoledronic acid results in increased expression of KYNU mRNA
CTD
PMID:24714768
NCBI chr 2:43,445,270...43,572,734
Ensembl chr 2:43,445,341...43,572,734
G
L3mbtl3
L3MBTL3 histone methyl-lysine binding protein
decreases expression
ISO
zoledronic acid results in decreased expression of L3MBTL3 mRNA
CTD
PMID:24714768
NCBI chr10:26,150,361...26,252,426
Ensembl chr10:26,150,366...26,251,967
G
Lama1
laminin, alpha 1
decreases expression
ISO
zoledronic acid results in decreased expression of LAMA1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr17:68,004,129...68,129,640
Ensembl chr17:68,004,254...68,129,642
G
Lama3
laminin, alpha 3
increases expression
ISO
zoledronic acid results in increased expression of LAMA3 mRNA
CTD
PMID:20977926 PMID:24714768 PMID:25596134
NCBI chr18:12,466,806...12,716,070
Ensembl chr18:12,466,876...12,716,070
G
Lama4
laminin, alpha 4
decreases expression
ISO
zoledronic acid results in decreased expression of LAMA4 mRNA
CTD
PMID:24714768
NCBI chr10:38,841,511...38,986,184
Ensembl chr10:38,841,511...38,986,184
G
Lama5
laminin, alpha 5
multiple interactions
ISO
[zoledronic acid co-treated with Gossypol] results in decreased expression of LAMA5 mRNA
CTD
PMID:19825521
NCBI chr 2:179,818,166...179,867,652
Ensembl chr 2:179,818,166...179,867,652
G
Lamb1
laminin B1
decreases expression
ISO
zoledronic acid results in decreased expression of LAMB1 mRNA
CTD
PMID:24714768
NCBI chr12:31,315,230...31,379,643
Ensembl chr12:31,315,233...31,379,643
G
Lamb3
laminin, beta 3
increases expression
ISO
zoledronic acid results in increased expression of LAMB3 mRNA
CTD
PMID:24714768
NCBI chr 1:192,976,661...193,026,186
Ensembl chr 1:192,890,007...193,026,186
G
Lamc2
laminin, gamma 2
increases expression
ISO
zoledronic acid results in increased expression of LAMC2 mRNA
CTD
PMID:24714768
NCBI chr 1:152,998,502...153,062,193
Ensembl chr 1:152,998,502...153,062,193
G
Lamp1
lysosomal-associated membrane protein 1
decreases expression
ISO
zoledronic acid results in decreased expression of LAMP1 protein
CTD
PMID:28871336
NCBI chr 8:13,209,161...13,225,338
Ensembl chr 8:13,209,161...13,225,338
G
Lbh
limb-bud and heart
increases expression
ISO
zoledronic acid results in increased expression of LBH mRNA
CTD
PMID:24714768
NCBI chr17:73,225,300...73,248,941
Ensembl chr17:73,225,300...73,248,942
G
Lcn2
lipocalin 2
increases expression increases secretion
ISO
zoledronic acid results in increased expression of LCN2 mRNA zoledronic acid results in increased secretion of LCN2 protein
CTD
PMID:24714768
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Lcp1
lymphocyte cytosolic protein 1
increases expression
ISO
zoledronic acid results in increased expression of LCP1 mRNA
CTD
PMID:24714768
NCBI chr14:75,368,570...75,468,282
Ensembl chr14:75,368,541...75,468,282
G
Ldaf1
lipid droplet assembly factor 1
increases expression
ISO
Zoledronic Acid results in increased expression of LDAF1 mRNA
CTD
PMID:24714768
NCBI chr 7:119,701,599...119,720,212
Ensembl chr 7:119,701,576...119,720,215
G
Ldb2
LIM domain binding 2
increases expression
ISO
zoledronic acid results in increased expression of LDB2 mRNA
CTD
PMID:24714768
NCBI chr 5:44,593,292...44,957,466
Ensembl chr 5:44,629,474...44,957,022
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
zoledronic acid results in increased expression of LDLR mRNA
CTD
PMID:20977926
NCBI chr 9:21,634,872...21,661,215
Ensembl chr 9:21,634,779...21,661,215
G
Ldoc1
regulator of NFKB signaling
decreases expression
ISO
zoledronic acid results in decreased expression of LDOC1 mRNA
CTD
PMID:24714768
NCBI chr X:60,753,217...60,754,556
Ensembl chr X:60,753,103...60,754,561
G
Lgi2
leucine-rich repeat LGI family, member 2
decreases expression
ISO
zoledronic acid results in decreased expression of LGI2 mRNA
CTD
PMID:24714768
NCBI chr 5:52,690,859...52,723,689
Ensembl chr 5:52,690,859...52,723,804
G
Lhfpl6
LHFPL tetraspan subfamily member 6
increases expression
ISO
zoledronic acid results in increased expression of LHFPL6 mRNA
CTD
PMID:24714768
NCBI chr 3:52,948,968...53,169,100
Ensembl chr 3:52,948,949...53,169,100
G
Lhx3
LIM homeobox protein 3
increases expression
ISO
zoledronic acid results in increased expression of LHX3 mRNA
CTD
PMID:20977926
NCBI chr 2:26,090,224...26,098,261
Ensembl chr 2:26,090,224...26,098,301
G
Limch1
LIM and calponin homology domains 1
increases expression
ISO
zoledronic acid results in increased expression of LIMCH1 mRNA
CTD
PMID:24714768
NCBI chr 5:66,903,232...67,214,502
Ensembl chr 5:66,903,170...67,214,501
G
Lin52
lin-52 DREAM MuvB core complex component
increases expression
ISO
zoledronic acid results in increased expression of LIN52 mRNA
CTD
PMID:20977926
NCBI chr12:84,497,965...84,593,293
Ensembl chr12:84,498,196...84,592,919
G
Lins1
lines homolog 1
increases expression
ISO
zoledronic acid results in increased expression of LINS1 mRNA
CTD
PMID:20977926
NCBI chr 7:66,339,565...66,367,004
Ensembl chr 7:66,339,637...66,367,004
G
Lipg
lipase, endothelial
increases expression
ISO
zoledronic acid results in increased expression of LIPG mRNA
CTD
PMID:24714768
NCBI chr18:75,072,393...75,095,380
Ensembl chr18:75,072,393...75,094,334
G
Litaf
LPS-induced TN factor
increases expression
ISO
zoledronic acid results in increased expression of LITAF mRNA
CTD
PMID:24714768
NCBI chr16:10,777,137...10,810,985
Ensembl chr16:10,777,139...10,884,021
G
Lix1
limb and CNS expressed 1
decreases expression
ISO
zoledronic acid results in decreased expression of LIX1 mRNA
CTD
PMID:24714768
NCBI chr17:17,622,948...17,679,649
Ensembl chr17:17,622,934...17,679,649
G
Llgl2
LLGL2 scribble cell polarity complex component
increases expression
ISO
zoledronic acid results in increased expression of LLGL2 mRNA
CTD
PMID:24714768
NCBI chr11:115,714,855...115,746,606
Ensembl chr11:115,714,875...115,746,606
G
Lmna
lamin A
decreases expression decreases farnesylation
ISO
zoledronic acid results in decreased expression of LMNA mRNA zoledronic acid results in decreased farnesylation of LMNA protein
CTD
PMID:16996129 PMID:24714768
NCBI chr 3:88,388,455...88,413,842
Ensembl chr 3:88,387,454...88,417,263
G
Lmnb1
lamin B1
decreases expression increases expression
ISO
zoledronic acid results in decreased expression of LMNB1 mRNA zoledronic acid results in increased expression of LMNB1 protein
CTD
PMID:24714768 PMID:28871336
NCBI chr18:56,840,885...56,886,496
Ensembl chr18:56,840,885...56,886,496
G
Lnpep
leucyl/cystinyl aminopeptidase
increases expression
ISO
zoledronic acid results in increased expression of LNPEP mRNA
CTD
PMID:20977926
NCBI chr17:17,747,985...17,846,303
Ensembl chr17:17,741,672...17,845,312
G
Lpar6
lysophosphatidic acid receptor 6
increases expression
ISO
Zoledronic Acid results in increased expression of LPAR6 mRNA
CTD
PMID:24714768
NCBI chr14:73,475,331...73,477,798
Ensembl chr14:73,475,335...73,480,734
G
Lpin1
lipin 1
increases expression
ISO
zoledronic acid results in increased expression of LPIN1 mRNA
CTD
PMID:20977926
NCBI chr12:16,585,670...16,697,020
Ensembl chr12:16,585,670...16,696,967
G
Lratd2
LRAT domain containing 1
decreases expression
ISO
Zoledronic Acid results in decreased expression of LRATD2 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr15:60,690,845...60,697,954
Ensembl chr15:60,690,843...60,725,627
G
Lrg1
leucine-rich alpha-2-glycoprotein 1
increases expression
ISO
zoledronic acid results in increased expression of LRG1 mRNA
CTD
PMID:24714768
NCBI chr17:56,426,678...56,428,946
Ensembl chr17:56,426,678...56,429,001
G
Lrp3
low density lipoprotein receptor-related protein 3
decreases expression
ISO
zoledronic acid results in decreased expression of LRP3 mRNA
CTD
PMID:24714768
NCBI chr 7:34,900,303...34,914,770
Ensembl chr 7:34,899,452...34,914,923
G
Lrrc14
leucine rich repeat containing 14
increases expression
ISO
zoledronic acid results in increased expression of LRRC14 mRNA
CTD
PMID:20977926
NCBI chr15:76,594,820...76,599,297
Ensembl chr15:76,594,823...76,601,899
G
Lrrc19
leucine rich repeat containing 19
decreases expression
ISO
zoledronic acid results in decreased expression of LRRC19 mRNA
CTD
PMID:24714768
NCBI chr 4:94,523,958...94,538,381
Ensembl chr 4:94,524,890...94,538,381
G
Lrrc26
leucine rich repeat containing 26
decreases expression
ISO
zoledronic acid results in decreased expression of LRRC26 mRNA
CTD
PMID:24714768
NCBI chr 2:25,179,923...25,181,205
Ensembl chr 2:25,179,927...25,181,192
G
Lrrc75b
leucine rich repeat containing 75B
decreases expression
ISO
zoledronic acid results in decreased expression of LRRC75B mRNA
CTD
PMID:24714768
NCBI chr10:75,385,953...75,396,532
Ensembl chr10:75,385,957...75,396,164
G
Lrrk2
leucine-rich repeat kinase 2
decreases expression
ISO
zoledronic acid results in decreased expression of LRRK2 mRNA
CTD
PMID:24714768
NCBI chr15:91,556,994...91,700,327
Ensembl chr15:91,557,378...91,700,323
G
Lss
lanosterol synthase
increases expression
ISO
zoledronic acid results in increased expression of LSS mRNA
CTD
PMID:18325729 PMID:24714768
NCBI chr10:76,367,303...76,392,973
Ensembl chr10:76,367,422...76,392,972
G
Ltb
lymphotoxin B
increases expression
ISO
zoledronic acid results in increased expression of LTB mRNA
CTD
PMID:24714768
NCBI chr17:35,413,483...35,415,281
Ensembl chr17:35,413,415...35,415,296
G
Ltbr
lymphotoxin B receptor
multiple interactions increases expression
ISO
[Tretinoin co-treated with zoledronic acid] results in decreased expression of LTBR mRNA zoledronic acid results in increased expression of LTBR mRNA
CTD
PMID:19036117 PMID:20349282
NCBI chr 6:125,283,534...125,291,026
Ensembl chr 6:125,283,534...125,290,848
G
Ltf
lactotransferrin
increases expression
ISO
zoledronic acid results in increased expression of LTF protein
CTD
PMID:28871336
NCBI chr 9:110,848,360...110,871,834
Ensembl chr 9:110,848,339...110,871,835
G
Lurap1l
leucine rich adaptor protein 1-like
decreases expression
ISO
zoledronic acid results in decreased expression of LURAP1L mRNA
CTD
PMID:24714768
NCBI chr 4:80,828,923...80,872,538
Ensembl chr 4:80,828,883...80,873,865
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
increases expression
ISO
zoledronic acid results in increased expression of LYN mRNA
CTD
PMID:24714768
NCBI chr 4:3,676,865...3,791,613
Ensembl chr 4:3,678,115...3,813,122
G
Lypd1
Ly6/Plaur domain containing 1
increases expression
ISO
zoledronic acid results in increased expression of LYPD1 mRNA
CTD
PMID:24714768
NCBI chr 1:125,795,359...125,841,134
Ensembl chr 1:125,795,359...125,840,838
G
Lypd6b
LY6/PLAUR domain containing 6B
increases expression
ISO
zoledronic acid results in increased expression of LYPD6B mRNA
CTD
PMID:24714768
NCBI chr 2:49,677,380...49,838,861
Ensembl chr 2:49,677,700...49,838,861
G
Lzts1
leucine zipper, putative tumor suppressor 1
multiple interactions decreases expression
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of LZTS1 mRNA zoledronic acid results in decreased expression of LZTS1 mRNA
CTD
PMID:16996129 PMID:24714768
NCBI chr 8:69,585,311...69,636,901
Ensembl chr 8:69,585,321...69,636,877
G
M6pr
mannose-6-phosphate receptor, cation dependent
decreases expression
ISO
zoledronic acid results in decreased expression of M6PR protein
CTD
PMID:28871336
NCBI chr 6:122,285,679...122,294,639
Ensembl chr 6:122,285,679...122,294,639
G
Mafb
MAF bZIP transcription factor B
increases expression
ISO
zoledronic acid results in increased expression of MAFB mRNA
CTD
PMID:24714768
NCBI chr 2:160,205,597...160,208,985
Ensembl chr 2:160,205,623...160,208,985
G
Maff
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian)
increases expression
ISO
zoledronic acid results in increased expression of MAFF mRNA
CTD
PMID:24714768
NCBI chr15:79,230,813...79,243,278
Ensembl chr15:79,230,821...79,243,276
G
Malt1
MALT1 paracaspase
increases expression
ISO
zoledronic acid results in increased expression of MALT1 mRNA
CTD
PMID:24714768
NCBI chr18:65,564,010...65,612,138
Ensembl chr18:65,564,009...65,612,138
G
Man1c1
mannosidase, alpha, class 1C, member 1
decreases expression
ISO
zoledronic acid results in decreased expression of MAN1C1 mRNA
CTD
PMID:24714768
NCBI chr 4:134,289,001...134,432,987
Ensembl chr 4:134,289,001...134,431,601
G
Map2
microtubule-associated protein 2
decreases expression
ISO
zoledronic acid results in decreased expression of MAP2 mRNA
CTD
PMID:24714768
NCBI chr 1:66,214,337...66,481,742
Ensembl chr 1:66,214,432...66,481,742
G
Map3k2
mitogen-activated protein kinase kinase kinase 2
decreases expression
ISO
zoledronic acid results in decreased expression of MAP3K2 mRNA
CTD
PMID:20977926
NCBI chr18:32,296,142...32,369,804
Ensembl chr18:32,296,142...32,369,804
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
increases expression
ISO
zoledronic acid results in increased expression of MAP3K8 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr18:4,331,325...4,352,978
Ensembl chr18:4,331,327...4,353,015
G
Map7d3
MAP7 domain containing 3
increases expression
ISO
zoledronic acid results in increased expression of MAP7D3 mRNA
CTD
PMID:20977926
NCBI chr X:55,840,193...55,867,866
Ensembl chr X:55,843,218...55,867,686
G
Mapk1
mitogen-activated protein kinase 1
decreases phosphorylation multiple interactions increases phosphorylation
ISO
zoledronic acid results in decreased phosphorylation of MAPK1 protein [Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased phosphorylation of MAPK1 protein; CCN1 protein affects the reaction [Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of MAPK1 protein]; Gefitinib promotes the reaction [[Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased phosphorylation of MAPK1 protein]; Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of MAPK1 protein zoledronic acid results in increased phosphorylation of MAPK1 protein
CTD
PMID:12799645 PMID:16322342 PMID:16996129 PMID:17059425 PMID:19530242
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk10
mitogen-activated protein kinase 10
decreases expression
ISO
zoledronic acid results in decreased expression of MAPK10 mRNA
CTD
PMID:24714768
NCBI chr 5:103,056,413...103,359,200
Ensembl chr 5:103,055,814...103,359,200
G
Mapk3
mitogen-activated protein kinase 3
multiple interactions decreases phosphorylation increases phosphorylation
ISO
[Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased phosphorylation of MAPK3 protein; CCN1 protein affects the reaction [Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of MAPK3 protein]; Gefitinib promotes the reaction [[Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased phosphorylation of MAPK3 protein]; Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of MAPK3 protein zoledronic acid results in decreased phosphorylation of MAPK3 protein zoledronic acid results in increased phosphorylation of MAPK3 protein
CTD
PMID:12799645 PMID:16322342 PMID:16996129 PMID:17059425 PMID:19530242
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO
zoledronic acid promotes the reaction [TNF protein results in increased phosphorylation of MAPK8 protein]
CTD
PMID:17059425
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mapkapk3
mitogen-activated protein kinase-activated protein kinase 3
decreases expression
ISO
zoledronic acid results in decreased expression of MAPKAPK3 mRNA
CTD
PMID:24714768
NCBI chr 9:107,132,125...107,167,082
Ensembl chr 9:107,132,126...107,167,076
G
Marchf3
membrane associated ring-CH-type finger 3
increases expression
ISO
Zoledronic Acid results in increased expression of MARCHF3 mRNA
CTD
PMID:24714768
NCBI chr18:56,894,788...57,058,587
Ensembl chr18:56,894,788...57,058,620
G
Marcks
myristoylated alanine rich protein kinase C substrate
increases expression
ISO
zoledronic acid results in increased expression of MARCKS mRNA
CTD
PMID:24714768
NCBI chr10:37,009,239...37,014,922
Ensembl chr10:37,009,371...37,014,916
G
Mast4
microtubule associated serine/threonine kinase family member 4
increases expression
ISO
zoledronic acid results in increased expression of MAST4 mRNA
CTD
PMID:24714768
NCBI chr13:102,868,996...103,471,607
Ensembl chr13:102,868,994...103,471,005
G
Matn3
matrilin 3
decreases expression
ISO
zoledronic acid results in decreased expression of MATN3 mRNA
CTD
PMID:24714768
NCBI chr12:8,997,929...9,022,028
Ensembl chr12:8,997,929...9,022,028
G
Max
Max protein
increases expression
ISO
zoledronic acid results in increased expression of MAX mRNA
CTD
PMID:20977926
NCBI chr12:76,984,045...77,009,123
Ensembl chr12:76,984,043...77,008,975
G
Mb21d2
Mab-21 domain containing 2
increases expression
ISO
zoledronic acid results in increased expression of MB21D2 mRNA
CTD
PMID:24714768
NCBI chr16:28,644,928...28,748,802
Ensembl chr16:28,644,928...28,748,425
G
Mbip
MAP3K12 binding inhibitory protein 1
increases expression
ISO
zoledronic acid results in increased expression of MBIP mRNA
CTD
PMID:24714768
NCBI chr12:56,375,091...56,392,681
Ensembl chr12:56,375,088...56,392,679
G
Mbtps2
membrane-bound transcription factor peptidase, site 2
increases expression
ISO
zoledronic acid results in increased expression of MBTPS2 mRNA
CTD
PMID:20977926
NCBI chr X:156,330,818...156,381,711
Ensembl chr X:156,318,367...156,381,711
G
Mcl1
myeloid cell leukemia sequence 1
multiple interactions
ISO
[Tretinoin co-treated with zoledronic acid] results in decreased expression of MCL1 mRNA
CTD
PMID:20349282
NCBI chr 3:95,564,017...95,583,553
Ensembl chr 3:95,566,099...95,570,487
G
Mcm10
minichromosome maintenance 10 replication initiation factor
decreases expression
ISO
zoledronic acid results in decreased expression of MCM10 mRNA
CTD
PMID:24714768
NCBI chr 2:4,995,535...5,017,602
Ensembl chr 2:4,994,525...5,017,602
G
Mcm2
minichromosome maintenance complex component 2
multiple interactions decreases expression
ISO
[zoledronic acid co-treated with docetaxel] results in decreased expression of MCM2 protein zoledronic acid results in decreased expression of MCM2 protein
CTD
PMID:17562444 PMID:28871336
NCBI chr 6:88,860,456...88,875,762
Ensembl chr 6:88,860,456...88,875,762
G
Mcm4
minichromosome maintenance complex component 4
increases expression
ISO
zoledronic acid results in increased expression of MCM4 mRNA
CTD
PMID:20977926
NCBI chr16:15,441,761...15,455,264
Ensembl chr16:15,441,761...15,455,264
G
Mcm6
minichromosome maintenance complex component 6
decreases expression
ISO
zoledronic acid results in decreased expression of MCM6 mRNA
CTD
PMID:24714768
NCBI chr 1:128,259,312...128,287,442
Ensembl chr 1:128,259,327...128,287,401
G
Mcur1
mitochondrial calcium uniporter regulator 1
increases expression
ISO
zoledronic acid results in increased expression of MCUR1 mRNA
CTD
PMID:24714768
NCBI chr13:43,691,882...43,714,284
Ensembl chr13:43,691,869...43,713,667
G
Mdk
midkine
multiple interactions
ISO
zoledronic acid promotes the reaction [Gossypol results in decreased expression of MDK mRNA]
CTD
PMID:19825521
NCBI chr 2:91,760,149...91,762,348
Ensembl chr 2:91,760,150...91,762,642
G
Mdm4
transformed mouse 3T3 cell double minute 4
increases expression
ISO
zoledronic acid results in increased expression of MDM4 mRNA
CTD
PMID:20977926
NCBI chr 1:132,913,843...132,958,325
Ensembl chr 1:132,887,222...132,958,299
G
Me1
malic enzyme 1, NADP(+)-dependent, cytosolic
increases expression
ISO
zoledronic acid results in increased expression of ME1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006
G
Mecom
MDS1 and EVI1 complex locus
decreases expression
ISO
Zoledronic Acid results in decreased expression of MECOM mRNA
CTD
PMID:24714768
NCBI chr 3:30,005,445...30,563,937
Ensembl chr 3:30,005,445...30,602,157
G
Med13l
mediator complex subunit 13-like
decreases expression
ISO
zoledronic acid results in decreased expression of MED13L mRNA
CTD
PMID:20977926
NCBI chr 5:118,698,363...118,903,503
Ensembl chr 5:118,698,744...118,903,503
G
Med20
mediator complex subunit 20
increases expression
ISO
zoledronic acid results in increased expression of MED20 mRNA
CTD
PMID:20977926
NCBI chr17:47,922,510...47,935,176
Ensembl chr17:47,922,507...47,935,343
G
Med23
mediator complex subunit 23
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of MED23 mRNA
CTD
PMID:16996129
NCBI chr10:24,745,889...24,789,358
Ensembl chr10:24,745,884...24,789,579
G
Megf11
multiple EGF-like-domains 11
increases expression
ISO
zoledronic acid results in increased expression of MEGF11 mRNA
CTD
PMID:24714768
NCBI chr 9:64,291,556...64,618,584
Ensembl chr 9:64,292,908...64,616,487
G
Melk
maternal embryonic leucine zipper kinase
decreases expression
ISO
zoledronic acid results in decreased expression of MELK mRNA
CTD
PMID:24714768
NCBI chr 4:44,300,876...44,364,301
Ensembl chr 4:44,300,876...44,364,675
G
Metrnl
meteorin, glial cell differentiation regulator-like
decreases expression
ISO
zoledronic acid results in decreased expression of METRNL mRNA
CTD
PMID:24714768
NCBI chr11:121,593,253...121,608,215
Ensembl chr11:121,592,370...121,607,132
G
Mex3c
mex3 RNA binding family member C
increases expression
ISO
zoledronic acid results in increased expression of MEX3C mRNA
CTD
PMID:20977926
NCBI chr18:73,705,710...73,725,649
Ensembl chr18:73,706,115...73,725,646
G
Mfsd4a
major facilitator superfamily domain containing 4A
decreases expression
ISO
zoledronic acid results in decreased expression of MFSD4A mRNA
CTD
PMID:24714768
NCBI chr 1:131,947,543...131,997,400
Ensembl chr 1:131,950,544...131,995,800
G
Mgat3
mannoside acetylglucosaminyltransferase 3
increases expression
ISO
zoledronic acid results in increased expression of MGAT3 mRNA
CTD
PMID:24714768
NCBI chr15:80,057,852...80,099,720
Ensembl chr15:80,057,922...80,099,720
G
Mgst1
microsomal glutathione S-transferase 1
decreases expression
ISO
zoledronic acid results in decreased expression of MGST1 mRNA
CTD
PMID:24714768
NCBI chr 6:138,117,525...138,133,753
Ensembl chr 6:138,117,314...138,133,753
G
Mid1
midline 1
increases expression
ISO
zoledronic acid results in increased expression of MID1 mRNA
CTD
PMID:24714768
NCBI chr X:168,468,178...168,773,692
Ensembl chr X:168,468,195...168,773,794
G
Mink1
misshapen-like kinase 1 (zebrafish)
decreases expression
ISO
zoledronic acid results in decreased expression of MINK1 mRNA
CTD
PMID:20977926
NCBI chr11:70,452,272...70,505,309
Ensembl chr11:70,453,707...70,505,309
G
Mir22hg
Mir22 host gene (non-protein coding)
decreases expression
ISO
zoledronic acid results in decreased expression of MIR22HG mRNA
CTD
PMID:24714768
NCBI chr11:75,352,365...75,357,516
Ensembl chr11:75,352,365...75,357,502
G
Mir302c
microRNA 302c
increases expression
ISO
Zoledronic Acid results in increased expression of MIR302C mRNA
CTD
PMID:24714768
NCBI chr 3:127,339,012...127,339,079
Ensembl chr 3:127,339,012...127,339,079
G
Mki67
antigen identified by monoclonal antibody Ki 67
multiple interactions
ISO
[zoledronic acid co-treated with Doxorubicin] results in decreased expression of MKI67 protein
CTD
PMID:18695136
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
G
Mllt11
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 11
decreases expression
ISO
zoledronic acid results in decreased expression of MLLT11 mRNA
CTD
PMID:24714768
NCBI chr 3:95,125,852...95,139,486
Ensembl chr 3:95,126,446...95,139,482
G
Mmel1
membrane metallo-endopeptidase-like 1
increases expression
ISO
zoledronic acid results in increased expression of MMEL1 mRNA
CTD
PMID:20977926
NCBI chr 4:154,954,042...154,979,987
Ensembl chr 4:154,954,042...154,979,985
G
Mmp10
matrix metallopeptidase 10
increases expression
ISO
zoledronic acid results in increased expression of MMP10 mRNA
CTD
PMID:24714768
NCBI chr 9:7,502,343...7,510,243
Ensembl chr 9:7,502,353...7,510,241
G
Mmp2
matrix metallopeptidase 2
decreases expression
ISO
zoledronic acid results in decreased expression of MMP2 protein
CTD
PMID:16475674
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp23
matrix metallopeptidase 23
increases expression
ISO
zoledronic acid results in increased expression of MMP23B mRNA
CTD
PMID:24714768
NCBI chr 4:155,735,111...155,738,982
Ensembl chr 4:155,735,112...155,737,841
G
Mmp9
matrix metallopeptidase 9
multiple interactions
EXP
zoledronic acid results in decreased expression of and results in decreased activity of MMP9 protein
CTD
PMID:15343380
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mocs1
molybdenum cofactor synthesis 1
increases expression
ISO
zoledronic acid results in increased expression of MOCS1 mRNA
CTD
PMID:24714768
NCBI chr17:49,735,378...49,762,463
Ensembl chr17:49,735,390...49,762,463
G
Mon2
MON2 homolog, regulator of endosome to Golgi trafficking
increases expression
ISO
zoledronic acid results in increased expression of MON2 protein
CTD
PMID:28871336
NCBI chr10:122,827,965...122,913,684
Ensembl chr10:122,827,965...122,912,410
G
Moxd1
monooxygenase, DBH-like 1
increases expression
ISO
zoledronic acid results in increased expression of MOXD1 mRNA
CTD
PMID:24714768
NCBI chr10:24,099,415...24,178,681
Ensembl chr10:24,099,415...24,178,688
G
Mpc2
mitochondrial pyruvate carrier 2
decreases expression
ISO
zoledronic acid results in decreased expression of MPC2 mRNA
CTD
PMID:24714768
NCBI chr 1:165,288,829...165,308,787
Ensembl chr 1:165,288,206...165,308,783
G
Mpdu1
mannose-P-dolichol utilization defect 1
increases expression
ISO
zoledronic acid results in increased expression of MPDU1 mRNA
CTD
PMID:20977926
NCBI chr11:69,547,523...69,553,475
Ensembl chr11:69,547,523...69,553,468
G
Mphosph8
M-phase phosphoprotein 8
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of MPHOSPH8 mRNA
CTD
PMID:16996129
NCBI chr14:56,905,692...56,934,887
Ensembl chr14:56,905,705...56,934,887
G
Mpzl2
myelin protein zero-like 2
increases expression
ISO
zoledronic acid results in increased expression of MPZL2 mRNA
CTD
PMID:24714768
NCBI chr 9:44,951,595...44,965,341
Ensembl chr 9:44,951,097...44,965,313
G
Mreg
melanoregulin
increases expression
ISO
zoledronic acid results in increased expression of MREG mRNA
CTD
PMID:20977926
NCBI chr 1:72,198,392...72,251,418
Ensembl chr 1:72,198,601...72,251,466
G
Mrtfa
myocardin related transcription factor A
increases expression
ISO
zoledronic acid results in increased expression of MRTFA mRNA
CTD
PMID:24714768
NCBI chr15:80,896,482...81,074,937
Ensembl chr15:80,896,482...81,074,958
G
Msh2
mutS homolog 2
decreases expression affects localization
ISO
zoledronic acid results in decreased expression of MSH2 protein zoledronic acid affects the localization of MSH2 protein
CTD
PMID:17070308
NCBI chr17:87,979,960...88,031,141
Ensembl chr17:87,979,758...88,031,141
G
Msh3
mutS homolog 3
increases expression
ISO
zoledronic acid results in increased expression of MSH3 mRNA
CTD
PMID:20977926
NCBI chr13:92,348,387...92,491,515
Ensembl chr13:92,348,380...92,491,511
G
Msmo1
methylsterol monoxygenase 1
increases expression
ISO
zoledronic acid results in increased expression of MSMO1 mRNA
CTD
PMID:24714768
NCBI chr 8:65,171,157...65,186,822
Ensembl chr 8:65,171,173...65,186,826
G
Mt2
metallothionein 2
increases expression
ISO
zoledronic acid results in increased expression of MT2A mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
G
Mta1
metastasis associated 1
decreases expression
ISO
zoledronic acid results in decreased expression of MTA1 protein
CTD
PMID:28871336
NCBI chr12:113,061,830...113,100,826
Ensembl chr12:113,061,898...113,100,826
G
Mterf4
mitochondrial transcription termination factor 4
increases expression
ISO
zoledronic acid results in increased expression of MTERF4 mRNA
CTD
PMID:20977926
NCBI chr 1:93,228,927...93,233,601
Ensembl chr 1:93,226,933...93,233,637
G
Mtpap
mitochondrial poly(A) polymerase
increases expression
ISO
zoledronic acid results in increased expression of MTPAP mRNA
CTD
PMID:20977926
NCBI chr18:4,375,573...4,399,888
Ensembl chr18:4,375,592...4,397,330
G
Mturn
maturin, neural progenitor differentiation regulator homolog (Xenopus)
decreases expression
ISO
zoledronic acid results in decreased expression of MTURN mRNA
CTD
PMID:24714768
NCBI chr 6:54,658,609...54,680,840
Ensembl chr 6:54,658,609...54,680,836
G
Musk
muscle, skeletal, receptor tyrosine kinase
decreases expression
ISO
zoledronic acid results in decreased expression of MUSK mRNA
CTD
PMID:24714768
NCBI chr 4:58,285,742...58,377,848
Ensembl chr 4:58,285,962...58,374,303
G
Mvd
mevalonate (diphospho) decarboxylase
increases expression
ISO
zoledronic acid results in increased expression of MVD mRNA
CTD
PMID:24714768
NCBI chr 8:123,160,335...123,170,161
Ensembl chr 8:123,160,340...123,170,161
G
Mvk
mevalonate kinase
increases expression
ISO
zoledronic acid results in increased expression of MVK mRNA
CTD
PMID:20977926
NCBI chr 5:114,582,324...114,598,652
Ensembl chr 5:114,582,330...114,598,652
G
Mvp
major vault protein
decreases expression increases expression
ISO
zoledronic acid results in decreased expression of MVP mRNA zoledronic acid results in increased expression of MVP mRNA
CTD
PMID:18225567 PMID:20977926
NCBI chr 7:126,586,036...126,613,729
Ensembl chr 7:126,586,032...126,613,793
G
Mxra7
matrix-remodelling associated 7
increases expression
ISO
zoledronic acid results in increased expression of MXRA7 mRNA
CTD
PMID:24714768
NCBI chr11:116,694,226...116,718,953
Ensembl chr11:116,693,888...116,718,872
G
Myl3
myosin, light polypeptide 3
decreases expression
ISO
zoledronic acid results in decreased expression of MYL3 mRNA
CTD
PMID:24714768
NCBI chr 9:110,592,746...110,598,870
Ensembl chr 9:110,570,929...110,598,866
G
N4bp2l1
NEDD4 binding protein 2-like 1
increases expression
ISO
zoledronic acid results in increased expression of N4BP2L1 mRNA
CTD
PMID:20977926
NCBI chr 5:150,495,108...150,518,288
Ensembl chr 5:150,495,109...150,520,653
G
Nab1
Ngfi-A binding protein 1
increases expression
ISO
zoledronic acid results in increased expression of NAB1 mRNA
CTD
PMID:24714768
NCBI chr 1:52,494,146...52,539,553
Ensembl chr 1:52,496,453...52,539,838
G
Naip2
NLR family, apoptosis inhibitory protein 2
affects expression
ISO
zoledronic acid affects the expression of NAIP mRNA
CTD
PMID:19036117
NCBI chr13:100,280,571...100,338,630
Ensembl chr13:100,280,571...100,338,600
G
Nampt
nicotinamide phosphoribosyltransferase
increases expression
ISO
zoledronic acid results in increased expression of NAMPT mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr12:32,870,334...32,903,368
Ensembl chr12:32,869,544...32,903,348
G
Nanos1
nanos C2HC-type zinc finger 1
increases expression
ISO
zoledronic acid results in increased expression of NANOS1 mRNA
CTD
PMID:20977926
NCBI chr19:60,744,425...60,748,352
Ensembl chr19:60,744,425...60,748,352
G
Napepld
N-acyl phosphatidylethanolamine phospholipase D
increases expression
ISO
zoledronic acid results in increased expression of NAPEPLD mRNA
CTD
PMID:24714768
NCBI chr 5:21,867,899...21,906,620
Ensembl chr 5:21,867,899...21,906,394
G
Nars1
asparaginyl-tRNA synthetase 1
decreases expression
ISO
Zoledronic Acid results in decreased expression of NARS1 mRNA
CTD
PMID:25596134
NCBI chr18:64,632,726...64,649,586
Ensembl chr18:64,632,718...64,649,723
G
Nat8
N-acetyltransferase 8 (GCN5-related)
decreases expression
ISO
zoledronic acid results in decreased expression of NAT8 mRNA
CTD
PMID:24714768
NCBI chr 6:85,807,369...85,813,839
Ensembl chr 6:85,807,370...85,809,064
G
Nat8b-ps
N-acetyltransferase 8B, pseudogene
decreases expression
ISO
zoledronic acid results in decreased expression of NAT8B mRNA
CTD
PMID:24714768
NCBI chr 6:85,909,539...85,910,364
Ensembl chr 6:85,909,663...85,910,361
G
Nav1
neuron navigator 1
decreases expression
ISO
zoledronic acid results in decreased expression of NAV1 mRNA
CTD
PMID:24714768
NCBI chr 1:135,362,318...135,616,082
Ensembl chr 1:135,362,318...135,615,843
G
Nav2
neuron navigator 2
decreases expression
ISO
zoledronic acid results in decreased expression of NAV2 mRNA
CTD
PMID:24714768
NCBI chr 7:48,608,796...49,259,838
Ensembl chr 7:48,558,464...49,259,838
G
Nbr1
NBR1, autophagy cargo receptor
increases expression
ISO
zoledronic acid results in increased expression of NBR1 mRNA
CTD
PMID:20977926
NCBI chr11:101,442,933...101,472,777
Ensembl chr11:101,442,975...101,472,777
G
Ncapg
non-SMC condensin I complex, subunit G
decreases expression
ISO
zoledronic acid results in decreased expression of NCAPG mRNA
CTD
PMID:24714768
NCBI chr 5:45,827,212...45,858,491
Ensembl chr 5:45,827,261...45,857,888
G
Nck1
non-catalytic region of tyrosine kinase adaptor protein 1
increases expression
ISO
zoledronic acid results in increased expression of NCK1 mRNA
CTD
PMID:24714768
NCBI chr 9:100,376,047...100,428,187
Ensembl chr 9:100,374,346...100,428,187
G
Nckap5
NCK-associated protein 5
increases expression
ISO
zoledronic acid results in increased expression of NCKAP5 mRNA
CTD
PMID:24714768
NCBI chr 1:125,841,373...126,758,529
Ensembl chr 1:125,841,357...126,758,536
G
Ncoa7
nuclear receptor coactivator 7
increases expression
ISO
zoledronic acid results in increased expression of NCOA7 mRNA
CTD
PMID:24714768
NCBI chr10:30,521,578...30,683,401
Ensembl chr10:30,504,995...30,679,322
G
Ndc80
NDC80 kinetochore complex component
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of NDC80 mRNA
CTD
PMID:16996129
NCBI chr17:71,803,095...71,833,852
Ensembl chr17:71,803,095...71,833,852
G
Nde1
nudE neurodevelopment protein 1
increases expression
ISO
zoledronic acid results in increased expression of NDE1 mRNA
CTD
PMID:20977926
NCBI chr16:13,981,139...14,010,792
Ensembl chr16:13,981,139...14,010,792
G
Ndrg4
N-myc downstream regulated gene 4
increases expression
ISO
zoledronic acid results in increased expression of NDRG4 mRNA
CTD
PMID:24714768
NCBI chr 8:96,403,602...96,441,584
Ensembl chr 8:96,403,608...96,441,747
G
Nefl
neurofilament, light polypeptide
decreases expression
ISO
zoledronic acid results in decreased expression of NEFL mRNA
CTD
PMID:24714768
NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544
G
Nefm
neurofilament, medium polypeptide
decreases expression
ISO
zoledronic acid results in decreased expression of NEFM mRNA
CTD
PMID:24714768
NCBI chr14:68,356,994...68,362,453
Ensembl chr14:68,320,039...68,362,295
G
Nek2
NIMA (never in mitosis gene a)-related expressed kinase 2
decreases expression
ISO
zoledronic acid results in decreased expression of NEK2 mRNA
CTD
PMID:24714768
NCBI chr 1:191,553,622...191,565,161
Ensembl chr 1:191,553,556...191,565,162
G
Nemp1
nuclear envelope integral membrane protein 1
increases expression
ISO
zoledronic acid results in increased expression of NEMP1 mRNA
CTD
PMID:20977926
NCBI chr10:127,512,934...127,536,918
Ensembl chr10:127,502,770...127,536,918
G
Neurl3
neuralized E3 ubiquitin protein ligase 3
increases expression
ISO
zoledronic acid results in increased expression of LINCR mRNA
CTD
PMID:24714768
NCBI chr 1:36,303,683...36,313,755
Ensembl chr 1:36,303,678...36,313,760
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
increases expression
ISO
Zoledronic Acid results in increased expression of NFE2L2 mRNA
CTD
PMID:20977926 PMID:35587103
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfe2l3
nuclear factor, erythroid derived 2, like 3
decreases expression
ISO
zoledronic acid results in decreased expression of NFE2L3 mRNA
CTD
PMID:20977926
NCBI chr 6:51,409,649...51,435,752
Ensembl chr 6:51,409,650...51,435,748
G
Nfkb2
nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100
increases expression
ISO
zoledronic acid results in increased expression of NFKB2 mRNA
CTD
PMID:24714768
NCBI chr19:46,285,478...46,300,839
Ensembl chr19:46,292,759...46,300,824
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
increases expression
ISO
zoledronic acid results in increased expression of NFKBIA mRNA
CTD
PMID:24714768
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nfkbiz
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta
increases expression
ISO
zoledronic acid results in increased expression of NFKBIZ mRNA
CTD
PMID:24714768
NCBI chr16:55,631,740...55,659,018
Ensembl chr16:55,631,738...55,659,262
G
Nhs
NHS actin remodeling regulator
decreases expression
ISO
zoledronic acid results in decreased expression of NHS mRNA
CTD
PMID:24714768
NCBI chr X:160,616,286...160,942,437
Ensembl chr X:160,616,292...160,942,726
G
Niban1
niban apoptosis regulator 1
increases expression
ISO
Zoledronic Acid results in increased expression of NIBAN1 mRNA
CTD
PMID:24714768
NCBI chr 1:151,447,215...151,597,690
Ensembl chr 1:151,446,937...151,597,690
G
Nicol1
NELL2 interacting cell ontogeny regulator 1
decreases expression
ISO
Zoledronic Acid results in decreased expression of NICOL1 mRNA
CTD
PMID:20977926
NCBI chr 5:34,140,863...34,142,353
Ensembl chr 5:34,140,777...34,142,357
G
Nid2
nidogen 2
increases expression
ISO
zoledronic acid results in increased expression of NID2 mRNA
CTD
PMID:24714768
NCBI chr14:19,801,325...19,861,855
Ensembl chr14:19,801,333...19,861,855
G
Ninj1
ninjurin 1
decreases expression
ISO
zoledronic acid results in decreased expression of NINJ1 mRNA
CTD
PMID:25596134
NCBI chr13:49,341,005...49,349,727
Ensembl chr13:49,340,961...49,349,720
G
Ninj2
ninjurin 2
decreases expression
ISO
zoledronic acid results in decreased expression of NINJ2 mRNA
CTD
PMID:24714768
NCBI chr 6:120,070,315...120,177,300
Ensembl chr 6:120,070,311...120,177,300
G
Nkrf
NF-kappaB repressing factor
decreases expression
ISO
zoledronic acid results in decreased expression of NKRF mRNA
CTD
PMID:20977926
NCBI chr X:36,149,644...36,167,118
Ensembl chr X:36,151,193...36,167,166
G
Nos2
nitric oxide synthase 2, inducible
multiple interactions increases expression
EXP ISO
[zoledronic acid results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide zoledronic acid results in increased expression of NOS2 mRNA
CTD
PMID:19818098 PMID:24714768
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nostrin
nitric oxide synthase trafficker
decreases expression
ISO
zoledronic acid results in decreased expression of NOSTRIN mRNA
CTD
PMID:24714768
NCBI chr 2:68,966,144...69,019,674
Ensembl chr 2:68,966,144...69,019,674
G
Notch3
notch 3
decreases expression
ISO
zoledronic acid results in decreased expression of NOTCH3 mRNA
CTD
PMID:24714768
NCBI chr17:32,339,794...32,385,869
Ensembl chr17:32,339,794...32,385,826
G
Nox4
NADPH oxidase 4
increases expression
ISO
zoledronic acid results in increased expression of NOX4 protein
CTD
PMID:28871336
NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918
G
Npat
nuclear protein in the AT region
increases expression
ISO
zoledronic acid results in increased expression of NPAT mRNA
CTD
PMID:20977926
NCBI chr 9:53,448,347...53,486,867
Ensembl chr 9:53,448,347...53,485,642
G
Npc1l1
NPC1 like intracellular cholesterol transporter 1
increases expression
ISO
zoledronic acid results in increased expression of NPC1L1 mRNA
CTD
PMID:24714768
NCBI chr11:6,161,011...6,180,245
Ensembl chr11:6,161,013...6,180,143
G
Npffr2
neuropeptide FF receptor 2
increases expression
ISO
zoledronic acid results in increased expression of NPFFR2 mRNA
CTD
PMID:24714768
NCBI chr 5:89,674,805...89,731,473
Ensembl chr 5:89,675,288...89,731,599
G
Npr3
natriuretic peptide receptor 3
decreases expression
ISO
zoledronic acid results in decreased expression of NPR3 mRNA
CTD
PMID:24714768
NCBI chr15:11,839,982...11,907,287
Ensembl chr15:11,839,982...11,907,373
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
decreases expression
ISO
zoledronic acid results in decreased expression of NQO1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
decreases expression
ISO
zoledronic acid results in decreased expression of NR1H4 mRNA
CTD
PMID:24714768
NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
G
Nrcam
neuronal cell adhesion molecule
increases expression
ISO
zoledronic acid results in increased expression of NRCAM mRNA
CTD
PMID:24714768
NCBI chr12:44,375,568...44,651,977
Ensembl chr12:44,375,668...44,648,747
G
Nrep
neuronal regeneration related protein
increases expression
ISO
zoledronic acid results in increased expression of NREP mRNA
CTD
PMID:20977926 PMID:25596134
NCBI chr18:33,570,072...33,597,444
Ensembl chr18:33,570,072...33,597,082
G
Nrg1
neuregulin 1
decreases expression
ISO
zoledronic acid results in decreased expression of NRG1 mRNA
CTD
PMID:24714768
NCBI chr 8:32,299,493...33,381,858
Ensembl chr 8:32,304,579...33,374,825 Ensembl chr 8:32,304,579...33,374,825
G
Nrip3
nuclear receptor interacting protein 3
increases expression
ISO
zoledronic acid results in increased expression of NRIP3 mRNA
CTD
PMID:24714768
NCBI chr 7:109,357,263...109,380,752
Ensembl chr 7:109,357,262...109,381,232
G
Nsdhl
NAD(P) dependent steroid dehydrogenase-like
increases expression
ISO
zoledronic acid results in increased expression of NSDHL mRNA
CTD
PMID:24714768
NCBI chr X:71,962,127...72,002,134
Ensembl chr X:71,962,163...72,002,120
G
Ntn1
netrin 1
increases expression
ISO
zoledronic acid results in increased expression of NTN1 mRNA
CTD
PMID:24714768
NCBI chr11:68,100,190...68,277,652
Ensembl chr11:68,100,190...68,291,649
G
Ntng1
netrin G1
decreases expression
ISO
zoledronic acid results in decreased expression of NTNG1 mRNA
CTD
PMID:24714768
NCBI chr 3:109,687,366...110,057,291
Ensembl chr 3:109,687,356...110,051,327
G
Ntpcr
nucleoside-triphosphatase, cancer-related
increases expression
ISO
zoledronic acid results in increased expression of NTPCR mRNA
CTD
PMID:25596134
NCBI chr 8:126,456,724...126,474,974
Ensembl chr 8:126,456,702...126,474,974
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
increases expression
ISO
zoledronic acid results in increased expression of NTRK2 mRNA
CTD
PMID:24714768
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
Nup93
nucleoporin 93
increases expression
ISO
zoledronic acid results in increased expression of NUP93 mRNA
CTD
PMID:24714768
NCBI chr 8:94,941,203...95,043,858
Ensembl chr 8:94,941,192...95,043,855
G
Nup98
nucleoporin 98
decreases expression
ISO
zoledronic acid results in decreased expression of NUP98 mRNA
CTD
PMID:24714768
NCBI chr 7:101,768,607...101,859,359
Ensembl chr 7:101,768,605...101,859,383
G
Nxnl2
nucleoredoxin-like 2
decreases expression
ISO
zoledronic acid results in decreased expression of NXNL2 mRNA
CTD
PMID:24714768
NCBI chr13:51,324,256...51,329,227
Ensembl chr13:51,325,058...51,329,224
G
Nxt2
nuclear transport factor 2-like export factor 2
increases expression
ISO
zoledronic acid results in increased expression of NXT2 mRNA
CTD
PMID:20977926
NCBI chr X:141,009,766...141,022,696
Ensembl chr X:141,009,766...141,022,688
G
Ogdhl
oxoglutarate dehydrogenase-like
decreases expression
ISO
zoledronic acid results in decreased expression of OGDHL mRNA
CTD
PMID:24714768
NCBI chr14:32,043,941...32,070,108
Ensembl chr14:32,043,976...32,070,108
G
Oip5
Opa interacting protein 5
decreases expression
ISO
zoledronic acid results in decreased expression of OIP5 mRNA
CTD
PMID:24714768
NCBI chr 2:119,440,013...119,448,986
Ensembl chr 2:119,439,993...119,448,950
G
Olfm4
olfactomedin 4
increases expression
ISO
zoledronic acid results in increased expression of OLFM4 mRNA
CTD
PMID:24714768
NCBI chr14:80,237,742...80,260,581
Ensembl chr14:80,221,521...80,260,579
G
Olr1
oxidized low density lipoprotein (lectin-like) receptor 1
increases expression
ISO
zoledronic acid results in increased expression of OLR1 protein
CTD
PMID:28871336
NCBI chr 6:129,456,113...129,484,312
Ensembl chr 6:129,462,207...129,484,128
G
Optn
optineurin
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of OPTN mRNA
CTD
PMID:16996129
NCBI chr 2:5,023,902...5,069,210
Ensembl chr 2:5,025,453...5,068,862
G
Or12d2
olfactory receptor family 12 subfamily D member 2
increases expression
ISO
Zoledronic Acid results in increased expression of OR12D2 mRNA
CTD
PMID:24714768
NCBI chr17:37,624,302...37,625,328
Ensembl chr17:37,622,686...37,627,945
G
Or2h1
olfactory receptor family 2 subfamily H member 1
increases expression
ISO
Zoledronic Acid results in increased expression of OR2H1 mRNA
CTD
PMID:24714768
NCBI chr17:37,403,022...37,443,877
Ensembl chr17:37,401,510...37,409,170
G
Or4k15
olfactory receptor family 4 subfamily K member 15
increases expression
ISO
zoledronic acid results in increased expression of OR4K15 mRNA
CTD
PMID:24714768
NCBI chr14:50,364,010...50,365,044
Ensembl chr14:50,360,643...50,366,203
G
Or51b17
olfactory receptor family 51 subfamily B member 17
increases expression
ISO
zoledronic acid results in increased expression of OR51B2 mRNA
CTD
PMID:20977926
NCBI chr 7:103,542,017...103,543,678
Ensembl chr 7:103,538,692...103,543,692
G
Or8h9
olfactory receptor family 8 subfamily H member 9
increases expression
ISO
Zoledronic Acid results in increased expression of OR8H1 mRNA
CTD
PMID:24714768
NCBI chr 2:86,788,862...86,789,800
Ensembl chr 2:86,785,470...86,791,037
G
Orc2
origin recognition complex, subunit 2
decreases expression
ISO
zoledronic acid results in decreased expression of ORC2 protein
CTD
PMID:28871336
NCBI chr 1:58,501,933...58,544,114
Ensembl chr 1:58,501,930...58,544,268
G
Osgepl1
O-sialoglycoprotein endopeptidase-like 1
decreases expression
ISO
zoledronic acid results in decreased expression of OSGEPL1 mRNA
CTD
PMID:20977926
NCBI chr 1:53,352,070...53,365,502
Ensembl chr 1:53,352,783...53,365,502
G
Osgin1
oxidative stress induced growth inhibitor 1
decreases expression
ISO
zoledronic acid results in decreased expression of OSGIN1 mRNA
CTD
PMID:25596134
NCBI chr 8:120,160,874...120,172,996
Ensembl chr 8:120,160,863...120,172,995
G
Ovgp1
oviductal glycoprotein 1
increases expression
ISO
zoledronic acid results in increased expression of OVGP1 mRNA
CTD
PMID:24714768
NCBI chr 3:105,881,118...105,894,739
Ensembl chr 3:105,881,027...105,894,739
G
P2rx4
purinergic receptor P2X, ligand-gated ion channel 4
increases expression
ISO
zoledronic acid results in increased expression of P2RX4 mRNA
CTD
PMID:24714768
NCBI chr 5:122,845,581...122,867,802
Ensembl chr 5:122,845,607...122,867,801
G
P3h2
prolyl 3-hydroxylase 2
decreases expression
ISO
zoledronic acid results in decreased expression of P3H2 mRNA
CTD
PMID:24714768
NCBI chr16:25,778,034...25,924,563
Ensembl chr16:25,778,038...25,924,534
G
P4ha1
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide
increases expression
ISO
zoledronic acid results in increased expression of P4HA1 mRNA
CTD
PMID:25596134
NCBI chr10:59,159,019...59,209,126
Ensembl chr10:59,159,118...59,209,126
G
P4ha2
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide
increases expression
ISO
zoledronic acid results in increased expression of P4HA2 mRNA
CTD
PMID:24714768
NCBI chr11:53,991,750...54,022,494
Ensembl chr11:53,990,921...54,022,491
G
P4hb
prolyl 4-hydroxylase, beta polypeptide
increases expression
ISO
zoledronic acid results in increased expression of P4HB mRNA
CTD
PMID:20977926
NCBI chr11:120,451,124...120,464,079
Ensembl chr11:120,451,124...120,464,079
G
Palm
paralemmin
decreases expression
ISO
zoledronic acid results in decreased expression of PALM mRNA
CTD
PMID:24714768
NCBI chr10:79,629,406...79,656,749
Ensembl chr10:79,629,406...79,656,730
G
Pals1
protein associated with LIN7 1, MAGUK family member
multiple interactions
ISO
[Zoledronic Acid co-treated with Fluvastatin] results in increased expression of PALS1 mRNA
CTD
PMID:16996129
NCBI chr12:78,795,606...78,887,488
Ensembl chr12:78,795,681...78,887,488
G
Pank1
pantothenate kinase 1
decreases expression
ISO
zoledronic acid results in decreased expression of PANK1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr19:34,784,335...34,862,420
Ensembl chr19:34,784,340...34,856,855
G
Pappa
pregnancy-associated plasma protein A
decreases expression
ISO
zoledronic acid results in decreased expression of PAPPA mRNA
CTD
PMID:24714768
NCBI chr 4:65,041,993...65,276,776
Ensembl chr 4:65,042,411...65,275,746
G
Pappa2
pappalysin 2
multiple interactions decreases expression
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of PAPPA2 mRNA zoledronic acid results in decreased expression of PAPPA2 mRNA
CTD
PMID:16996129 PMID:24714768
NCBI chr 1:158,539,297...158,788,019
Ensembl chr 1:158,539,297...158,808,060
G
Paqr5
progestin and adipoQ receptor family member V
decreases expression
ISO
zoledronic acid results in decreased expression of PAQR5 mRNA
CTD
PMID:24714768
NCBI chr 9:61,861,020...61,934,085
Ensembl chr 9:61,860,763...61,934,138
G
Paqr8
progestin and adipoQ receptor family member VIII
increases expression
ISO
zoledronic acid results in increased expression of PAQR8 mRNA
CTD
PMID:24714768
NCBI chr 1:20,960,772...21,009,874
Ensembl chr 1:20,960,830...21,009,874
G
Pard6a
par-6 family cell polarity regulator alpha
decreases expression
ISO
zoledronic acid results in decreased expression of PARD6A mRNA
CTD
PMID:24714768
NCBI chr 8:106,427,780...106,430,126
Ensembl chr 8:106,427,780...106,430,128
G
Parm1
prostate androgen-regulated mucin-like protein 1
increases expression
ISO
zoledronic acid results in increased expression of PARM1 mRNA
CTD
PMID:24714768
NCBI chr 5:91,665,559...91,771,870
Ensembl chr 5:91,665,474...91,774,753
G
Parp1
poly (ADP-ribose) polymerase family, member 1
increases expression increases cleavage multiple interactions
ISO
zoledronic acid results in increased expression of PARP1 mRNA zoledronic acid results in increased cleavage of PARP1 protein arsenic trioxide promotes the reaction [zoledronic acid results in increased cleavage of PARP1 protein]
CTD
PMID:10780527 PMID:20977926 PMID:24714768
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pbk
PDZ binding kinase
decreases expression
ISO
zoledronic acid results in decreased expression of PBK mRNA
CTD
PMID:24714768
NCBI chr14:66,043,337...66,055,271
Ensembl chr14:66,043,286...66,055,271
G
Pbld1
phenazine biosynthesis-like protein domain containing 1
decreases expression
ISO
zoledronic acid results in decreased expression of PBLD mRNA
CTD
PMID:24714768
NCBI chr10:62,896,404...62,913,743
Ensembl chr10:62,895,941...62,913,741
G
Pcdh17
protocadherin 17
increases expression
ISO
zoledronic acid results in increased expression of PCDH17 mRNA
CTD
PMID:24714768
NCBI chr14:84,680,626...84,775,005
Ensembl chr14:84,681,003...84,776,442
G
Pcdh20
protocadherin 20
decreases expression
ISO
zoledronic acid results in decreased expression of PCDH20 mRNA
CTD
PMID:24714768
NCBI chr14:88,702,183...88,708,832
Ensembl chr14:88,702,179...88,708,832
G
Pced1b
PC-esterase domain containing 1B
increases expression
ISO
zoledronic acid results in increased expression of PCED1B mRNA
CTD
PMID:24714768
NCBI chr15:97,143,563...97,283,574
Ensembl chr15:97,144,988...97,283,561
G
Pcgf5
polycomb group ring finger 5
increases expression
ISO
zoledronic acid results in increased expression of PCGF5 mRNA
CTD
PMID:20977926
NCBI chr19:36,325,729...36,438,370
Ensembl chr19:36,325,709...36,438,370
G
Pclaf
PCNA clamp associated factor
decreases expression
ISO
zoledronic acid results in decreased expression of PCLAF mRNA
CTD
PMID:24714768
NCBI chr 9:65,797,605...65,810,833
Ensembl chr 9:65,797,519...65,810,548
G
Pcolce2
procollagen C-endopeptidase enhancer 2
decreases expression
ISO
zoledronic acid results in decreased expression of PCOLCE2 mRNA
CTD
PMID:24714768
NCBI chr 9:95,519,681...95,577,604
Ensembl chr 9:95,519,654...95,580,149
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
increases expression
ISO
zoledronic acid results in increased expression of PCSK9 mRNA
CTD
PMID:24714768
NCBI chr 4:106,299,531...106,321,522
Ensembl chr 4:106,299,526...106,321,526
G
Pcyox1
prenylcysteine oxidase 1
increases expression
ISO
zoledronic acid results in increased expression of PCYOX1 mRNA
CTD
PMID:20977926
NCBI chr 6:86,362,988...86,374,132
Ensembl chr 6:86,362,988...86,374,136
G
Pde1a
phosphodiesterase 1A, calmodulin-dependent
decreases expression
ISO
zoledronic acid results in decreased expression of PDE1A mRNA
CTD
PMID:24714768
NCBI chr 2:79,664,797...80,026,862
Ensembl chr 2:79,664,797...79,959,802
G
Pde4b
phosphodiesterase 4B, cAMP specific
decreases expression
ISO
zoledronic acid results in decreased expression of PDE4B mRNA
CTD
PMID:24714768
NCBI chr 4:101,944,529...102,464,459
Ensembl chr 4:101,944,740...102,464,456
G
Pde5a
phosphodiesterase 5A, cGMP-specific
decreases expression
ISO
zoledronic acid results in decreased expression of PDE5A mRNA
CTD
PMID:24714768
NCBI chr 3:122,522,822...122,653,023
Ensembl chr 3:122,522,596...122,653,023
G
Pde7b
phosphodiesterase 7B
decreases expression
ISO
zoledronic acid results in decreased expression of PDE7B mRNA
CTD
PMID:24714768
NCBI chr10:20,272,798...20,600,824
Ensembl chr10:20,273,750...20,600,824
G
Pde8a
phosphodiesterase 8A
increases expression
ISO
zoledronic acid results in increased expression of PDE8A mRNA
CTD
PMID:25596134
NCBI chr 7:80,863,013...80,984,283
Ensembl chr 7:80,863,344...80,984,281
G
Pdgfa
platelet derived growth factor, alpha
multiple interactions
ISO
[zoledronic acid co-treated with Gossypol] results in decreased expression of PDGFA mRNA
CTD
PMID:19825521
NCBI chr 5:138,961,761...138,986,336
Ensembl chr 5:138,961,769...138,983,125
G
Pdgfc
platelet-derived growth factor, C polypeptide
decreases expression
ISO
zoledronic acid results in decreased expression of PDGFC mRNA
CTD
PMID:24714768
NCBI chr 3:80,943,723...81,121,347
Ensembl chr 3:80,943,723...81,121,347
G
Pdgfra
platelet derived growth factor receptor, alpha polypeptide
increases expression
ISO
zoledronic acid results in increased expression of PDGFRA mRNA
CTD
PMID:24714768
NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
G
Pdgfrl
platelet-derived growth factor receptor-like
increases expression
ISO
zoledronic acid results in increased expression of PDGFRL mRNA
CTD
PMID:24714768
NCBI chr 8:41,379,270...41,443,819
Ensembl chr 8:41,379,249...41,443,822
G
Pdhb
pyruvate dehydrogenase (lipoamide) beta
increases expression
ISO
zoledronic acid results in increased expression of PDHB protein
CTD
PMID:28871336
NCBI chr14:14,296,470...14,303,782
Ensembl chr14:14,296,748...14,303,777
G
Pdk4
pyruvate dehydrogenase kinase, isoenzyme 4
decreases expression
ISO
zoledronic acid results in decreased expression of PDK4 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 6:5,483,351...5,496,278
Ensembl chr 6:5,483,351...5,496,309
G
Pdlim7
PDZ and LIM domain 7
increases expression
ISO
zoledronic acid results in increased expression of PDLIM7 mRNA
CTD
PMID:20977926
NCBI chr13:55,645,300...55,661,281
Ensembl chr13:55,643,608...55,661,489
G
Pdzk1
PDZ domain containing 1
decreases expression
ISO
zoledronic acid results in decreased expression of PDZK1 mRNA
CTD
PMID:24714768
NCBI chr 3:96,736,772...96,778,242
Ensembl chr 3:96,736,600...96,778,242
G
Pdzk1ip1
PDZK1 interacting protein 1
increases expression
ISO
zoledronic acid results in increased expression of PDZK1IP1 mRNA
CTD
PMID:24714768
NCBI chr 4:114,945,905...114,951,091
Ensembl chr 4:114,945,905...114,951,096
G
Pea15a
proliferation and apoptosis adaptor protein 15A
increases expression
ISO
zoledronic acid results in increased expression of PEA15 mRNA
CTD
PMID:24714768
NCBI chr 1:172,024,295...172,034,298
Ensembl chr 1:172,024,295...172,034,371
G
Pecam1
platelet/endothelial cell adhesion molecule 1
multiple interactions
EXP
zoledronic acid promotes the reaction [[Imatinib Mesylate co-treated with Paclitaxel] results in decreased expression of PECAM1 protein]
CTD
PMID:15867366
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Peli1
pellino 1
increases expression
ISO
zoledronic acid results in increased expression of PELI1 mRNA
CTD
PMID:24714768
NCBI chr11:21,041,283...21,100,327
Ensembl chr11:21,041,291...21,100,323
G
Pfkfb4
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
increases expression
ISO
zoledronic acid results in increased expression of PFKFB4 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 9:108,817,336...108,861,302
Ensembl chr 9:108,820,846...108,861,296
G
Pgcka1
PDCD10 and GCKIII kinases associated 1
increases expression
ISO
Zoledronic Acid results in increased expression of PGCKA1 mRNA
CTD
PMID:24714768
NCBI chr 5:63,969,833...64,056,968
Ensembl chr 5:63,969,706...64,056,968
G
Pglyrp4
peptidoglycan recognition protein 4
increases expression
ISO
zoledronic acid results in increased expression of PGLYRP4 mRNA
CTD
PMID:20977926
NCBI chr 3:90,634,008...90,648,824
Ensembl chr 3:90,634,213...90,648,824
G
Pgm5
phosphoglucomutase 5
decreases expression
ISO
zoledronic acid results in decreased expression of PGM5 mRNA
CTD
PMID:24714768
NCBI chr19:24,655,625...24,839,206
Ensembl chr19:24,660,380...24,839,219
G
Phactr1
phosphatase and actin regulator 1
increases expression
ISO
zoledronic acid results in increased expression of PHACTR1 mRNA
CTD
PMID:24714768
NCBI chr13:42,833,909...43,292,002
Ensembl chr13:42,834,099...43,292,002
G
Phgdh
3-phosphoglycerate dehydrogenase
decreases expression
ISO
zoledronic acid results in decreased expression of PHGDH mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 3:98,220,487...98,247,285
Ensembl chr 3:98,220,486...98,247,306
G
Phlda3
pleckstrin homology like domain, family A, member 3
decreases expression
ISO
zoledronic acid results in decreased expression of PHLDA3 mRNA
CTD
PMID:25596134
NCBI chr 1:135,693,823...135,696,872
Ensembl chr 1:135,693,857...135,696,874
G
Phldb1
pleckstrin homology like domain, family B, member 1
decreases expression
ISO
zoledronic acid results in decreased expression of PHLDB1 mRNA
CTD
PMID:24714768
NCBI chr 9:44,597,605...44,649,800
Ensembl chr 9:44,597,601...44,646,495
G
Phpt1
phosphohistidine phosphatase 1
increases expression
ISO
zoledronic acid results in increased expression of PHPT1 mRNA
CTD
PMID:20977926
NCBI chr 2:25,463,442...25,465,528
Ensembl chr 2:25,463,442...25,465,236
G
Pigr
polymeric immunoglobulin receptor
increases expression
ISO
zoledronic acid results in increased expression of PIGR mRNA
CTD
PMID:24714768
NCBI chr 1:130,754,421...130,779,986
Ensembl chr 1:130,754,421...130,779,986
G
Pik3ap1
phosphoinositide-3-kinase adaptor protein 1
increases expression
ISO
zoledronic acid results in increased expression of PIK3AP1 mRNA
CTD
PMID:24714768
NCBI chr19:41,260,980...41,373,541
Ensembl chr19:41,260,816...41,373,541
G
Pik3c2a
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha
increases expression
ISO
zoledronic acid results in increased expression of PIK3C2A mRNA
CTD
PMID:20977926
NCBI chr 7:115,936,500...116,042,693
Ensembl chr 7:115,936,500...116,042,684
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
increases expression
ISO
zoledronic acid results in increased expression of PIK3R1 mRNA
CTD
PMID:24714768
NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725
G
Pilra
paired immunoglobin-like type 2 receptor alpha
increases expression
ISO
zoledronic acid results in increased expression of PILRA mRNA
CTD
PMID:24714768
NCBI chr 5:137,820,214...137,834,540
Ensembl chr 5:137,820,214...137,834,543
G
Pilrb2
paired immunoglobin-like type 2 receptor beta 2
increases expression
ISO
zoledronic acid results in increased expression of PILRB mRNA
CTD
PMID:20977926
NCBI chr 5:137,864,083...137,870,083
Ensembl chr 5:137,864,089...137,870,077
G
Pim2
proviral integration site 2
increases expression
ISO
zoledronic acid results in increased expression of PIM2 mRNA
CTD
PMID:24714768
NCBI chr X:7,744,545...7,749,671
Ensembl chr X:7,744,501...7,749,671
G
Pip4p2
phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2
decreases expression
ISO
zoledronic acid results in decreased expression of PIP4P2 mRNA
CTD
PMID:24714768
NCBI chr 4:14,864,219...14,915,501
Ensembl chr 4:14,864,076...14,915,176
G
Pir
pirin
increases expression
ISO
zoledronic acid results in increased expression of PIR mRNA
CTD
PMID:25596134
NCBI chr X:163,052,427...163,156,009
Ensembl chr X:163,052,367...163,156,007
G
Pisd
phosphatidylserine decarboxylase
increases expression
ISO
zoledronic acid results in increased expression of PISD mRNA
CTD
PMID:24714768
NCBI chr 5:32,893,645...32,943,008
Ensembl chr 5:32,893,645...32,942,990
G
Pkhd1
polycystic kidney and hepatic disease 1
decreases expression
ISO
zoledronic acid results in decreased expression of PKHD1 mRNA
CTD
PMID:24714768
NCBI chr 1:20,128,003...20,688,306
Ensembl chr 1:20,128,003...20,688,288
G
Pkia
protein kinase inhibitor, alpha
decreases expression
ISO
zoledronic acid results in decreased expression of PKIA mRNA
CTD
PMID:24714768
NCBI chr 3:7,431,695...7,510,426
Ensembl chr 3:7,431,729...7,510,426
G
Pkib
protein kinase inhibitor beta, cAMP dependent, testis specific
decreases expression
ISO
zoledronic acid results in decreased expression of PKIB mRNA
CTD
PMID:24714768
NCBI chr10:57,508,077...57,617,208
Ensembl chr10:57,508,077...57,617,208
G
Pkp4
plakophilin 4
decreases expression
ISO
zoledronic acid results in decreased expression of PKP4 mRNA
CTD
PMID:24714768
NCBI chr 2:58,991,123...59,185,549
Ensembl chr 2:58,991,194...59,185,552
G
Pla1a
phospholipase A1 member A
increases expression
ISO
zoledronic acid results in increased expression of PLA1A mRNA
CTD
PMID:24714768
NCBI chr16:38,214,245...38,253,553
Ensembl chr16:38,216,479...38,253,507
G
Pla2g4c
phospholipase A2, group IVC (cytosolic, calcium-independent)
increases expression
ISO
zoledronic acid results in increased expression of PLA2G4C mRNA
CTD
PMID:24714768
NCBI chr 7:13,045,432...13,094,597
Ensembl chr 7:13,058,580...13,094,597
G
Pla2g4f
phospholipase A2, group IVF
decreases expression
ISO
zoledronic acid results in decreased expression of PLA2G4F mRNA
CTD
PMID:24714768
NCBI chr 2:120,130,433...120,144,646
Ensembl chr 2:120,130,438...120,144,646
G
Plat
plasminogen activator, tissue
increases expression
ISO
zoledronic acid results in increased expression of PLAT mRNA
CTD
PMID:24714768
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Plau
plasminogen activator, urokinase
increases expression
ISO
zoledronic acid results in increased expression of PLAU mRNA
CTD
PMID:20977926
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Plcb1
phospholipase C, beta 1
decreases expression
ISO
zoledronic acid results in decreased expression of PLCB1 mRNA
CTD
PMID:24714768
NCBI chr 2:134,628,084...135,317,178
Ensembl chr 2:134,627,987...135,317,178
G
Plcd4
phospholipase C, delta 4
decreases expression
ISO
zoledronic acid results in decreased expression of PLCD4 mRNA
CTD
PMID:24714768
NCBI chr 1:74,581,175...74,605,137
Ensembl chr 1:74,582,047...74,606,953
G
Plcl2
phospholipase C-like 2
increases expression
ISO
zoledronic acid results in increased expression of PLCL2 mRNA
CTD
PMID:24714768
NCBI chr17:50,815,893...50,995,522
Ensembl chr17:50,816,431...50,995,512
G
Pld5
phospholipase D family member 5
increases expression
ISO
zoledronic acid results in increased expression of PLD5 mRNA
CTD
PMID:24714768
NCBI chr 1:175,789,867...176,109,078
Ensembl chr 1:175,789,872...176,102,878
G
Plec
plectin
decreases expression
ISO
zoledronic acid results in decreased expression of PLEC mRNA; zoledronic acid results in decreased expression of PLEC protein
CTD
PMID:25596134 PMID:28871336
NCBI chr15:76,055,174...76,115,578
Ensembl chr15:76,055,174...76,116,774
G
Plek
pleckstrin
increases expression
ISO
zoledronic acid results in increased expression of PLEK mRNA
CTD
PMID:20977926
NCBI chr11:16,921,206...16,958,718
Ensembl chr11:16,921,206...17,002,381
G
Plekhh2
pleckstrin homology domain containing, family H (with MyTH4 domain) member 2
decreases expression
ISO
zoledronic acid results in decreased expression of PLEKHH2 mRNA
CTD
PMID:24714768
NCBI chr17:84,819,303...84,929,571
Ensembl chr17:84,819,323...84,929,566
G
Plk1
polo like kinase 1
decreases expression
ISO
zoledronic acid results in decreased expression of PLK1 mRNA
CTD
PMID:20977926
NCBI chr 7:121,758,658...121,769,107
Ensembl chr 7:121,758,662...121,769,096
G
Plod2
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2
increases expression
ISO
zoledronic acid results in increased expression of PLOD2 mRNA
CTD
PMID:24714768
NCBI chr 9:92,421,828...92,490,481
Ensembl chr 9:92,424,276...92,490,481
G
Plpp3
phospholipid phosphatase 3
increases expression
ISO
zoledronic acid results in increased expression of PLPP3 mRNA
CTD
PMID:24714768
NCBI chr 4:105,014,544...105,089,964
Ensembl chr 4:105,014,544...105,089,961
G
Plscr1
phospholipid scramblase 1
increases expression
ISO
zoledronic acid results in increased expression of PLSCR1 mRNA
CTD
PMID:24714768
NCBI chr 9:92,132,265...92,154,034
Ensembl chr 9:92,131,803...92,154,331
G
Pnkd
paroxysmal nonkinesiogenic dyskinesia
increases expression
ISO
zoledronic acid results in increased expression of PNKD mRNA
CTD
PMID:24714768
NCBI chr 1:74,323,757...74,392,851
Ensembl chr 1:74,324,089...74,392,853
G
Pnrc2
proline-rich nuclear receptor coactivator 2
increases expression
ISO
zoledronic acid results in increased expression of PNRC2 mRNA
CTD
PMID:20977926
NCBI chr 4:135,598,229...135,601,157
Ensembl chr 4:135,598,229...135,601,161
G
Poglut2
protein O-glucosyltransferase 2
decreases expression
ISO
Zoledronic Acid results in decreased expression of POGLUT2 mRNA
CTD
PMID:24714768
NCBI chr 1:44,143,060...44,158,844
Ensembl chr 1:44,145,706...44,157,968
G
Polr2a
polymerase (RNA) II (DNA directed) polypeptide A
decreases expression
ISO
zoledronic acid results in decreased expression of POLR2A mRNA
CTD
PMID:20977926
NCBI chr11:69,624,823...69,649,459
Ensembl chr11:69,624,823...69,649,463
G
Polr2d
polymerase (RNA) II (DNA directed) polypeptide D
increases expression
ISO
zoledronic acid results in increased expression of POLR2D mRNA
CTD
PMID:20977926
NCBI chr18:31,922,178...31,929,762
Ensembl chr18:31,922,212...31,929,754
G
Pomgnt1
protein O-linked mannose beta 1,2-N-acetylglucosaminyltransferase
increases expression
ISO
zoledronic acid results in increased expression of POMGNT1 mRNA
CTD
PMID:20977926
NCBI chr 4:116,007,700...116,017,041
Ensembl chr 4:115,981,037...116,017,046
G
Pon1
paraoxonase 1
increases activity multiple interactions
ISO
zoledronic acid results in increased activity of PON1 protein [zoledronic acid results in increased activity of PON1 protein] which results in increased metabolism of phenyl acetate
CTD
PMID:27387541
NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
G
Pon2
paraoxonase 2
multiple interactions
ISO
[Tretinoin co-treated with zoledronic acid] results in increased expression of PON2 protein
CTD
PMID:20349282
NCBI chr 6:5,264,620...5,298,408
Ensembl chr 6:5,264,147...5,298,455
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions decreases expression
EXP ISO
Fenofibrate inhibits the reaction [zoledronic acid results in decreased expression of PPARA mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of PPARA mRNA] zoledronic acid results in decreased expression of PPARA mRNA; zoledronic acid results in decreased expression of PPARA protein
CTD
PMID:28871336
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
G
Ppard
peroxisome proliferator activator receptor delta
increases expression
ISO
zoledronic acid results in increased expression of PPARD mRNA
CTD
PMID:24714768
NCBI chr17:28,451,715...28,520,446
Ensembl chr17:28,451,674...28,520,448
G
Pparg
peroxisome proliferator activated receptor gamma
affects activity
ISO
zoledronic acid affects the activity of PPARG protein
CTD
PMID:25596134
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ppargc1a
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
decreases expression multiple interactions
ISO EXP
zoledronic acid results in decreased expression of PPARGC1A mRNA; zoledronic acid results in decreased expression of PPARGC1A protein Fenofibrate inhibits the reaction [zoledronic acid results in decreased expression of PPARGC1A mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of PPARGC1A mRNA]
CTD
PMID:24714768 PMID:28871336
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
G
Ppbp
pro-platelet basic protein
increases expression
ISO
zoledronic acid results in increased expression of PPBP mRNA
CTD
PMID:24714768
NCBI chr 5:90,916,377...90,917,922
Ensembl chr 5:90,916,377...90,917,922
G
Ppl
periplakin
decreases expression
ISO
zoledronic acid results in decreased expression of PPL mRNA
CTD
PMID:24714768
NCBI chr16:4,904,155...4,950,345
Ensembl chr16:4,904,155...4,950,285
G
Ppm1h
protein phosphatase 1H (PP2C domain containing)
increases expression
ISO
zoledronic acid results in increased expression of PPM1H mRNA
CTD
PMID:24714768
NCBI chr10:122,512,720...122,781,700
Ensembl chr10:122,514,667...122,781,700
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
multiple interactions increases expression
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of PPP1R15A mRNA zoledronic acid results in increased expression of PPP1R15A mRNA
CTD
PMID:16996129 PMID:20977926
NCBI chr 7:45,172,341...45,175,692
Ensembl chr 7:45,172,340...45,175,692
G
Ppp1r1a
protein phosphatase 1, regulatory inhibitor subunit 1A
decreases expression
ISO
zoledronic acid results in decreased expression of PPP1R1A mRNA
CTD
PMID:24714768
NCBI chr15:103,438,706...103,446,465
Ensembl chr15:103,438,706...103,446,430
G
Ppp1r1b
protein phosphatase 1, regulatory inhibitor subunit 1B
decreases expression
ISO
zoledronic acid results in decreased expression of PPP1R1B mRNA
CTD
PMID:24714768
NCBI chr11:98,239,232...98,248,622
Ensembl chr11:98,239,230...98,248,622
G
Ppp2r2b
protein phosphatase 2, regulatory subunit B, beta
affects expression
ISO
zoledronic acid affects the expression of PPP2R2B mRNA
CTD
PMID:24714768
NCBI chr18:42,777,811...43,192,827
Ensembl chr18:42,770,497...43,216,192
G
Ppp3ca
protein phosphatase 3, catalytic subunit, alpha isoform
increases expression
ISO
zoledronic acid results in increased expression of PPP3CA mRNA
CTD
PMID:24714768
NCBI chr 3:136,375,778...136,643,488
Ensembl chr 3:136,375,885...136,643,488
G
Prc1
protein regulator of cytokinesis 1
decreases expression
ISO
zoledronic acid results in decreased expression of PRC1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 7:79,944,224...79,966,007
Ensembl chr 7:79,944,198...79,966,007
G
Prdm1
PR domain containing 1, with ZNF domain
increases expression
ISO
zoledronic acid results in increased expression of PRDM1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr10:44,313,170...44,404,579
Ensembl chr10:44,313,173...44,404,497
G
Prdx3
peroxiredoxin 3
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of PRDX3 mRNA
CTD
PMID:16996129
NCBI chr19:60,852,504...60,862,976
Ensembl chr19:60,852,489...60,862,994
G
Prex2
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2
increases expression
ISO
zoledronic acid results in increased expression of PREX2 mRNA
CTD
PMID:24714768
NCBI chr 1:11,063,496...11,373,907
Ensembl chr 1:11,063,689...11,373,905
G
Prkab2
protein kinase, AMP-activated, beta 2 non-catalytic subunit
decreases expression
ISO
zoledronic acid results in decreased expression of PRKAB2 mRNA
CTD
PMID:25596134
NCBI chr 3:97,565,527...97,581,128
Ensembl chr 3:97,565,509...97,581,128
G
Prkacb
protein kinase, cAMP dependent, catalytic, beta
increases expression
ISO
zoledronic acid results in increased expression of PRKACB mRNA
CTD
PMID:20977926
NCBI chr 3:146,435,334...146,518,691
Ensembl chr 3:146,435,329...146,518,745
G
Prom1
prominin 1
increases expression
ISO
zoledronic acid results in increased expression of PROM1 mRNA
CTD
PMID:24714768
NCBI chr 5:44,150,963...44,260,850
Ensembl chr 5:44,150,962...44,259,374
G
Proser2
proline and serine rich 2
increases expression
ISO
zoledronic acid results in increased expression of PROSER2 mRNA
CTD
PMID:24714768
NCBI chr 2:6,103,304...6,135,100
Ensembl chr 2:6,102,418...6,135,022
G
Proser3
proline and serine rich 3
increases expression
ISO
zoledronic acid results in increased expression of PROSER3 mRNA
CTD
PMID:20977926
NCBI chr 7:30,238,553...30,251,802
Ensembl chr 7:30,238,559...30,251,724
G
Prr14
proline rich 14
increases expression
ISO
zoledronic acid results in increased expression of PRR14 mRNA
CTD
PMID:20977926
NCBI chr 7:127,070,189...127,075,932
Ensembl chr 7:127,058,783...127,075,931
G
Prr15l
proline rich 15-like
decreases expression
ISO
zoledronic acid results in decreased expression of PRR15L mRNA
CTD
PMID:24714768
NCBI chr11:96,816,987...96,826,474
Ensembl chr11:96,818,930...96,828,656
G
Prrg4
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane)
increases expression
ISO
zoledronic acid results in increased expression of PRRG4 mRNA
CTD
PMID:20977926
NCBI chr 2:104,657,374...104,680,216
Ensembl chr 2:104,661,086...104,680,221
G
Prrx2
paired related homeobox 2
increases expression
ISO
zoledronic acid results in increased expression of PRRX2 mRNA
CTD
PMID:24714768
NCBI chr 2:30,735,076...30,771,263
Ensembl chr 2:30,724,984...30,771,263
G
Prss23
serine protease 23
decreases expression
ISO
zoledronic acid results in decreased expression of PRSS23 mRNA
CTD
PMID:24714768
NCBI chr 7:89,156,988...89,176,399
Ensembl chr 7:89,156,991...89,176,395
G
Prss35
serine protease 35
increases expression
ISO
zoledronic acid results in increased expression of PRSS35 mRNA
CTD
PMID:24714768
NCBI chr 9:86,625,291...86,640,496
Ensembl chr 9:86,625,702...86,640,496
G
Prune2
prune homolog 2
increases expression
ISO
zoledronic acid results in increased expression of PRUNE2 mRNA
CTD
PMID:24714768
NCBI chr19:16,933,033...17,201,322
Ensembl chr19:16,933,482...17,201,296
G
Prxl2b
peroxiredoxin like 2B
increases expression
ISO
zoledronic acid results in increased expression of PRXL2B mRNA
CTD
PMID:24714768
NCBI chr 4:154,980,884...154,983,522
Ensembl chr 4:154,979,961...154,983,592
G
Psat1
phosphoserine aminotransferase 1
decreases expression
ISO
zoledronic acid results in decreased expression of PSAT1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr19:15,882,487...15,902,423
Ensembl chr19:15,882,042...15,924,701
G
Psrc1
proline/serine-rich coiled-coil 1
decreases expression
ISO
zoledronic acid results in decreased expression of PSRC1 mRNA
CTD
PMID:20977926 PMID:24714768
NCBI chr 3:108,291,120...108,295,547
Ensembl chr 3:108,291,155...108,295,547
G
Ptger4
prostaglandin E receptor 4 (subtype EP4)
increases expression
ISO
zoledronic acid results in increased expression of PTGER4 mRNA
CTD
PMID:24714768
NCBI chr15:5,262,880...5,273,668
Ensembl chr15:5,236,142...5,273,668
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression multiple interactions increases expression
ISO
zoledronic acid results in decreased expression of PTGS2 mRNA [zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of PTGS2 protein; gefitinib promotes the reaction [[zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of PTGS2 protein] zoledronic acid results in increased expression of PTGS2 mRNA
CTD
PMID:16322342 PMID:20977926 PMID:24714768
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Pth1r
parathyroid hormone 1 receptor
decreases expression
ISO
zoledronic acid results in decreased expression of PTH1R mRNA
CTD
PMID:24714768
NCBI chr 9:110,551,132...110,576,213
Ensembl chr 9:110,551,153...110,576,213
G
Pthlh
parathyroid hormone-like peptide
affects response to substance decreases expression
ISO
PTHLH protein affects the susceptibility to zoledronic acid zoledronic acid results in decreased expression of PTHLH mRNA
CTD
PMID:16278781 PMID:16475708 PMID:24714768
NCBI chr 6:147,153,607...147,165,511
Ensembl chr 6:147,153,599...147,165,681
G
Ptk2
PTK2 protein tyrosine kinase 2
decreases phosphorylation increases expression
ISO
zoledronic acid results in decreased phosphorylation of PTK2 protein zoledronic acid results in increased expression of PTK2 mRNA
CTD
PMID:12933798 PMID:20977926
NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129
G
Ptpn13
protein tyrosine phosphatase, non-receptor type 13
decreases expression
ISO
zoledronic acid results in decreased expression of PTPN13 mRNA
CTD
PMID:24714768
NCBI chr 5:103,573,058...103,746,227
Ensembl chr 5:103,573,058...103,746,169
G
Ptpn20
protein tyrosine phosphatase, non-receptor type 20
increases expression
ISO
zoledronic acid results in increased expression of PTPN20 mRNA
CTD
PMID:24714768
NCBI chr14:33,311,150...33,362,711
Ensembl chr14:33,311,164...33,362,711
G
Ptprg
protein tyrosine phosphatase receptor type G
increases expression
ISO
zoledronic acid results in increased expression of PTPRG mRNA
CTD
PMID:24714768
NCBI chr14:10,227,722...10,916,341
Ensembl chr14:10,227,722...10,916,220
G
Pygl
liver glycogen phosphorylase
decreases expression
ISO
zoledronic acid results in decreased expression of PYGL mRNA
CTD
PMID:25596134
NCBI chr12:70,237,589...70,274,457
Ensembl chr12:70,237,585...70,278,262
G
Qpct
glutaminyl-peptide cyclotransferase (glutaminyl cyclase)
increases expression
ISO
zoledronic acid results in increased expression of QPCT mRNA
CTD
PMID:24714768
NCBI chr17:79,359,335...79,397,807
Ensembl chr17:79,359,335...79,397,807
G
Rab10
RAB10, member RAS oncogene family
increases expression
ISO
zoledronic acid results in increased expression of RAB10 protein
CTD
PMID:28871336
NCBI chr12:3,297,428...3,359,969
Ensembl chr12:3,297,428...3,359,969
G
Rab11fip5
RAB11 family interacting protein 5 (class I)
increases expression
ISO
zoledronic acid results in increased expression of RAB11FIP5 protein
CTD
PMID:28871336
NCBI chr 6:85,311,944...85,351,663
Ensembl chr 6:85,311,944...85,351,616
G
Rab23
RAB23, member RAS oncogene family
increases expression
ISO
zoledronic acid results in increased expression of RAB23 mRNA
CTD
PMID:20977926
NCBI chr 1:33,758,991...33,781,642
Ensembl chr 1:33,758,968...33,781,645
G
Rab26
RAB26, member RAS oncogene family
increases expression
ISO
zoledronic acid results in increased expression of RAB26 mRNA
CTD
PMID:25596134
NCBI chr17:24,748,038...24,752,696
Ensembl chr17:24,746,215...24,753,184
G
Rab27b
RAB27B, member RAS oncogene family
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of RAB27B mRNA
CTD
PMID:16996129
NCBI chr18:70,112,202...70,274,704
Ensembl chr18:70,112,202...70,274,676
G
Rab2b
RAB2B, member RAS oncogene family
increases expression
ISO
zoledronic acid results in increased expression of RAB2B protein
CTD
PMID:28871336
NCBI chr14:52,499,216...52,516,852
Ensembl chr14:52,499,216...52,517,002
G
Rab31
RAB31, member RAS oncogene family
increases expression
ISO
zoledronic acid results in increased expression of RAB31 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr17:65,958,721...66,079,747
Ensembl chr17:65,958,724...66,079,747
G
Rab32
RAB32, member RAS oncogene family
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of RAB32 mRNA
CTD
PMID:16996129
NCBI chr10:10,420,783...10,433,951
Ensembl chr10:10,420,746...10,434,009
G
Rab35
RAB35, member RAS oncogene family
increases expression
ISO
zoledronic acid results in increased expression of RAB35 protein
CTD
PMID:28871336
NCBI chr 5:115,769,953...115,785,217
Ensembl chr 5:115,769,967...115,785,795
G
Rab5b
RAB5B, member RAS oncogene family
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of RAB5B mRNA
CTD
PMID:16996129
NCBI chr10:128,511,980...128,532,160
Ensembl chr10:128,513,044...128,532,133
G
Rab6a
RAB6A, member RAS oncogene family
increases expression
ISO
zoledronic acid results in increased expression of RAB6A mRNA
CTD
PMID:20977926
NCBI chr 7:100,256,778...100,290,475
Ensembl chr 7:100,256,617...100,290,475
G
Rab7
RAB7, member RAS oncogene family
increases expression
ISO
zoledronic acid results in increased expression of RAB7A protein
CTD
PMID:28871336
NCBI chr 6:87,976,088...88,022,252
Ensembl chr 6:87,976,088...88,022,252
G
Rab9
RAB9, member RAS oncogene family
increases expression
ISO
zoledronic acid results in increased expression of RAB9A protein
CTD
PMID:28871336
NCBI chr X:165,240,247...165,262,863
Ensembl chr X:165,240,249...165,262,863
G
Rabep2
rabaptin, RAB GTPase binding effector protein 2
decreases expression
ISO
zoledronic acid results in decreased expression of RABEP2 protein
CTD
PMID:28871336
NCBI chr 7:126,027,596...126,045,079
Ensembl chr 7:126,027,931...126,048,417
G
Rabgap1l
RAB GTPase activating protein 1-like
multiple interactions decreases expression
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of RABGAP1L mRNA zoledronic acid results in decreased expression of RABGAP1L protein
CTD
PMID:16996129 PMID:28871336
NCBI chr 1:160,046,744...160,621,046
Ensembl chr 1:160,046,744...160,620,781
G
Rabl2
RAB, member RAS oncogene family-like 2
increases expression
ISO
zoledronic acid results in increased expression of RABL2B protein
CTD
PMID:28871336
NCBI chr15:89,466,730...89,476,126
Ensembl chr15:89,466,736...89,476,126
G
Rac1
Rac family small GTPase 1
multiple interactions increases expression
EXP ISO
zoledronic acid results in increased abundance of [Guanosine Triphosphate binds to RAC1 protein] zoledronic acid results in increased expression of RAC1 protein zoledronic acid results in increased expression of [RAC1 protein binds to Guanosine Triphosphate]
CTD
PMID:16734383 PMID:28871336
NCBI chr 5:143,491,236...143,513,786
Ensembl chr 5:143,489,389...143,513,791
G
Rack1
receptor for activated C kinase 1
increases expression
ISO
zoledronic acid results in increased expression of RACK1 protein
CTD
PMID:28871336
NCBI chr11:48,691,187...48,697,068
Ensembl chr11:48,691,159...48,697,261
G
Rad17
RAD17 checkpoint clamp loader component
multiple interactions
ISO
[Tretinoin co-treated with zoledronic acid] results in increased expression of RAD17 protein
CTD
PMID:20349282
NCBI chr13:100,753,672...100,787,569
Ensembl chr13:100,753,672...100,787,559
G
Rad51d
RAD51 paralog D
increases expression
ISO
zoledronic acid results in increased expression of RAD51D mRNA
CTD
PMID:20977926
NCBI chr11:82,762,786...82,781,571
Ensembl chr11:82,767,260...82,781,440
G
Radx
RPA1 related single stranded DNA binding protein, X-linked
decreases expression
ISO
zoledronic acid results in decreased expression of RADX mRNA
CTD
PMID:24714768
NCBI chr X:138,381,116...138,455,333
Ensembl chr X:138,381,116...138,455,331
G
Raf1
v-raf-leukemia viral oncogene 1
decreases expression
ISO
zoledronic acid results in decreased expression of RAF1 protein
CTD
PMID:12799645
NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596
G
Rai14
retinoic acid induced 14
decreases expression
ISO
zoledronic acid results in decreased expression of RAI14 mRNA
CTD
PMID:24714768
NCBI chr15:10,569,057...10,719,353
Ensembl chr15:10,569,055...10,714,710
G
Rai2
retinoic acid induced 2
increases expression
ISO
zoledronic acid results in increased expression of RAI2 mRNA
CTD
PMID:24714768
NCBI chr X:160,500,032...160,562,490
Ensembl chr X:160,500,065...160,562,492
G
Rala
v-ral simian leukemia viral oncogene A (ras related)
increases expression
ISO
zoledronic acid results in increased expression of RALA protein
CTD
PMID:28871336
NCBI chr13:18,055,160...18,118,802
Ensembl chr13:18,055,156...18,118,824
G
Ranbp3l
RAN binding protein 3-like
decreases expression
ISO
zoledronic acid results in decreased expression of RANBP3L mRNA
CTD
PMID:24714768
NCBI chr15:8,997,209...9,071,355
Ensembl chr15:8,997,433...9,067,417
G
Rap1a
RAS-related protein 1a
multiple interactions decreases prenylation decreases geranoylation increases expression decreases expression
ISO EXP
geranylgeraniol inhibits the reaction [zoledronic acid results in decreased geranoylation of RAP1A protein] zoledronic acid results in decreased prenylation of RAP1A protein [zoledronic acid co-treated with Doxorubicin] results in decreased expression of RAP1A protein modified form zoledronic acid results in increased expression of RAP1A protein Zoledronic Acid results in decreased expression of RAP1A protein modified form
CTD
PMID:12406088 PMID:16539721 PMID:16602111 PMID:16675582 PMID:16996129 PMID:19442620 PMID:19621390 PMID:19789217 PMID:24157872 PMID:28871336 More...
NCBI chr 3:105,634,576...105,708,740
Ensembl chr 3:105,634,583...105,708,652
G
Rap1b
RAS related protein 1b
increases expression
ISO
zoledronic acid results in increased expression of RAP1B mRNA
CTD
PMID:24714768
NCBI chr10:117,650,502...117,681,879
Ensembl chr10:117,649,776...117,681,940
G
Rap1gap
Rap1 GTPase-activating protein
decreases expression
ISO
zoledronic acid results in decreased expression of RAP1GAP mRNA
CTD
PMID:24714768
NCBI chr 4:137,391,549...137,457,172
Ensembl chr 4:137,392,037...137,457,172
G
Rara
retinoic acid receptor, alpha
decreases expression
ISO
zoledronic acid results in decreased expression of RARA mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr11:98,818,626...98,865,768
Ensembl chr11:98,818,644...98,865,768
G
Rasal1
RAS protein activator like 1 (GAP1 like)
decreases expression
ISO
zoledronic acid results in decreased expression of RASAL1 mRNA
CTD
PMID:24714768
NCBI chr 5:120,786,105...120,817,662
Ensembl chr 5:120,786,877...120,817,662
G
Rasgrp1
RAS guanyl releasing protein 1
increases expression
ISO
zoledronic acid results in increased expression of RASGRP1 mRNA
CTD
PMID:24714768
NCBI chr 2:117,110,464...117,173,358
Ensembl chr 2:117,110,474...117,173,482
G
Rasl11b
RAS-like, family 11, member B
decreases expression
ISO
zoledronic acid results in decreased expression of RASL11B mRNA
CTD
PMID:24714768
NCBI chr 5:74,355,987...74,360,138
Ensembl chr 5:74,355,947...74,360,142
G
Rassf5
Ras association (RalGDS/AF-6) domain family member 5
increases expression
ISO
zoledronic acid results in increased expression of RASSF5 mRNA
CTD
PMID:20977926
NCBI chr 1:131,104,147...131,172,915
Ensembl chr 1:131,104,147...131,172,995
G
Rassf7
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7
decreases expression
ISO
zoledronic acid results in decreased expression of RASSF7 protein
CTD
PMID:28871336
NCBI chr 7:140,795,338...140,798,571
Ensembl chr 7:140,795,773...140,798,571
G
Rbbp9
retinoblastoma binding protein 9, serine hydrolase
increases expression
ISO
zoledronic acid results in increased expression of RBBP9 mRNA
CTD
PMID:20977926
NCBI chr 2:144,384,185...144,392,779
Ensembl chr 2:144,384,185...144,392,789
G
Rbm14
RNA binding motif protein 14
increases expression
ISO
zoledronic acid results in increased expression of RBM14 mRNA
CTD
PMID:20977926
NCBI chr19:4,850,594...4,861,662
Ensembl chr19:4,850,597...4,861,662
G
Rbm8a
RNA binding motif protein 8a
increases expression
ISO
zoledronic acid results in increased expression of RBM8A mRNA
CTD
PMID:20977926
NCBI chr 3:96,537,244...96,541,107
Ensembl chr 3:96,537,249...96,541,107
G
Rbpms2
RNA binding protein with multiple splicing 2
decreases expression
ISO
zoledronic acid results in decreased expression of RBPMS2 mRNA
CTD
PMID:24714768
NCBI chr 9:65,536,638...65,567,818
Ensembl chr 9:65,536,930...65,567,810
G
Rbx1
ring-box 1
decreases expression
ISO
zoledronic acid results in decreased expression of RBX1 protein
CTD
PMID:28871336
NCBI chr15:81,350,517...81,360,570
Ensembl chr15:81,350,497...81,360,570
G
Rcbtb2
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2
increases expression
ISO
zoledronic acid results in increased expression of RCBTB2 mRNA
CTD
PMID:24714768
NCBI chr14:73,376,185...73,421,495
Ensembl chr14:73,360,477...73,445,283
G
Rcn1
reticulocalbin 1
decreases expression
ISO
zoledronic acid results in decreased expression of RCN1 protein
CTD
PMID:28871336
NCBI chr 2:105,216,293...105,229,664
Ensembl chr 2:105,216,636...105,229,664
G
Rcn2
reticulocalbin 2
decreases expression
ISO
zoledronic acid results in decreased expression of RCN2 protein
CTD
PMID:28871336
NCBI chr 9:55,949,129...55,966,367
Ensembl chr 9:55,949,129...55,969,166
G
Rdh10
retinol dehydrogenase 10 (all-trans)
increases expression
ISO
zoledronic acid results in increased expression of RDH10 mRNA
CTD
PMID:24714768
NCBI chr 1:16,176,106...16,202,774
Ensembl chr 1:16,175,998...16,203,958
G
Reg3b
regenerating islet-derived 3 beta
increases expression
ISO
zoledronic acid results in increased expression of REG3A mRNA
CTD
PMID:24714768
NCBI chr 6:78,347,868...78,350,449
Ensembl chr 6:78,347,640...78,350,449
G
Relb
avian reticuloendotheliosis viral (v-rel) oncogene related B
increases expression
ISO
zoledronic acid results in increased expression of RELB mRNA
CTD
PMID:24714768
NCBI chr 7:19,340,142...19,363,352
Ensembl chr 7:19,340,142...19,363,363
G
Reps2
RALBP1 associated Eps domain containing protein 2
increases expression
ISO
zoledronic acid results in increased expression of REPS2 mRNA
CTD
PMID:24714768
NCBI chr X:161,194,949...161,426,701
Ensembl chr X:161,194,950...161,426,645
G
Rerg
RAS-like, estrogen-regulated, growth-inhibitor
decreases expression
ISO
zoledronic acid results in decreased expression of RERG mRNA
CTD
PMID:24714768
NCBI chr 6:137,031,822...137,147,494
Ensembl chr 6:137,031,823...137,147,495
G
Retreg1
reticulophagy regulator 1
increases expression
ISO
zoledronic acid results in increased expression of RETREG1 mRNA
CTD
PMID:24714768
NCBI chr15:25,840,795...25,973,782
Ensembl chr15:25,843,266...25,973,773
G
Rgl1
ral guanine nucleotide dissociation stimulator,-like 1
increases expression
ISO
zoledronic acid results in increased expression of RGL1 mRNA
CTD
PMID:24714768
NCBI chr 1:152,392,513...152,642,056
Ensembl chr 1:152,392,511...152,642,102
G
Rgs11
regulator of G-protein signaling 11
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of RGS11 mRNA
CTD
PMID:16996129
NCBI chr17:26,421,500...26,430,295
Ensembl chr17:26,421,925...26,430,298
G
Rgs14
regulator of G-protein signaling 14
increases expression
ISO
zoledronic acid results in increased expression of RGS14 mRNA
CTD
PMID:20977926
NCBI chr13:55,517,269...55,532,504
Ensembl chr13:55,517,545...55,532,500
G
Rhbdd2
rhomboid domain containing 2
increases expression
ISO
zoledronic acid results in increased expression of RHBDD2 mRNA
CTD
PMID:20977926
NCBI chr 5:135,661,508...135,675,230
Ensembl chr 5:135,661,472...135,675,302
G
Rhbdf2
rhomboid 5 homolog 2
increases expression
ISO
zoledronic acid results in increased expression of RHBDF2 mRNA
CTD
PMID:24714768
NCBI chr11:116,488,991...116,517,786
Ensembl chr11:116,488,991...116,517,845
G
Rhoa
ras homolog family member A
multiple interactions decreases geranoylation
ISO EXP
[zoledronic acid results in decreased geranoylation of RHOA protein] which results in increased expression of IBSP mRNA; geranylgeraniol inhibits the reaction [zoledronic acid results in decreased expression of and affects the localization of RHOA protein]; zoledronic acid inhibits the reaction [RHOA protein results in decreased expression of IBSP mRNA]; zoledronic acid results in decreased expression of and affects the localization of RHOA protein; zoledronic acid results in increased expression of [RHOA protein binds to Guanosine Triphosphate]; zoledronic acid results in increased expression of and affects the localization of RHOA protein zoledronic acid results in increased abundance of [Guanosine Triphosphate binds to RHOA protein]
CTD
PMID:15324309 PMID:16734383 PMID:28871336
NCBI chr 9:108,183,359...108,215,142
Ensembl chr 9:108,183,328...108,215,133
G
Rhob
ras homolog family member B
increases expression multiple interactions
ISO
zoledronic acid results in increased expression of RHOB mRNA [zoledronic acid co-treated with fluvastatin] results in increased expression of RHOB mRNA; zoledronic acid results in increased expression of and affects the localization of RHOB protein
CTD
PMID:16996129 PMID:20977926 PMID:28871336
NCBI chr12:8,547,661...8,550,009
Ensembl chr12:8,547,661...8,550,009
G
Rhobtb1
Rho-related BTB domain containing 1
decreases expression
ISO
zoledronic acid results in decreased expression of RHOBTB1 mRNA
CTD
PMID:24714768
NCBI chr10:68,987,106...69,127,621
Ensembl chr10:68,987,264...69,127,621
G
Rhobtb3
Rho-related BTB domain containing 3
decreases expression
ISO
zoledronic acid results in decreased expression of RHOBTB3 mRNA
CTD
PMID:24714768
NCBI chr13:76,017,656...76,092,054
Ensembl chr13:76,017,656...76,092,044
G
Rhoc
ras homolog family member C
affects localization
ISO
zoledronic acid affects the localization of RHOC protein
CTD
PMID:28871336
NCBI chr 3:104,696,350...104,701,775
Ensembl chr 3:104,695,691...104,701,775
G
Rhog
ras homolog family member G
increases expression
ISO
zoledronic acid results in increased expression of RHOG protein
CTD
PMID:28871336
NCBI chr 7:101,888,330...101,899,325
Ensembl chr 7:101,888,330...101,905,261
G
Rhov
ras homolog family member V
increases expression
ISO
zoledronic acid results in increased expression of RHOV mRNA
CTD
PMID:24714768
NCBI chr 2:119,099,682...119,108,489
Ensembl chr 2:119,099,682...119,101,753
G
Rims2
regulating synaptic membrane exocytosis 2
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of RIMS2 mRNA
CTD
PMID:16996129
NCBI chr15:39,061,681...39,547,768
Ensembl chr15:39,061,656...39,547,768
G
Rims3
regulating synaptic membrane exocytosis 3
decreases expression
ISO
zoledronic acid results in decreased expression of RIMS3 mRNA
CTD
PMID:24714768
NCBI chr 4:120,711,976...120,753,777
Ensembl chr 4:120,712,013...120,753,776
G
Rin2
Ras and Rab interactor 2
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of RIN2 mRNA
CTD
PMID:16996129
NCBI chr 2:145,613,647...145,729,536
Ensembl chr 2:145,517,135...145,729,536
G
Ripk2
receptor (TNFRSF)-interacting serine-threonine kinase 2
increases expression
ISO
zoledronic acid results in increased expression of RIPK2 mRNA
CTD
PMID:24714768
NCBI chr 4:16,122,740...16,163,674
Ensembl chr 4:16,122,733...16,163,647
G
Ripor3
RIPOR family member 3
decreases expression
ISO
zoledronic acid results in decreased expression of RIPOR3 mRNA
CTD
PMID:24714768
NCBI chr 2:167,822,081...167,892,809
Ensembl chr 2:167,822,084...167,852,538
G
Ripply3
ripply transcriptional repressor 3
decreases expression
ISO
zoledronic acid results in decreased expression of RIPPLY3 mRNA
CTD
PMID:24714768
NCBI chr16:94,129,281...94,137,794
Ensembl chr16:94,129,279...94,137,794
G
Rnd1
Rho family GTPase 1
increases expression
ISO
zoledronic acid results in increased expression of RND1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr15:98,567,086...98,575,342
Ensembl chr15:98,561,302...98,575,342
G
Rnf114
ring finger protein 114
increases expression
ISO
zoledronic acid results in increased expression of RNF114 mRNA
CTD
PMID:20977926
NCBI chr 2:167,334,565...167,358,093
Ensembl chr 2:167,334,565...167,358,093
G
Rnf141
ring finger protein 141
decreases expression
ISO
zoledronic acid results in decreased expression of RNF141 mRNA
CTD
PMID:20977926
NCBI chr 7:110,398,676...110,443,659
Ensembl chr 7:110,399,639...110,443,664
G
Rnf144b
ring finger protein 144B
increases expression
ISO
zoledronic acid results in increased expression of RNF144B mRNA
CTD
PMID:24714768
NCBI chr13:47,276,196...47,401,470
Ensembl chr13:47,276,132...47,401,467
G
Rnf167
ring finger protein 167
increases expression
ISO
zoledronic acid results in increased expression of RNF167 mRNA
CTD
PMID:20977926
NCBI chr11:70,538,056...70,542,247
Ensembl chr11:70,538,061...70,542,247
G
Rnft2
ring finger protein, transmembrane 2
decreases expression
ISO
zoledronic acid results in decreased expression of RNFT2 mRNA
CTD
PMID:24714768
NCBI chr 5:118,328,799...118,388,518
Ensembl chr 5:118,328,801...118,383,181
G
Rpl7
ribosomal protein L7
increases expression
ISO
zoledronic acid results in increased expression of RPL7 mRNA
CTD
PMID:20977926
NCBI chr 1:16,171,519...16,174,657
Ensembl chr 1:16,171,519...16,174,886
G
Rps9
ribosomal protein S9
decreases expression
ISO
zoledronic acid results in decreased expression of RPS9 mRNA
CTD
PMID:20977926
NCBI chr 7:3,707,035...3,709,896
Ensembl chr 7:3,706,992...3,709,896
G
Rptor
regulatory associated protein of MTOR, complex 1
decreases expression
ISO
zoledronic acid results in decreased expression of RPTOR mRNA; zoledronic acid results in decreased expression of RPTOR protein
CTD
PMID:20977926 PMID:28871336
NCBI chr11:119,493,731...119,790,417
Ensembl chr11:119,493,731...119,790,402
G
Rras2
related RAS viral (r-ras) oncogene 2
increases expression
ISO
zoledronic acid results in increased expression of RRAS2 protein
CTD
PMID:28871336
NCBI chr 7:113,646,017...113,717,016
Ensembl chr 7:113,646,017...113,717,016
G
Rrm2
ribonucleotide reductase M2
decreases expression
ISO
zoledronic acid results in decreased expression of RRM2 mRNA
CTD
PMID:24714768
NCBI chr12:24,758,253...24,764,145
Ensembl chr12:24,758,240...24,764,145
G
Rsph1
radial spoke head 1 homolog (Chlamydomonas)
increases expression
ISO
zoledronic acid results in increased expression of RSPH1 mRNA
CTD
PMID:24714768
NCBI chr17:31,473,993...31,496,270
Ensembl chr17:31,473,993...31,496,357
G
Rsrc1
arginine/serine-rich coiled-coil 1
decreases expression
ISO
zoledronic acid results in decreased expression of RSRC1 mRNA
CTD
PMID:20977926
NCBI chr 3:66,888,694...67,265,736
Ensembl chr 3:66,888,723...67,265,729
G
Runx2
runt related transcription factor 2
increases expression
ISO
zoledronic acid results in increased expression of RUNX2 mRNA
CTD
PMID:25596134
NCBI chr17:44,806,873...45,125,518
Ensembl chr17:44,806,874...45,125,684
G
Rxfp1
relaxin/insulin-like family peptide receptor 1
increases expression
ISO
zoledronic acid results in increased expression of RXFP1 mRNA
CTD
PMID:24714768
NCBI chr 3:79,548,910...79,645,258
Ensembl chr 3:79,548,918...79,645,187
G
S100a14
S100 calcium binding protein A14
decreases expression
ISO
zoledronic acid results in decreased expression of S100A14 mRNA
CTD
PMID:24714768
NCBI chr 3:90,434,156...90,436,144
Ensembl chr 3:90,434,163...90,436,144
G
S100a2
S100 calcium binding protein A2
decreases expression
ISO
zoledronic acid results in decreased expression of S100A2 mRNA
CTD
PMID:24714768
NCBI chr 3:90,497,554...90,498,815
Ensembl chr 3:90,467,670...90,498,838
G
S100a3
S100 calcium binding protein A3
increases expression
ISO
zoledronic acid results in increased expression of S100A3 mRNA
CTD
PMID:24714768
NCBI chr 3:90,467,571...90,510,922
Ensembl chr 3:90,491,966...90,510,009
G
S100a6
S100 calcium binding protein A6 (calcyclin)
decreases expression
ISO
zoledronic acid results in decreased expression of S100A6 protein
CTD
PMID:28871336
NCBI chr 3:90,520,491...90,531,797
Ensembl chr 3:90,520,189...90,531,488
G
S100a9
S100 calcium binding protein A9 (calgranulin B)
increases expression
ISO
zoledronic acid results in increased expression of S100A9 mRNA
CTD
PMID:24714768
NCBI chr 3:90,599,937...90,603,028
Ensembl chr 3:90,599,939...90,603,028
G
Saa1
serum amyloid A 1
increases expression
ISO
zoledronic acid results in increased expression of SAA1 mRNA
CTD
PMID:24714768
NCBI chr 7:46,389,921...46,392,404
Ensembl chr 7:46,389,921...46,392,404
G
Saa2
serum amyloid A 2
increases expression
ISO
zoledronic acid results in increased expression of SAA2 mRNA
CTD
PMID:24714768
NCBI chr 7:46,401,257...46,403,737
Ensembl chr 7:46,401,214...46,403,737
G
Saa4
serum amyloid A 4
increases expression
ISO
zoledronic acid results in increased expression of SAA4 mRNA
CTD
PMID:24714768
NCBI chr 7:46,377,416...46,382,027
Ensembl chr 7:46,377,422...46,382,027
G
Sall2
spalt like transcription factor 2
decreases expression
ISO
zoledronic acid results in decreased expression of SALL2 mRNA
CTD
PMID:24714768
NCBI chr14:52,548,634...52,566,127
Ensembl chr14:52,548,629...52,566,219
G
Samd11
sterile alpha motif domain containing 11
decreases expression
ISO
zoledronic acid results in decreased expression of SAMD11 mRNA
CTD
PMID:24714768
NCBI chr 4:156,331,423...156,342,409
Ensembl chr 4:156,331,423...156,340,717
G
Sapcd2
suppressor APC domain containing 2
decreases expression
ISO
zoledronic acid results in decreased expression of SAPCD2 mRNA
CTD
PMID:24714768
NCBI chr 2:25,261,974...25,268,225
Ensembl chr 2:25,262,333...25,268,225
G
Sash1
SAM and SH3 domain containing 1
decreases expression
ISO
zoledronic acid results in decreased expression of SASH1 mRNA
CTD
PMID:24714768
NCBI chr10:8,597,981...8,821,290
Ensembl chr10:8,597,983...8,761,814
G
Sav1
salvador family WW domain containing 1
increases expression
ISO
zoledronic acid results in increased expression of SAV1 mRNA
CTD
PMID:24714768
NCBI chr12:70,011,786...70,033,864
Ensembl chr12:70,011,786...70,033,776
G
Sbno2
strawberry notch 2
increases expression
ISO
zoledronic acid results in increased expression of SBNO2 protein
CTD
PMID:28871336
NCBI chr10:79,892,826...79,941,942
Ensembl chr10:79,892,826...79,941,405
G
Sc5d
sterol-C5-desaturase
increases expression
ISO
zoledronic acid results in increased expression of SC5D mRNA
CTD
PMID:24714768
NCBI chr 9:42,162,888...42,175,607
Ensembl chr 9:42,162,891...42,175,552
G
Scarb2
scavenger receptor class B, member 2
decreases expression
ISO
zoledronic acid results in decreased expression of SCARB2 protein
CTD
PMID:28871336
NCBI chr 5:92,589,170...92,653,516
Ensembl chr 5:92,589,173...92,654,692
G
Scd3
stearoyl-coenzyme A desaturase 3
decreases expression
ISO
zoledronic acid results in decreased expression of SCD5 mRNA
CTD
PMID:24714768
NCBI chr19:44,191,727...44,232,455
Ensembl chr19:44,191,708...44,232,455
G
Scel
sciellin
decreases expression
ISO
zoledronic acid results in decreased expression of SCEL mRNA
CTD
PMID:24714768
NCBI chr14:103,750,499...103,850,782
Ensembl chr14:103,750,778...103,850,233
G
Scg5
secretogranin V
increases expression
ISO
zoledronic acid results in increased expression of SCG5 mRNA
CTD
PMID:24714768
NCBI chr 2:113,606,708...113,659,423
Ensembl chr 2:113,606,707...113,659,466
G
Scgb2a2
secretoglobin, family 2A, member 2
increases expression
ISO
zoledronic acid results in increased expression of SCGB2A1 mRNA
CTD
PMID:24714768
NCBI chr19:9,824,922...9,829,564
Ensembl chr19:9,824,926...9,830,172
G
Scnn1g
sodium channel, nonvoltage-gated 1 gamma
increases expression
ISO
zoledronic acid results in increased expression of SCNN1G mRNA
CTD
PMID:24714768
NCBI chr 7:121,333,643...121,367,705
Ensembl chr 7:121,333,702...121,367,698
G
Scoc
short coiled-coil protein
increases expression
ISO
zoledronic acid results in increased expression of SCOC mRNA
CTD
PMID:20977926
NCBI chr 8:84,161,121...84,185,055
Ensembl chr 8:84,156,713...84,185,020
G
Sctr
secretin receptor
decreases expression
ISO
zoledronic acid results in decreased expression of SCTR mRNA
CTD
PMID:24714768
NCBI chr 1:119,934,710...119,991,269
Ensembl chr 1:119,934,624...119,991,266
G
Sdc1
syndecan 1
decreases expression
ISO
zoledronic acid results in decreased expression of SDC1 mRNA
CTD
PMID:24714768
NCBI chr12:8,821,396...8,843,716
Ensembl chr12:8,821,323...8,843,715
G
Sdc2
syndecan 2
decreases expression
ISO
zoledronic acid results in decreased expression of SDC2 mRNA
CTD
PMID:24714768
NCBI chr15:32,920,869...33,034,867
Ensembl chr15:32,920,869...33,035,081
G
Sdc4
syndecan 4
increases expression
ISO
zoledronic acid results in increased expression of SDC4 mRNA; zoledronic acid results in increased expression of SDC4 protein
CTD
PMID:24714768 PMID:28871336
NCBI chr 2:164,266,167...164,285,512
Ensembl chr 2:164,266,167...164,285,807
G
Sdcbp2
syndecan binding protein (syntenin) 2
increases expression
ISO
zoledronic acid results in increased expression of SDCBP2 mRNA
CTD
PMID:24714768
NCBI chr 2:151,414,203...151,431,925
Ensembl chr 2:151,414,542...151,431,925
G
Secisbp2l
SECIS binding protein 2-like
increases expression
ISO
zoledronic acid results in increased expression of SECISBP2L mRNA
CTD
PMID:20977926
NCBI chr 2:125,578,906...125,624,790
Ensembl chr 2:125,578,906...125,624,790
G
Sell
selectin, lymphocyte
increases expression
ISO
zoledronic acid results in increased expression of SELL mRNA
CTD
PMID:24714768
NCBI chr 1:163,889,556...163,908,354
Ensembl chr 1:163,889,551...163,911,750
G
Sema5b
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B
decreases expression
ISO
zoledronic acid results in decreased expression of SEMA5B mRNA
CTD
PMID:24714768
NCBI chr16:35,361,517...35,485,103
Ensembl chr16:35,361,515...35,485,102
G
Serpina3b
serine (or cysteine) peptidase inhibitor, clade A, member 3B
increases expression increases secretion
ISO
zoledronic acid results in increased expression of SERPINA3 mRNA zoledronic acid results in increased secretion of SERPINA3 protein
CTD
PMID:24714768
NCBI chr12:104,094,245...104,105,805
Ensembl chr12:104,094,255...104,105,804
G
Serpinb3d
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3D
increases expression
ISO
zoledronic acid results in increased expression of SERPINB3 mRNA
CTD
PMID:24714768
NCBI chr 1:107,005,893...107,011,210
Ensembl chr 1:107,005,897...107,011,236
G
Serpinb7
serine (or cysteine) peptidase inhibitor, clade B, member 7
increases expression
ISO
zoledronic acid results in increased expression of SERPINB7 mRNA
CTD
PMID:24714768
NCBI chr 1:107,350,418...107,380,419
Ensembl chr 1:107,327,385...107,380,419
G
Serpinf2
serine (or cysteine) peptidase inhibitor, clade F, member 2
decreases expression
ISO
zoledronic acid results in decreased expression of SERPINF2 mRNA
CTD
PMID:24714768
NCBI chr11:75,322,562...75,330,327
Ensembl chr11:75,322,558...75,330,417
G
Serpinh1
serine (or cysteine) peptidase inhibitor, clade H, member 1
increases expression
ISO
zoledronic acid results in increased expression of SERPINH1 mRNA
CTD
PMID:20977926 PMID:24714768
NCBI chr 7:98,994,583...99,002,321
Ensembl chr 7:98,994,583...99,002,446
G
Sertad1
SERTA domain containing 1
decreases expression
ISO
zoledronic acid results in decreased expression of SERTAD1 mRNA
CTD
PMID:25596134
NCBI chr 7:27,186,378...27,189,741
Ensembl chr 7:27,186,335...27,189,741
G
Sertad4
SERTA domain containing 4
decreases expression
ISO
zoledronic acid results in decreased expression of SERTAD4 mRNA
CTD
PMID:24714768
NCBI chr 1:192,526,796...192,538,060
Ensembl chr 1:192,526,796...192,538,064
G
Sesn1
sestrin 1
decreases expression
ISO
zoledronic acid results in decreased expression of SESN1 mRNA
CTD
PMID:25596134
NCBI chr10:41,686,570...41,784,432
Ensembl chr10:41,685,931...41,784,420
G
Setbp1
SET binding protein 1
decreases expression
ISO
zoledronic acid results in decreased expression of SETBP1 mRNA
CTD
PMID:24714768
NCBI chr18:78,793,593...79,153,659
Ensembl chr18:78,793,595...79,152,606
G
Setd1a
SET domain containing 1A
decreases expression
ISO
zoledronic acid results in decreased expression of SETD1A mRNA
CTD
PMID:20977926
NCBI chr 7:127,376,561...127,399,294
Ensembl chr 7:127,375,842...127,399,294
G
Sfxn3
sideroflexin 3
decreases expression
ISO
zoledronic acid results in decreased expression of SFXN3 mRNA
CTD
PMID:20977926
NCBI chr19:45,036,015...45,044,822
Ensembl chr19:45,035,942...45,044,822
G
Sgms1
sphingomyelin synthase 1
increases expression
ISO
zoledronic acid results in increased expression of SGMS1 mRNA
CTD
PMID:24714768
NCBI chr19:32,100,127...32,367,285
Ensembl chr19:32,100,127...32,367,114
G
Sgpp2
sphingosine-1-phosphate phosphatase 2
increases expression
ISO
zoledronic acid results in increased expression of SGPP2 mRNA
CTD
PMID:24714768
NCBI chr 1:78,286,186...78,396,926
Ensembl chr 1:78,286,982...78,396,926
G
Sh2d1b2
SH2 domain containing 1B2
increases expression
ISO
zoledronic acid results in increased expression of SH2D1B mRNA
CTD
PMID:24714768
NCBI chr 1:170,060,440...170,079,156
Ensembl chr 1:170,060,318...170,081,177
G
Sh2d4a
SH2 domain containing 4A
increases expression
ISO
zoledronic acid results in increased expression of SH2D4A mRNA
CTD
PMID:24714768
NCBI chr 8:68,729,180...68,800,356
Ensembl chr 8:68,729,219...68,800,351
G
Shc4
SHC (Src homology 2 domain containing) family, member 4
decreases expression
ISO
zoledronic acid results in decreased expression of SHC4 mRNA
CTD
PMID:24714768
NCBI chr 2:125,469,359...125,566,085
Ensembl chr 2:125,469,367...125,566,068
G
Shisa3
shisa family member 3
decreases expression
ISO
zoledronic acid results in decreased expression of SHISA3 mRNA
CTD
PMID:24714768
NCBI chr 5:67,765,226...67,771,330
Ensembl chr 5:67,765,225...67,780,895
G
Shroom1
shroom family member 1
increases expression
ISO
zoledronic acid results in increased expression of SHROOM1 mRNA
CTD
PMID:20977926
NCBI chr11:53,347,904...53,358,593
Ensembl chr11:53,348,032...53,358,593
G
Sirpb1a
signal-regulatory protein beta 1A
increases expression
ISO
Zoledronic Acid results in increased expression of SIRPB1 mRNA
CTD
PMID:24714768
NCBI chr 3:15,436,887...15,491,487
Ensembl chr 3:15,436,713...15,491,580
G
Skp1
S-phase kinase-associated protein 1
decreases expression
ISO
zoledronic acid results in decreased expression of SKP1 protein
CTD
PMID:28871336
NCBI chr11:52,121,349...52,137,685
Ensembl chr11:52,122,822...52,137,685
G
Slc11a2
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2
increases expression
ISO
zoledronic acid results in increased expression of SLC11A2 mRNA
CTD
PMID:24714768
NCBI chr15:100,285,779...100,322,090
Ensembl chr15:100,285,779...100,322,953
G
Slc12a1
solute carrier family 12, member 1
decreases expression
ISO
zoledronic acid results in decreased expression of SLC12A1 mRNA
CTD
PMID:24714768
NCBI chr 2:124,994,430...125,071,922
Ensembl chr 2:124,994,425...125,071,922
G
Slc14a1
solute carrier family 14 (urea transporter), member 1
decreases expression
ISO
zoledronic acid results in decreased expression of SLC14A1 mRNA
CTD
PMID:24714768
NCBI chr18:78,143,306...78,185,334
Ensembl chr18:78,143,306...78,185,334
G
Slc15a1
solute carrier family 15 (oligopeptide transporter), member 1
increases expression
ISO
zoledronic acid results in increased expression of SLC15A1 mRNA
CTD
PMID:24714768
NCBI chr14:121,697,033...121,742,666
Ensembl chr14:121,697,033...121,742,664
G
Slc15a2
solute carrier family 15 (H+/peptide transporter), member 2
decreases expression
ISO
zoledronic acid results in decreased expression of SLC15A2 mRNA
CTD
PMID:24714768
NCBI chr16:36,570,523...36,605,506
Ensembl chr16:36,570,539...36,605,324
G
Slc16a1
solute carrier family 16 (monocarboxylic acid transporters), member 1
increases expression
ISO
zoledronic acid results in increased expression of SLC16A1 mRNA
CTD
PMID:20977926
NCBI chr 3:104,545,980...104,565,778
Ensembl chr 3:104,545,984...104,565,778
G
Slc16a10
solute carrier family 16 (monocarboxylic acid transporters), member 10
increases expression
ISO
zoledronic acid results in increased expression of SLC16A10 mRNA
CTD
PMID:24714768
NCBI chr10:39,909,528...40,018,262
Ensembl chr10:39,909,528...40,018,254
G
Slc16a14
solute carrier family 16 (monocarboxylic acid transporters), member 14
decreases expression
ISO
zoledronic acid results in decreased expression of SLC16A14 mRNA
CTD
PMID:24714768
NCBI chr 1:84,881,344...84,912,927
Ensembl chr 1:84,883,619...84,912,855
G
Slc16a4
solute carrier family 16 (monocarboxylic acid transporters), member 4
decreases expression
ISO
zoledronic acid results in decreased expression of SLC16A4 mRNA
CTD
PMID:24714768
NCBI chr 3:107,198,543...107,219,437
Ensembl chr 3:107,198,546...107,219,431
G
Slc1a3
solute carrier family 1 (glial high affinity glutamate transporter), member 3
increases expression
ISO
zoledronic acid results in increased expression of SLC1A3 mRNA
CTD
PMID:24714768
NCBI chr15:8,663,608...8,742,648
Ensembl chr15:8,663,608...8,740,248
G
Slc1a5
solute carrier family 1 (neutral amino acid transporter), member 5
decreases expression
ISO
zoledronic acid results in decreased expression of SLC1A5 mRNA
CTD
PMID:25596134
NCBI chr 7:16,515,259...16,532,199
Ensembl chr 7:16,515,265...16,532,199
G
Slc22a23
solute carrier family 22, member 23
increases expression
ISO
zoledronic acid results in increased expression of SLC22A23 mRNA
CTD
PMID:24714768
NCBI chr13:34,363,141...34,530,666
Ensembl chr13:34,363,141...34,529,165
G
Slc22a4
solute carrier family 22 (organic cation transporter), member 4
increases expression
ISO
zoledronic acid results in increased expression of SLC22A4 mRNA
CTD
PMID:24714768
NCBI chr11:53,873,941...53,920,866
Ensembl chr11:53,873,949...53,918,916
G
Slc23a2
solute carrier family 23 (nucleobase transporters), member 2
increases expression
ISO
zoledronic acid results in increased expression of SLC23A2 mRNA
CTD
PMID:20977926
NCBI chr 2:131,894,416...131,987,287
Ensembl chr 2:131,894,416...131,987,028
G
Slc25a20
solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20
decreases expression
EXP
zoledronic acid results in decreased expression of SLC25A20 mRNA
CTD
PMID:28871336
NCBI chr 9:108,539,335...108,561,841
Ensembl chr 9:108,539,287...108,561,840
G
Slc25a24
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24
increases expression
ISO
zoledronic acid results in increased expression of SLC25A24 mRNA
CTD
PMID:24714768
NCBI chr 3:109,030,465...109,075,725
Ensembl chr 3:109,030,465...109,075,773
G
Slc25a40
solute carrier family 25, member 40
increases expression
ISO
zoledronic acid results in increased expression of SLC25A40 mRNA
CTD
PMID:20977926
NCBI chr 5:8,472,730...8,504,840
Ensembl chr 5:8,472,850...8,504,797
G
Slc27a1
solute carrier family 27 (fatty acid transporter), member 1
increases expression
ISO
zoledronic acid results in increased expression of SLC27A1 mRNA
CTD
PMID:20977926
NCBI chr 8:72,021,372...72,039,951
Ensembl chr 8:72,021,526...72,039,946
G
Slc27a2
solute carrier family 27 (fatty acid transporter), member 2
decreases expression increases expression multiple interactions
ISO EXP
zoledronic acid results in decreased expression of SLC27A2 mRNA zoledronic acid results in increased expression of SLC27A2 mRNA; zoledronic acid results in increased expression of SLC27A2 protein SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of ACOX1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of ACOX2 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of CPT1A mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of CPT2 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of PPARA mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of PPARGC1A mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of ACTA2 protein]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of COL1A1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of COL3A1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of COL4A1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of FN1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of FN1 protein]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of IL6 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of TIMP1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of TIMP2 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of TNF mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of VIM mRNA]
CTD
PMID:24714768 PMID:25596134 PMID:28871336
NCBI chr 2:126,394,944...126,430,163
Ensembl chr 2:126,394,327...126,430,163
G
Slc28a3
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3
increases expression
ISO
zoledronic acid results in increased expression of SLC28A3 mRNA
CTD
PMID:24714768
NCBI chr13:58,701,121...58,758,691
Ensembl chr13:58,693,213...58,758,691
G
Slc29a4
solute carrier family 29 (nucleoside transporters), member 4
decreases expression
ISO
zoledronic acid results in decreased expression of SLC29A4 mRNA
CTD
PMID:24714768
NCBI chr 5:142,678,226...142,708,245
Ensembl chr 5:142,678,267...142,708,245
G
Slc34a2
solute carrier family 34 (sodium phosphate), member 2
increases expression
ISO
zoledronic acid results in increased expression of SLC34A2 mRNA
CTD
PMID:24714768
NCBI chr 5:53,206,695...53,229,006
Ensembl chr 5:53,195,423...53,229,006
G
Slc35b3
solute carrier family 35, member B3
increases expression
ISO
zoledronic acid results in increased expression of SLC35B3 mRNA
CTD
PMID:24714768
NCBI chr13:39,116,112...39,144,855
Ensembl chr13:39,116,112...39,144,851
G
Slc37a1
solute carrier family 37 (glycerol-3-phosphate transporter), member 1
increases expression
ISO
zoledronic acid results in increased expression of SLC37A1 mRNA
CTD
PMID:24714768
NCBI chr17:31,495,722...31,569,683
Ensembl chr17:31,505,766...31,569,713
G
Slc37a4
solute carrier family 37 (glucose-6-phosphate transporter), member 4
increases expression
ISO
zoledronic acid results in increased expression of SLC37A4 mRNA
CTD
PMID:24714768
NCBI chr 9:44,308,243...44,314,263
Ensembl chr 9:44,308,149...44,314,265
G
Slc39a10
solute carrier family 39 (zinc transporter), member 10
decreases expression
ISO
zoledronic acid results in decreased expression of SLC39A10 mRNA
CTD
PMID:24714768
NCBI chr 1:46,846,704...46,964,952
Ensembl chr 1:46,846,704...46,932,012
G
Slc39a8
solute carrier family 39 (metal ion transporter), member 8
increases expression
ISO
zoledronic acid results in increased expression of SLC39A8 mRNA
CTD
PMID:24714768
NCBI chr 3:135,522,644...135,594,333
Ensembl chr 3:135,531,040...135,594,333
G
Slc3a1
solute carrier family 3, member 1
decreases expression
ISO
zoledronic acid results in decreased expression of SLC3A1 mRNA
CTD
PMID:24714768
NCBI chr17:85,335,775...85,371,669
Ensembl chr17:85,335,804...85,371,664
G
Slc3a2
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2
decreases expression
ISO
zoledronic acid results in decreased expression of SLC3A2 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr19:8,684,931...8,700,733
Ensembl chr19:8,684,246...8,700,733
G
Slc40a1
solute carrier family 40 (iron-regulated transporter), member 1
increases expression
ISO
zoledronic acid results in increased expression of SLC40A1 mRNA
CTD
PMID:24714768
NCBI chr 1:45,947,230...45,965,690
Ensembl chr 1:45,947,228...45,965,683
G
Slc44a2
solute carrier family 44, member 2
decreases expression
ISO
zoledronic acid results in decreased expression of SLC44A2 mRNA
CTD
PMID:24714768
NCBI chr 9:21,232,015...21,266,324
Ensembl chr 9:21,231,994...21,266,324
G
Slc45a3
solute carrier family 45, member 3
decreases expression
ISO
zoledronic acid results in decreased expression of SLC45A3 mRNA
CTD
PMID:24714768
NCBI chr 1:131,890,653...131,910,710
Ensembl chr 1:131,890,705...131,910,707
G
Slc46a3
solute carrier family 46, member 3
increases expression
ISO
zoledronic acid results in increased expression of SLC46A3 mRNA
CTD
PMID:24714768
NCBI chr 5:147,812,707...147,831,670
Ensembl chr 5:147,815,247...147,831,625
G
Slc47a1
solute carrier family 47, member 1
decreases expression
ISO
zoledronic acid results in decreased expression of SLC47A1 mRNA
CTD
PMID:24714768
NCBI chr11:61,234,226...61,269,668
Ensembl chr11:61,234,227...61,269,171
G
Slc4a4
solute carrier family 4 (anion exchanger), member 4
decreases expression
ISO
zoledronic acid results in decreased expression of SLC4A4 mRNA
CTD
PMID:24714768
NCBI chr 5:88,941,717...89,387,515
Ensembl chr 5:89,034,345...89,387,512
G
Slc5a3
solute carrier family 5 (inositol transporters), member 3
decreases expression
ISO
zoledronic acid results in decreased expression of SLC5A3 mRNA
CTD
PMID:24714768
NCBI chr16:91,855,210...91,884,361
Ensembl chr16:91,855,210...91,884,361
G
Slc6a20b
solute carrier family 6 (neurotransmitter transporter), member 20B
increases expression
ISO
zoledronic acid results in increased expression of SLC6A20 mRNA
CTD
PMID:24714768
NCBI chr 9:123,422,888...123,461,603
Ensembl chr 9:123,419,865...123,461,630
G
Slc6a8
solute carrier family 6 (neurotransmitter transporter, creatine), member 8
decreases expression
ISO
zoledronic acid results in decreased expression of SLC6A8 mRNA
CTD
PMID:24714768
NCBI chr X:72,716,739...72,726,108
Ensembl chr X:72,716,756...72,726,108
G
Slc7a2
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2
decreases expression
ISO
zoledronic acid results in decreased expression of SLC7A2 mRNA
CTD
PMID:24714768
NCBI chr 8:41,315,404...41,375,107
Ensembl chr 8:41,315,433...41,375,345
G
Slc7a5
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5
decreases expression
ISO
zoledronic acid results in decreased expression of SLC7A5 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 8:122,607,885...122,634,425
Ensembl chr 8:122,607,889...122,634,433
G
Slco2a1
solute carrier organic anion transporter family, member 2a1
increases expression
ISO
zoledronic acid results in increased expression of SLCO2A1 mRNA
CTD
PMID:24714768
NCBI chr 9:102,885,686...102,973,201
Ensembl chr 9:102,865,911...102,973,201
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
increases expression
ISO
zoledronic acid results in increased expression of SLCO2B1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 7:99,307,011...99,360,547
Ensembl chr 7:99,307,011...99,360,547
G
Slco3a1
solute carrier organic anion transporter family, member 3a1
decreases expression increases expression
ISO
zoledronic acid results in decreased expression of SLCO3A1 mRNA zoledronic acid results in increased expression of SLCO3A1 mRNA
CTD
PMID:20977926 PMID:24714768
NCBI chr 7:73,925,166...74,204,528
Ensembl chr 7:73,925,167...74,204,528
G
Slco4a1
solute carrier organic anion transporter family, member 4a1
increases expression
ISO
zoledronic acid results in increased expression of SLCO4A1 mRNA
CTD
PMID:24714768
NCBI chr 2:180,098,019...180,116,646
Ensembl chr 2:180,098,038...180,116,660
G
Slco4c1
solute carrier organic anion transporter family, member 4C1
decreases expression
ISO
zoledronic acid results in decreased expression of SLCO4C1 mRNA
CTD
PMID:24714768
NCBI chr 1:96,744,918...96,800,027
Ensembl chr 1:96,743,995...96,799,896
G
Slf2
SMC5-SMC6 complex localization factor 2
decreases expression
ISO
zoledronic acid results in decreased expression of SLF2 mRNA
CTD
PMID:24714768
NCBI chr19:44,906,948...44,972,225
Ensembl chr19:44,919,558...44,972,225
G
Slfn5
schlafen 5
increases expression
ISO
zoledronic acid results in increased expression of SLFN5 mRNA
CTD
PMID:24714768
NCBI chr11:82,842,175...82,855,681
Ensembl chr11:82,842,175...82,855,666
G
Slitrk4
SLIT and NTRK-like family, member 4
decreases expression
ISO
zoledronic acid results in decreased expression of SLITRK4 mRNA
CTD
PMID:24714768
NCBI chr X:63,308,489...63,320,951
Ensembl chr X:63,308,491...63,320,602
G
Slmap
sarcolemma associated protein
increases expression
ISO
zoledronic acid results in increased expression of SLMAP mRNA
CTD
PMID:20977926
NCBI chr14:26,134,323...26,256,103
Ensembl chr14:26,134,323...26,256,086
G
Slpi
secretory leukocyte peptidase inhibitor
increases expression
ISO
zoledronic acid results in increased expression of SLPI mRNA; zoledronic acid results in increased expression of SLPI protein
CTD
PMID:24714768 PMID:28871336
NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015
G
Smad3
SMAD family member 3
increases expression increases phosphorylation multiple interactions
ISO EXP
zoledronic acid results in increased expression of SMAD3 mRNA zoledronic acid results in increased phosphorylation of SMAD3 protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [zoledronic acid results in increased phosphorylation of SMAD3 protein]
CTD
PMID:24714768 PMID:28871336
NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276
G
Smco4
single-pass membrane protein with coiled-coil domains 4
decreases expression
ISO
zoledronic acid results in decreased expression of SMCO4 mRNA
CTD
PMID:24714768
NCBI chr 9:15,379,736...15,456,556
Ensembl chr 9:15,404,728...15,456,556
G
Smim24
small integral membrane protein 24
decreases expression
ISO
zoledronic acid results in decreased expression of SMIM24 mRNA
CTD
PMID:24714768
NCBI chr10:81,228,898...81,230,913
Ensembl chr10:81,228,885...81,231,226
G
Smoc2
SPARC related modular calcium binding 2
increases expression
ISO
zoledronic acid results in increased expression of SMOC2 mRNA
CTD
PMID:24714768
NCBI chr17:14,499,768...14,625,052
Ensembl chr17:14,499,768...14,625,052
G
Smox
spermine oxidase
decreases expression
ISO
zoledronic acid results in decreased expression of SMOX mRNA
CTD
PMID:24714768
NCBI chr 2:131,333,624...131,367,103
Ensembl chr 2:131,333,416...131,367,842
G
Smtn
smoothelin
decreases expression
ISO
zoledronic acid results in decreased expression of SMTN mRNA
CTD
PMID:24714768
NCBI chr11:3,467,522...3,489,337
Ensembl chr11:3,467,521...3,490,612
G
Snap25
synaptosomal-associated protein 25
increases expression
ISO
zoledronic acid results in increased expression of SNAP25 mRNA
CTD
PMID:24714768
NCBI chr 2:136,555,359...136,624,348
Ensembl chr 2:136,555,373...136,624,348
G
Snhg12
small nucleolar RNA host gene 12
increases expression
ISO
Zoledronic Acid results in increased expression of SNHG12 mRNA
CTD
PMID:20977926
NCBI chr 4:132,035,989...132,038,335
Ensembl chr 4:132,035,905...132,038,762
G
Snph
syntaphilin
increases expression
ISO
zoledronic acid results in increased expression of SNPH mRNA
CTD
PMID:24714768
NCBI chr 2:151,432,469...151,474,527
Ensembl chr 2:151,432,469...151,474,513
G
Socs1
suppressor of cytokine signaling 1
increases expression
ISO
zoledronic acid results in increased expression of SOCS1 mRNA
CTD
PMID:24714768
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
G
Sod2
superoxide dismutase 2, mitochondrial
increases expression
ISO
zoledronic acid results in increased expression of SOD2 mRNA
CTD
PMID:24714768
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Sod3
superoxide dismutase 3, extracellular
increases expression
ISO
zoledronic acid results in increased expression of SOD3 mRNA
CTD
PMID:24714768
NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760
G
Sorcs3
sortilin-related VPS10 domain containing receptor 3
decreases expression
ISO
zoledronic acid results in decreased expression of SORCS3 mRNA
CTD
PMID:24714768
NCBI chr19:48,194,464...48,793,944
Ensembl chr19:48,194,464...48,793,944
G
Sos2
SOS Ras/Rho guanine nucleotide exchange factor 2
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of SOS2 mRNA
CTD
PMID:16996129
NCBI chr12:69,630,535...69,728,626
Ensembl chr12:69,630,536...69,728,626
G
Sostdc1
sclerostin domain containing 1
increases expression
ISO
zoledronic acid results in increased expression of SOSTDC1 mRNA
CTD
PMID:24714768
NCBI chr12:36,364,168...36,368,451
Ensembl chr12:36,364,138...36,368,451
G
Sowahc
sosondowah ankyrin repeat domain family member C
decreases expression
ISO
zoledronic acid results in decreased expression of SOWAHC mRNA
CTD
PMID:24714768
NCBI chr10:59,057,744...59,062,256
Ensembl chr10:59,057,775...59,062,256
G
Sox13
SRY (sex determining region Y)-box 13
increases expression
ISO
zoledronic acid results in increased expression of SOX13 mRNA
CTD
PMID:20977926
NCBI chr 1:133,310,038...133,352,159
Ensembl chr 1:133,310,041...133,352,115
G
Sox17
SRY (sex determining region Y)-box 17
increases expression
ISO
zoledronic acid results in increased expression of SOX17 mRNA
CTD
PMID:24714768
NCBI chr 1:4,561,154...4,567,624
Ensembl chr 1:4,561,154...4,567,577
G
Sox2
SRY (sex determining region Y)-box 2
increases expression
ISO
zoledronic acid results in increased expression of SOX2 mRNA
CTD
PMID:24714768
NCBI chr 3:34,704,144...34,706,610
Ensembl chr 3:34,704,554...34,706,610
G
Sox4
SRY (sex determining region Y)-box 4
decreases expression
ISO
zoledronic acid results in decreased expression of SOX4 mRNA
CTD
PMID:24714768
NCBI chr13:29,132,902...29,137,682
Ensembl chr13:29,132,902...29,137,696
G
Sox9
SRY (sex determining region Y)-box 9
decreases expression
ISO
zoledronic acid results in decreased expression of SOX9 mRNA
CTD
PMID:24714768
NCBI chr11:112,673,036...112,678,583
Ensembl chr11:112,673,050...112,678,586
G
Sp1
trans-acting transcription factor 1
increases expression
ISO
zoledronic acid results in increased expression of SP1 mRNA
CTD
PMID:20977926
NCBI chr15:102,314,751...102,344,839
Ensembl chr15:102,314,578...102,344,839
G
Spart
spartin
decreases expression
ISO
Zoledronic Acid results in decreased expression of SPART protein
CTD
PMID:28871336
NCBI chr 3:55,019,500...55,044,753
Ensembl chr 3:55,019,529...55,044,743
G
Spata7
spermatogenesis associated 7
increases expression
ISO
zoledronic acid results in increased expression of SPATA7 mRNA
CTD
PMID:20977926
NCBI chr12:98,594,169...98,636,078
Ensembl chr12:98,594,416...98,636,074
G
Spc24
SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae)
decreases expression
ISO
zoledronic acid results in decreased expression of SPC24 mRNA
CTD
PMID:24714768
NCBI chr 9:21,666,730...21,671,741
Ensembl chr 9:21,666,738...21,671,599
G
Speer4f2
spermatogenesis associated glutamate (E)-rich protein 4f2
increases expression
ISO
zoledronic acid results in increased expression of C3ORF36 mRNA
CTD
PMID:24714768
NCBI chr 5:17,578,184...17,582,990
Ensembl chr 5:17,578,178...17,583,026
G
Spin2c
spindlin family, member 2C
multiple interactions
ISO
[Zoledronic Acid co-treated with Fluvastatin] results in increased expression of SPIN2A mRNA
CTD
PMID:16996129
NCBI chr X:152,615,246...152,617,239
Ensembl chr X:152,615,221...152,617,239
G
Spink1
serine peptidase inhibitor, Kazal type 1
increases expression
ISO
zoledronic acid results in increased expression of SPINK1 mRNA
CTD
PMID:24714768
NCBI chr18:43,861,134...43,870,302
Ensembl chr18:43,861,147...43,870,622
G
Spock1
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1
decreases expression
ISO
zoledronic acid results in decreased expression of SPOCK1 mRNA
CTD
PMID:24714768
NCBI chr13:57,569,008...58,056,194
Ensembl chr13:57,569,008...58,056,146
G
Sprr2f
small proline-rich protein 2F
increases expression
ISO
zoledronic acid results in increased expression of SPRR2F mRNA
CTD
PMID:24714768
NCBI chr 3:92,272,494...92,273,754
Ensembl chr 3:92,272,494...92,273,749
G
Sprr2h
small proline-rich protein 2H
increases expression
ISO
Zoledronic Acid results in increased expression of SPRR2A mRNA
CTD
PMID:24714768
NCBI chr 3:92,292,992...92,294,631
Ensembl chr 3:92,292,992...92,294,631
G
Spryd3
SPRY domain containing 3
decreases expression
ISO
zoledronic acid results in decreased expression of SPRYD3 mRNA
CTD
PMID:20977926
NCBI chr15:102,024,961...102,044,678
Ensembl chr15:102,024,963...102,044,669
G
Sptan1
spectrin alpha, non-erythrocytic 1
decreases expression
ISO
zoledronic acid results in decreased expression of SPTAN1 protein
CTD
PMID:28871336
NCBI chr 2:29,855,572...29,921,463
Ensembl chr 2:29,855,572...29,921,463
G
Sptlc3
serine palmitoyltransferase, long chain base subunit 3
decreases expression
ISO
zoledronic acid results in decreased expression of SPTLC3 mRNA
CTD
PMID:24714768
NCBI chr 2:139,335,833...139,478,981
Ensembl chr 2:139,335,833...139,479,594
G
Spx
spexin hormone
increases expression
ISO
zoledronic acid results in increased expression of SPX mRNA
CTD
PMID:24714768
NCBI chr 6:142,359,114...142,365,466
Ensembl chr 6:142,359,167...142,365,456
G
Sqle
squalene epoxidase
increases expression
ISO
zoledronic acid results in increased expression of SQLE mRNA
CTD
PMID:18325729 PMID:20977926 PMID:24714768
NCBI chr15:59,186,941...59,203,042
Ensembl chr15:59,186,926...59,203,041
G
Sqor
sulfide quinone oxidoreductase
increases expression
ISO
zoledronic acid results in increased expression of SQOR mRNA
CTD
PMID:24714768
NCBI chr 2:122,607,249...122,651,473
Ensembl chr 2:122,607,157...122,651,489
G
Srd5a2
steroid 5 alpha-reductase 2
increases expression
ISO
zoledronic acid results in increased expression of SRD5A2 mRNA
CTD
PMID:24714768
NCBI chr17:74,321,886...74,354,855
Ensembl chr17:74,323,950...74,354,911
G
Srd5a3
steroid 5 alpha-reductase 3
increases expression
ISO
zoledronic acid results in increased expression of SRD5A3 mRNA
CTD
PMID:25596134
NCBI chr 5:76,285,296...76,303,350
Ensembl chr 5:76,288,118...76,303,351
G
Srgap3
SLIT-ROBO Rho GTPase activating protein 3
increases expression
ISO
zoledronic acid results in increased expression of SRGAP3 mRNA
CTD
PMID:24714768
NCBI chr 6:112,694,932...112,924,466
Ensembl chr 6:112,694,932...112,924,227
G
Srsf11
serine and arginine-rich splicing factor 11
decreases expression
ISO
zoledronic acid results in decreased expression of SRSF11 mRNA
CTD
PMID:20977926
NCBI chr 3:157,716,552...157,742,304
Ensembl chr 3:157,716,110...157,742,276
G
Ss18
SS18, subunit of BAF chromatin remodeling complex
increases expression
ISO
zoledronic acid results in increased expression of SS18 mRNA
CTD
PMID:20977926
NCBI chr18:14,758,686...14,817,476
Ensembl chr18:14,757,255...14,815,971
G
Ssh2
slingshot protein phosphatase 2
decreases expression
ISO
zoledronic acid results in decreased expression of SSH2 mRNA
CTD
PMID:24714768
NCBI chr11:77,107,020...77,351,046
Ensembl chr11:77,107,113...77,351,046
G
Sstr1
somatostatin receptor 1
decreases expression
ISO
zoledronic acid results in decreased expression of SSTR1 mRNA
CTD
PMID:24714768
NCBI chr12:58,258,524...58,262,822
Ensembl chr12:58,258,558...58,260,673
G
Ssx2ip
SSX family member 2 interacting protein
increases expression
ISO
zoledronic acid results in increased expression of SSX2IP mRNA
CTD
PMID:20977926
NCBI chr 3:146,110,397...146,145,899
Ensembl chr 3:146,110,397...146,145,899
G
St6gal1
beta galactoside alpha 2,6 sialyltransferase 1
increases expression
ISO
zoledronic acid results in increased expression of ST6GAL1 mRNA
CTD
PMID:20977926
NCBI chr16:23,043,478...23,179,100
Ensembl chr16:23,043,490...23,179,100
G
St6galnac1
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1
increases expression
ISO
zoledronic acid results in increased expression of ST6GALNAC1 mRNA
CTD
PMID:24714768
NCBI chr11:116,655,851...116,666,333
Ensembl chr11:116,655,851...116,666,333
G
Stag2
STAG2 cohesin complex component
decreases expression
ISO
zoledronic acid results in decreased expression of STAG2 protein
CTD
PMID:28871336
NCBI chr X:41,238,172...41,366,063
Ensembl chr X:41,238,194...41,366,062
G
Stard13
StAR related lipid transfer domain containing 13
decreases expression
ISO
zoledronic acid results in decreased expression of STARD13 mRNA
CTD
PMID:24714768
NCBI chr 5:150,960,975...151,351,780
Ensembl chr 5:150,960,975...151,157,301
G
Stard8
StAR related lipid transfer domain containing 8
decreases expression
ISO
zoledronic acid results in decreased expression of STARD8 mRNA
CTD
PMID:24714768
NCBI chr X:98,046,539...98,118,334
Ensembl chr X:98,046,854...98,118,334
G
Stat1
signal transducer and activator of transcription 1
increases expression
ISO
zoledronic acid results in increased expression of STAT1 mRNA
CTD
PMID:24714768
NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
G
Stat3
signal transducer and activator of transcription 3
increases expression
ISO
zoledronic acid results in increased expression of STAT3 mRNA
CTD
PMID:24714768
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
G
Stat5a
signal transducer and activator of transcription 5A
increases expression
ISO
zoledronic acid results in increased expression of STAT5A mRNA
CTD
PMID:24714768
NCBI chr11:100,750,177...100,775,995
Ensembl chr11:100,750,177...100,775,995
G
Stc1
stanniocalcin 1
increases expression
ISO
zoledronic acid results in increased expression of STC1 protein
CTD
PMID:28871336
NCBI chr14:69,266,738...69,278,850
Ensembl chr14:69,266,687...69,279,253
G
Stc2
stanniocalcin 2
increases expression
ISO
zoledronic acid results in increased expression of STC2 mRNA
CTD
PMID:24714768
NCBI chr11:31,309,441...31,320,061
Ensembl chr11:31,307,307...31,320,074
G
Steap1
six transmembrane epithelial antigen of the prostate 1
increases expression
ISO
zoledronic acid results in increased expression of STEAP1 mRNA
CTD
PMID:24714768
NCBI chr 5:5,786,322...5,799,317
Ensembl chr 5:5,786,317...5,799,326
G
Sting1
stimulator of interferon response cGAMP interactor 1
increases expression
ISO
Zoledronic Acid results in increased expression of STING1 mRNA
CTD
PMID:24714768
NCBI chr18:35,866,731...35,873,607
Ensembl chr18:35,866,732...35,873,607
G
Stk32a
serine/threonine kinase 32A
decreases expression
ISO
zoledronic acid results in decreased expression of STK32A mRNA
CTD
PMID:24714768
NCBI chr18:43,340,762...43,450,546
Ensembl chr18:43,340,648...43,451,747
G
Stk32b
serine/threonine kinase 32B
decreases expression
ISO
zoledronic acid results in decreased expression of STK32B mRNA
CTD
PMID:24714768
NCBI chr 5:37,604,169...37,874,503
Ensembl chr 5:37,604,169...37,874,515
G
Stk40
serine/threonine kinase 40
decreases expression
ISO
zoledronic acid results in decreased expression of STK40 mRNA
CTD
PMID:20977926
NCBI chr 4:125,997,738...126,034,822
Ensembl chr 4:125,997,750...126,034,822
G
Stmn1
stathmin 1
decreases expression
ISO
zoledronic acid results in decreased expression of STMN1 mRNA
CTD
PMID:24714768
NCBI chr 4:134,195,631...134,201,154
Ensembl chr 4:134,195,631...134,201,154
G
Stoml1
stomatin-like 1
increases expression
ISO
zoledronic acid results in increased expression of STOML1 mRNA
CTD
PMID:24714768
NCBI chr 9:58,160,443...58,169,807
Ensembl chr 9:58,160,447...58,169,803
G
Stx16
syntaxin 16
increases expression
ISO
zoledronic acid results in increased expression of STX16 mRNA
CTD
PMID:20977926
NCBI chr 2:173,918,052...173,941,564
Ensembl chr 2:173,918,101...173,941,564
G
Stx17
syntaxin 17
increases expression
ISO
zoledronic acid results in increased expression of STX17 mRNA
CTD
PMID:20977926
NCBI chr 4:48,124,912...48,186,507
Ensembl chr 4:48,124,915...48,186,507
G
Stxbp4
syntaxin binding protein 4
decreases expression
ISO
zoledronic acid results in decreased expression of STXBP4 mRNA
CTD
PMID:24714768
NCBI chr11:90,367,318...90,528,962
Ensembl chr11:90,367,318...90,528,910
G
Sucnr1
succinate receptor 1
decreases expression
ISO
zoledronic acid results in decreased expression of SUCNR1 mRNA
CTD
PMID:24714768
NCBI chr 3:59,989,290...59,994,987
Ensembl chr 3:59,989,290...59,994,987
G
Sugct
succinyl-CoA glutarate-CoA transferase
increases expression
ISO
zoledronic acid results in increased expression of SUGCT mRNA
CTD
PMID:24714768
NCBI chr13:17,032,057...17,869,380
Ensembl chr13:17,032,057...17,870,138
G
Sulf2
sulfatase 2
increases expression
ISO
zoledronic acid results in increased expression of SULF2 mRNA
CTD
PMID:25596134
NCBI chr 2:165,915,819...165,997,603
Ensembl chr 2:165,915,009...165,997,583
G
Svil
supervillin
increases expression
ISO
zoledronic acid results in increased expression of SVIL mRNA
CTD
PMID:24714768
NCBI chr18:4,920,497...5,119,290
Ensembl chr18:4,920,540...5,119,299
G
Sybu
syntabulin (syntaxin-interacting)
decreases expression
ISO
Zoledronic Acid results in decreased expression of SYBU mRNA
CTD
PMID:24714768
NCBI chr15:44,535,252...44,651,466
Ensembl chr15:44,535,252...44,651,459
G
Synj1
synaptojanin 1
increases expression
ISO
zoledronic acid results in increased expression of SYNJ1 mRNA
CTD
PMID:20977926
NCBI chr16:90,732,980...90,810,543
Ensembl chr16:90,732,980...90,808,196
G
Syt13
synaptotagmin XIII
decreases expression
ISO
zoledronic acid results in decreased expression of SYT13 mRNA
CTD
PMID:24714768
NCBI chr 2:92,745,446...92,786,403
Ensembl chr 2:92,745,443...92,786,403
G
Sytl2
synaptotagmin-like 2
decreases expression
ISO
zoledronic acid results in decreased expression of SYTL2 mRNA
CTD
PMID:24714768
NCBI chr 7:89,951,421...90,059,927
Ensembl chr 7:89,951,460...90,059,927
G
Tab2
TGF-beta activated kinase 1/MAP3K7 binding protein 2
increases expression
ISO
zoledronic acid results in increased expression of TAB2 mRNA
CTD
PMID:20977926
NCBI chr10:7,781,412...7,832,039
Ensembl chr10:7,781,417...7,831,994
G
Tacc3
transforming, acidic coiled-coil containing protein 3
decreases expression
ISO
zoledronic acid results in decreased expression of TACC3 mRNA
CTD
PMID:24714768
NCBI chr 5:33,814,808...33,836,331
Ensembl chr 5:33,815,472...33,836,339
G
Taf9b
TATA-box binding protein associated factor 9B
increases expression
ISO
zoledronic acid results in increased expression of TAF9B mRNA
CTD
PMID:20977926
NCBI chr X:105,250,480...105,264,764
Ensembl chr X:105,250,489...105,264,764
G
Tapbp
TAP binding protein
increases expression
ISO
zoledronic acid results in increased expression of TAPBP mRNA
CTD
PMID:24714768
NCBI chr17:34,138,452...34,148,264
Ensembl chr17:34,134,873...34,148,266
G
Tbc1d16
TBC1 domain family, member 16
increases expression
ISO
zoledronic acid results in increased expression of TBC1D16 mRNA
CTD
PMID:24714768
NCBI chr11:119,033,869...119,119,354
Ensembl chr11:119,033,871...119,119,325
G
Tbc1d2b
TBC1 domain family, member 2B
increases expression
ISO
zoledronic acid results in increased expression of TBC1D2B mRNA
CTD
PMID:24714768
NCBI chr 9:90,084,100...90,152,861
Ensembl chr 9:90,084,080...90,152,857
G
Tbc1d4
TBC1 domain family, member 4
decreases expression
ISO
zoledronic acid results in decreased expression of TBC1D4 mRNA
CTD
PMID:24714768
NCBI chr14:101,679,800...101,846,717
Ensembl chr14:101,679,796...101,846,627
G
Tbc1d8
TBC1 domain family, member 8
increases expression
ISO
zoledronic acid results in increased expression of TBC1D8 mRNA
CTD
PMID:24714768
NCBI chr 1:39,410,576...39,517,860
Ensembl chr 1:39,410,573...39,517,836
G
Tbl1xr1
transducin (beta)-like 1X-linked receptor 1
increases expression
ISO
zoledronic acid results in increased expression of TBL1XR1 mRNA
CTD
PMID:20977926
NCBI chr 3:22,130,756...22,270,758
Ensembl chr 3:22,130,816...22,270,758
G
Tcaim
T cell activation inhibitor, mitochondrial
increases expression
ISO
zoledronic acid results in increased expression of TCAIM mRNA
CTD
PMID:20977926
NCBI chr 9:122,634,586...122,665,397
Ensembl chr 9:122,634,604...122,665,399
G
Tcim
transcriptional and immune response regulator
increases expression
ISO
zoledronic acid results in increased expression of TCIM mRNA
CTD
PMID:24714768
NCBI chr 8:24,927,188...24,928,962
Ensembl chr 8:24,927,196...24,929,000
G
Tcp1
t-complex protein 1
decreases expression
ISO
zoledronic acid results in decreased expression of TCP1 mRNA
CTD
PMID:24714768
NCBI chr17:13,135,216...13,143,954
Ensembl chr17:13,134,588...13,143,954
G
Tead2
TEA domain family member 2
decreases expression
ISO
zoledronic acid results in decreased expression of TEAD2 mRNA
CTD
PMID:24714768
NCBI chr 7:44,865,216...44,882,892
Ensembl chr 7:44,865,177...44,883,068
G
Tenm4
teneurin transmembrane protein 4
increases expression
ISO
zoledronic acid results in increased expression of TENM4 mRNA
CTD
PMID:24714768
NCBI chr 7:95,550,262...96,560,300
Ensembl chr 7:95,820,453...96,560,300
G
Tent5b
terminal nucleotidyltransferase 5B
decreases expression
ISO
zoledronic acid results in decreased expression of TENT5B mRNA
CTD
PMID:24714768
NCBI chr 4:133,207,444...133,215,251
Ensembl chr 4:133,207,443...133,215,249
G
Tesc
tescalcin
decreases expression
ISO
zoledronic acid results in decreased expression of TESC mRNA
CTD
PMID:24714768
NCBI chr 5:118,165,808...118,199,943
Ensembl chr 5:118,165,808...118,199,943
G
Tespa1
thymocyte expressed, positive selection associated 1
decreases expression
ISO
zoledronic acid results in decreased expression of TESPA1 mRNA
CTD
PMID:20977926
NCBI chr10:130,158,696...130,199,338
Ensembl chr10:130,158,739...130,199,980
G
Tfap2b
transcription factor AP-2 beta
decreases expression
ISO
zoledronic acid results in decreased expression of TFAP2B mRNA
CTD
PMID:24714768
NCBI chr 1:19,279,132...19,309,071
Ensembl chr 1:19,279,138...19,308,800
G
Tfcp2l1
transcription factor CP2-like 1
decreases expression
ISO
zoledronic acid results in decreased expression of TFCP2L1 mRNA
CTD
PMID:24714768
NCBI chr 1:118,555,646...118,612,898
Ensembl chr 1:118,555,675...118,612,898
G
Tfip11
tuftelin interacting protein 11
decreases expression
ISO
zoledronic acid results in decreased expression of TFIP11 mRNA
CTD
PMID:20977926
NCBI chr 5:112,474,235...112,485,939
Ensembl chr 5:112,474,224...112,485,939
G
Tfpi
tissue factor pathway inhibitor
increases expression
ISO
zoledronic acid results in increased expression of TFPI mRNA
CTD
PMID:24714768
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
G
Tfpi2
tissue factor pathway inhibitor 2
increases expression
ISO
zoledronic acid results in increased expression of TFPI2 mRNA
CTD
PMID:24714768
NCBI chr 6:3,962,589...3,988,977
Ensembl chr 6:3,962,595...3,988,919
G
Tfrc
transferrin receptor
increases expression
ISO
zoledronic acid results in increased expression of TFRC mRNA
CTD
PMID:20977926
NCBI chr16:32,427,714...32,451,612
Ensembl chr16:32,427,738...32,451,612
G
Tgfb1
transforming growth factor, beta 1
multiple interactions increases expression
ISO EXP
[Alendronate co-treated with zoledronic acid] results in increased expression of TGFB1 protein zoledronic acid results in increased expression of TGFB1 protein zoledronic acid results in increased expression of TGFB1 mRNA zoledronic acid results in increased expression of and results in increased secretion of TGFB1 protein
CTD
PMID:18504149 PMID:28871336
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tgfb1i1
transforming growth factor beta 1 induced transcript 1
increases expression
ISO
zoledronic acid results in increased expression of TGFB1I1 protein
CTD
PMID:28871336
NCBI chr 7:127,845,963...127,852,884
Ensembl chr 7:127,845,984...127,854,871
G
Tgfb2
transforming growth factor, beta 2
increases expression
ISO
zoledronic acid results in increased expression of TGFB2 mRNA
CTD
PMID:24714768
NCBI chr 1:186,354,984...186,441,504
Ensembl chr 1:186,354,989...186,438,186
G
Tgfbrap1
transforming growth factor, beta receptor associated protein 1
increases expression
ISO
zoledronic acid results in increased expression of TGFBRAP1 protein
CTD
PMID:28871336
NCBI chr 1:43,086,360...43,137,788
Ensembl chr 1:43,086,360...43,137,797
G
Tgm2
transglutaminase 2, C polypeptide
increases expression
ISO
zoledronic acid results in increased expression of TGM2 mRNA
CTD
PMID:24714768
NCBI chr 2:157,958,325...157,988,312
Ensembl chr 2:157,958,322...157,988,356
G
Thbs1
thrombospondin 1
decreases expression
ISO
zoledronic acid results in decreased expression of THBS1 mRNA
CTD
PMID:24714768
NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614
G
Tifa
TRAF-interacting protein with forkhead-associated domain
increases expression
ISO
zoledronic acid results in increased expression of TIFA mRNA
CTD
PMID:24714768
NCBI chr 3:127,582,524...127,592,043
Ensembl chr 3:127,583,454...127,625,813
G
Tigar
Trp53 induced glycolysis regulatory phosphatase
decreases expression
ISO
zoledronic acid results in decreased expression of TIGAR mRNA
CTD
PMID:25596134
NCBI chr 6:127,062,079...127,086,564
Ensembl chr 6:127,062,079...127,086,520
G
Timp1
tissue inhibitor of metalloproteinase 1
multiple interactions increases expression
EXP ISO
Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of TIMP1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of TIMP1 mRNA] zoledronic acid results in increased expression of TIMP1 mRNA; zoledronic acid results in increased expression of TIMP1 protein
CTD
PMID:28871336
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
G
Timp2
tissue inhibitor of metalloproteinase 2
increases expression multiple interactions
ISO EXP
zoledronic acid results in increased expression of TIMP2 mRNA; zoledronic acid results in increased expression of TIMP2 protein Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of TIMP2 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of TIMP2 mRNA]
CTD
PMID:28871336
NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
G
Tinag
tubulointerstitial nephritis antigen
decreases expression
ISO
zoledronic acid results in decreased expression of TINAG mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 9:76,858,980...76,953,084
Ensembl chr 9:76,858,975...76,953,076
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
increases expression
ISO
zoledronic acid results in increased expression of TIPARP mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 3:65,435,868...65,462,939
Ensembl chr 3:65,435,831...65,462,939
G
Tlcd3a
TLC domain containing 3A
increases expression
ISO
Zoledronic Acid results in increased expression of TLCD3A mRNA
CTD
PMID:20977926
NCBI chr11:76,070,497...76,100,243
Ensembl chr11:76,070,497...76,105,653
G
Tle4
transducin-like enhancer of split 4
increases expression
ISO
zoledronic acid results in increased expression of TLE4 mRNA
CTD
PMID:24714768
NCBI chr19:14,425,434...14,575,542
Ensembl chr19:14,425,514...14,575,415
G
Tlr5
toll-like receptor 5
increases expression
ISO
zoledronic acid results in increased expression of TLR5 mRNA
CTD
PMID:24714768
NCBI chr 1:182,782,317...182,804,010
Ensembl chr 1:182,782,353...182,804,010
G
Tm4sf4
transmembrane 4 superfamily member 4
decreases expression
ISO
zoledronic acid results in decreased expression of TM4SF4 mRNA
CTD
PMID:24714768
NCBI chr 3:57,332,831...57,349,098
Ensembl chr 3:57,332,735...57,349,098
G
Tm7sf2
transmembrane 7 superfamily member 2
increases expression
ISO
zoledronic acid results in increased expression of TM7SF2 mRNA
CTD
PMID:24714768
NCBI chr19:6,112,851...6,117,880
Ensembl chr19:6,112,851...6,118,403
G
Tmc5
transmembrane channel-like gene family 5
increases expression
ISO
zoledronic acid results in increased expression of TMC5 mRNA
CTD
PMID:24714768
NCBI chr 7:118,196,520...118,274,308
Ensembl chr 7:118,196,520...118,274,309
G
Tmcc1
transmembrane and coiled coil domains 1
decreases expression
ISO
zoledronic acid results in decreased expression of TMCC1 mRNA
CTD
PMID:24714768
NCBI chr 6:115,995,572...116,170,485
Ensembl chr 6:115,995,572...116,170,447
G
Tmco3
transmembrane and coiled-coil domains 3
increases expression
ISO
zoledronic acid results in increased expression of TMCO3 mRNA
CTD
PMID:20977926
NCBI chr 8:13,333,214...13,372,924
Ensembl chr 8:13,338,190...13,372,924
G
Tmem125
transmembrane protein 125
decreases expression
ISO
zoledronic acid results in decreased expression of TMEM125 mRNA
CTD
PMID:24714768
NCBI chr 4:118,398,138...118,402,110
Ensembl chr 4:118,398,138...118,401,241
G
Tmem132a
transmembrane protein 132A
increases expression
ISO
zoledronic acid results in increased expression of TMEM132A mRNA
CTD
PMID:24714768
NCBI chr19:10,835,193...10,847,569
Ensembl chr19:10,835,186...10,847,304
G
Tmem154
transmembrane protein 154
decreases expression
ISO
zoledronic acid results in decreased expression of TMEM154 mRNA
CTD
PMID:24714768
NCBI chr 3:84,573,499...84,611,882
Ensembl chr 3:84,573,499...84,611,882
G
Tmem171
transmembrane protein 171
increases expression
ISO
zoledronic acid results in increased expression of TMEM171 mRNA
CTD
PMID:24714768
NCBI chr13:98,822,744...98,832,142
Ensembl chr13:98,822,743...98,831,342
G
Tmem213
transmembrane protein 213
decreases expression
ISO
zoledronic acid results in decreased expression of TMEM213 mRNA
CTD
PMID:24714768
NCBI chr 6:38,086,288...38,092,741
Ensembl chr 6:38,086,190...38,092,744
G
Tmem259
transmembrane protein 259
increases expression
ISO
zoledronic acid results in increased expression of TMEM259 mRNA
CTD
PMID:20977926
NCBI chr10:79,812,954...79,820,159
Ensembl chr10:79,810,782...79,820,164
G
Tmem267
transmembrane protein 267
increases expression
ISO
zoledronic acid results in increased expression of TMEM267 mRNA
CTD
PMID:24714768
NCBI chr13:119,624,622...120,071,995
Ensembl chr13:119,624,575...120,072,595
G
Tmem30a
transmembrane protein 30A
increases expression
ISO
zoledronic acid results in increased expression of TMEM30A mRNA
CTD
PMID:20977926
NCBI chr 9:79,676,223...79,700,712
Ensembl chr 9:79,676,225...79,700,789
G
Tmem37
transmembrane protein 37
decreases expression
ISO
zoledronic acid results in decreased expression of TMEM37 mRNA
CTD
PMID:24714768
NCBI chr 1:119,995,106...120,001,799
Ensembl chr 1:119,995,107...120,001,804
G
Tmem52b
transmembrane protein 52B
decreases expression
ISO
zoledronic acid results in decreased expression of TMEM52B mRNA
CTD
PMID:24714768
NCBI chr 6:129,489,512...129,496,190
Ensembl chr 6:129,489,518...129,496,190
G
Tmem72
transmembrane protein 72
decreases expression
ISO
zoledronic acid results in decreased expression of TMEM72 mRNA
CTD
PMID:24714768
NCBI chr 6:116,668,500...116,693,943
Ensembl chr 6:116,656,024...116,693,874
G
Tmem74b
transmembrane protein 74B
increases expression
ISO
zoledronic acid results in increased expression of TMEM74B mRNA
CTD
PMID:24714768
NCBI chr 2:151,543,294...151,558,665
Ensembl chr 2:151,543,928...151,554,077
G
Tmem86a
transmembrane protein 86A
decreases expression
ISO
zoledronic acid results in decreased expression of TMEM86A mRNA
CTD
PMID:24714768
NCBI chr 7:46,700,388...46,704,524
Ensembl chr 7:46,700,349...46,704,525
G
Tmem87b
transmembrane protein 87B
increases expression
ISO
zoledronic acid results in increased expression of TMEM87B mRNA
CTD
PMID:20977926
NCBI chr 2:128,659,991...128,696,181
Ensembl chr 2:128,660,038...128,696,181
G
Tmem97
transmembrane protein 97
increases expression
ISO
zoledronic acid results in increased expression of TMEM97 mRNA
CTD
PMID:24714768
NCBI chr11:78,432,643...78,441,561
Ensembl chr11:78,432,643...78,441,603
G
Tmod1
tropomodulin 1
increases expression
ISO
zoledronic acid results in increased expression of TMOD1 mRNA
CTD
PMID:24714768
NCBI chr 4:46,038,940...46,116,032
Ensembl chr 4:46,038,935...46,116,032
G
Tmprss3
transmembrane protease, serine 3
increases expression
ISO
zoledronic acid results in increased expression of TMPRSS3 mRNA
CTD
PMID:24714768
NCBI chr17:31,398,237...31,419,478
Ensembl chr17:31,398,239...31,417,951
G
Tmsb10
thymosin beta 10
decreases expression
ISO
zoledronic acid results in decreased expression of TMSB10 protein
CTD
PMID:28871336
NCBI chr 6:72,934,330...72,935,731
Ensembl chr 6:72,934,330...72,935,731
G
Tmsb15a
thymosin beta 15a
decreases expression
ISO
zoledronic acid results in decreased expression of TMSB15A mRNA
CTD
PMID:24714768
NCBI chr X:134,619,416...134,626,010
Ensembl chr X:134,619,416...134,626,010
G
Tmsb4x
thymosin, beta 4, X chromosome
decreases expression
ISO
zoledronic acid results in decreased expression of TMSB4X protein
CTD
PMID:28871336
NCBI chr X:165,990,089...165,996,475
Ensembl chr X:165,990,089...165,992,311
G
Tmtc2
transmembrane and tetratricopeptide repeat containing 2
increases expression
ISO
zoledronic acid results in increased expression of TMTC2 mRNA
CTD
PMID:20977926
NCBI chr10:105,023,524...105,410,340
Ensembl chr10:105,023,524...105,410,312
G
Tnc
tenascin C
increases expression
ISO
zoledronic acid results in increased expression of TNC mRNA
CTD
PMID:24714768
NCBI chr 4:63,878,022...63,965,554
Ensembl chr 4:63,878,022...63,965,252
G
Tnf
tumor necrosis factor
increases expression multiple interactions
ISO EXP
Zoledronic Acid results in increased expression of TNF mRNA; Zoledronic Acid results in increased expression of TNF protein zoledronic acid promotes the reaction [TNF protein results in increased phosphorylation of MAPK8 protein] SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of TNF mRNA]
CTD
PMID:9351880 PMID:17059425 PMID:19036117 PMID:24714768 PMID:28871336 PMID:35587103 More...
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfaip2
tumor necrosis factor, alpha-induced protein 2
increases expression
ISO
zoledronic acid results in increased expression of TNFAIP2 mRNA
CTD
PMID:24714768
NCBI chr12:111,408,898...111,421,452
Ensembl chr12:111,408,903...111,421,452
G
Tnfaip3
tumor necrosis factor, alpha-induced protein 3
increases expression
ISO
zoledronic acid results in increased expression of TNFAIP3 mRNA
CTD
PMID:24714768
NCBI chr10:18,876,658...18,891,158
Ensembl chr10:18,876,658...18,891,405
G
Tnfaip6
tumor necrosis factor alpha induced protein 6
increases expression
ISO
zoledronic acid results in increased expression of TNFAIP6 mRNA
CTD
PMID:20977926
NCBI chr 2:51,928,125...51,946,693
Ensembl chr 2:51,928,021...51,946,698
G
Tnfaip8
tumor necrosis factor, alpha-induced protein 8
increases expression
ISO
zoledronic acid results in increased expression of TNFAIP8 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr18:50,112,494...50,226,296
Ensembl chr18:50,112,494...50,240,240
G
Tnfrsf10b
tumor necrosis factor receptor superfamily, member 10b
multiple interactions increases expression
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of TNFRSF10A mRNA zoledronic acid results in increased expression of TNFRSF10A mRNA
CTD
PMID:16996129 PMID:19036117
NCBI chr14:70,004,921...70,021,860
Ensembl chr14:70,004,921...70,021,860
G
Tnfrsf11b
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)
affects expression multiple interactions increases expression increases secretion
ISO EXP
zoledronic acid affects the expression of TNFRSF11B protein zoledronic acid inhibits the reaction [Dexamethasone results in decreased expression of TNFRSF11B mRNA]; zoledronic acid inhibits the reaction [Dexamethasone results in decreased expression of TNFRSF11B protein] zoledronic acid results in increased expression of TNFRSF11B mRNA; zoledronic acid results in increased expression of TNFRSF11B protein zoledronic acid results in increased secretion of TNFRSF11B protein TNFRSF11B protein affects the reaction [zoledronic acid results in decreased activity of ALPL protein]
CTD
PMID:11855844 PMID:14753746 PMID:16121404 PMID:17041912 PMID:18496637 PMID:18980195 PMID:19036117 PMID:24714768 More...
NCBI chr15:54,114,014...54,141,700
Ensembl chr15:54,114,015...54,141,880
G
Tnfrsf12a
tumor necrosis factor receptor superfamily, member 12a
multiple interactions
ISO
[Tretinoin co-treated with zoledronic acid] results in increased expression of TNFRSF12A mRNA
CTD
PMID:20349282
NCBI chr17:23,894,419...23,896,423
Ensembl chr17:23,894,419...23,896,442
G
Tnfrsf14
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)
increases expression
ISO
zoledronic acid results in increased expression of TNFRSF14 mRNA
CTD
PMID:24714768
NCBI chr 4:155,002,944...155,013,077
Ensembl chr 4:155,006,390...155,013,020
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
increases expression multiple interactions
ISO
zoledronic acid results in increased expression of TNFRSF1A mRNA [Tretinoin co-treated with zoledronic acid] results in increased expression of TNFRSF1A mRNA
CTD
PMID:19036117 PMID:20349282
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
increases expression
ISO
zoledronic acid results in increased expression of TNFRSF1B mRNA
CTD
PMID:24714768
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
G
Tnfrsf21
tumor necrosis factor receptor superfamily, member 21
decreases expression increases expression
ISO
zoledronic acid results in decreased expression of TNFRSF21 mRNA zoledronic acid results in increased expression of TNFRSF21 mRNA
CTD
PMID:19036117 PMID:25596134
NCBI chr17:43,327,446...43,400,079
Ensembl chr17:43,327,446...43,400,080
G
Tnfrsf25
tumor necrosis factor receptor superfamily, member 25
decreases expression
ISO
zoledronic acid results in decreased expression of TNFRSF25 mRNA
CTD
PMID:19036117
NCBI chr 4:152,199,985...152,204,568
Ensembl chr 4:152,200,391...152,204,576
G
Tnfrsf9
tumor necrosis factor receptor superfamily, member 9
decreases expression increases expression
ISO
zoledronic acid results in decreased expression of TNFRSF9 mRNA zoledronic acid results in increased expression of TNFRSF9 mRNA
CTD
PMID:19036117 PMID:24714768
NCBI chr 4:151,004,612...151,030,561
Ensembl chr 4:150,999,019...151,030,559
G
Tnfsf11
tumor necrosis factor (ligand) superfamily, member 11
multiple interactions affects expression decreases expression
ISO
ADAM17 protein promotes the reaction [zoledronic acid results in decreased expression of TNFSF11 protein]; TAPI-2 inhibits the reaction [zoledronic acid results in decreased expression of TNFSF11 protein] zoledronic acid affects the expression of TNFSF11 protein
CTD
PMID:14753746 PMID:17041912
NCBI chr14:78,514,886...78,545,483
Ensembl chr14:78,514,885...78,545,483
G
Tnfsf15
tumor necrosis factor (ligand) superfamily, member 15
increases expression
ISO
zoledronic acid results in increased expression of TNFSF15 mRNA
CTD
PMID:24714768
NCBI chr 4:63,642,837...63,663,296
Ensembl chr 4:63,642,840...63,663,350
G
Tnfsf8
tumor necrosis factor (ligand) superfamily, member 8
increases expression
ISO
zoledronic acid results in increased expression of TNFSF8 mRNA
CTD
PMID:20977926
NCBI chr 4:63,749,439...63,779,745
Ensembl chr 4:63,749,545...63,779,584
G
Tnfsf9
tumor necrosis factor (ligand) superfamily, member 9
increases expression
ISO
zoledronic acid results in increased expression of TNFSF9 mRNA
CTD
PMID:25596134
NCBI chr17:57,412,113...57,414,757
Ensembl chr17:57,412,325...57,414,757
G
Tnip1
TNFAIP3 interacting protein 1
increases expression
ISO
zoledronic acid results in increased expression of TNIP1 mRNA
CTD
PMID:24714768
NCBI chr11:54,801,613...54,853,766
Ensembl chr11:54,801,611...54,853,743
G
Tnip3
TNFAIP3 interacting protein 3
increases expression
ISO
zoledronic acid results in increased expression of TNIP3 mRNA
CTD
PMID:24714768
NCBI chr 6:65,567,382...65,611,024 NCBI chr 6:65,502,319...65,554,145
Ensembl chr 6:65,502,297...65,611,024
G
Tnks1bp1
tankyrase 1 binding protein 1
increases expression
ISO
zoledronic acid results in increased expression of TNKS1BP1 mRNA
CTD
PMID:24714768
NCBI chr 2:84,878,356...84,903,392
Ensembl chr 2:84,878,366...84,903,392
G
Tnpo3
transportin 3
decreases expression
ISO
zoledronic acid results in decreased expression of TNPO3 mRNA
CTD
PMID:20977926
NCBI chr 6:29,540,826...29,609,918
Ensembl chr 6:29,540,826...29,609,886
G
Tob1
transducer of ErbB-2.1
increases expression
ISO
zoledronic acid results in increased expression of TOB1 mRNA
CTD
PMID:20977926
NCBI chr11:94,100,668...94,106,321
Ensembl chr11:94,102,280...94,106,321
G
Tollip
toll interacting protein
increases expression
ISO
zoledronic acid results in increased expression of TOLLIP mRNA
CTD
PMID:20977926
NCBI chr 7:141,435,317...141,456,198
Ensembl chr 7:141,428,550...141,472,244
G
Top2a
topoisomerase (DNA) II alpha
decreases expression
ISO
zoledronic acid results in decreased expression of TOP2A mRNA
CTD
PMID:24714768
NCBI chr11:98,883,773...98,915,037
Ensembl chr11:98,883,769...98,915,015
G
Tor2a
torsin family 2, member A
decreases expression
ISO
zoledronic acid results in decreased expression of TOR2A mRNA
CTD
PMID:24714768
NCBI chr 2:32,647,289...32,652,256
Ensembl chr 2:32,647,246...32,652,256
G
Tox4
TOX high mobility group box family member 4
increases expression
ISO
zoledronic acid results in increased expression of TOX4 mRNA
CTD
PMID:20977926
NCBI chr14:52,516,603...52,532,966
Ensembl chr14:52,516,603...52,533,858
G
Tpcn1
two pore channel 1
increases expression
ISO
zoledronic acid results in increased expression of TPCN1 mRNA
CTD
PMID:25596134
NCBI chr 5:120,672,222...120,726,731
Ensembl chr 5:120,672,218...120,726,738
G
Tpd52l1
tumor protein D52-like 1
decreases expression
ISO
zoledronic acid results in decreased expression of TPD52L1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr10:31,208,369...31,321,989
Ensembl chr10:31,208,372...31,321,954
G
Tpm2
tropomyosin 2, beta
decreases expression
ISO
zoledronic acid results in decreased expression of TPM2 protein
CTD
PMID:28871336
NCBI chr 4:43,513,726...43,523,583
Ensembl chr 4:43,514,711...43,523,765
G
Tpra1
transmembrane protein, adipocyte asscociated 1
increases expression
ISO
zoledronic acid results in increased expression of TPRA1 mRNA
CTD
PMID:24714768
NCBI chr 6:88,879,238...88,889,216
Ensembl chr 6:88,879,233...88,889,220
G
Tpst2
protein-tyrosine sulfotransferase 2
decreases expression
ISO
zoledronic acid results in decreased expression of TPST2 mRNA
CTD
PMID:24714768
NCBI chr 5:112,424,548...112,463,222
Ensembl chr 5:112,424,557...112,463,227
G
Tpt1
tumor protein, translationally-controlled 1
decreases expression
ISO
zoledronic acid results in decreased expression of TPT1 protein
CTD
PMID:28871336
NCBI chr14:76,082,771...76,085,743
Ensembl chr14:76,082,533...76,085,965
G
Tpx2
TPX2, microtubule-associated
decreases expression
ISO
zoledronic acid results in decreased expression of TPX2 mRNA
CTD
PMID:24714768
NCBI chr 2:152,689,859...152,737,241
Ensembl chr 2:152,689,884...152,737,241
G
Tradd
TNFRSF1A-associated via death domain
increases expression
ISO
zoledronic acid results in increased expression of TRADD mRNA
CTD
PMID:19036117
NCBI chr 8:105,985,207...105,991,226
Ensembl chr 8:105,984,918...105,991,241
G
Traf2
TNF receptor-associated factor 2
increases expression
ISO
zoledronic acid results in increased expression of TRAF2 mRNA
CTD
PMID:19036117
NCBI chr 2:25,407,994...25,436,952
Ensembl chr 2:25,407,994...25,436,952
G
Traf3
TNF receptor-associated factor 3
increases expression
ISO
zoledronic acid results in increased expression of TRAF3 mRNA
CTD
PMID:19036117 PMID:24714768
NCBI chr12:111,132,799...111,233,589
Ensembl chr12:111,132,804...111,233,587
G
Traip
TRAF-interacting protein
increases expression
ISO
zoledronic acid results in increased expression of TRAIP mRNA
CTD
PMID:20977926
NCBI chr 9:107,828,158...107,849,469
Ensembl chr 9:107,827,335...107,849,469
G
Traj18
T cell receptor alpha joining 18
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of STK17A mRNA
CTD
PMID:16996129
NCBI chr14:54,438,234...54,438,299
Ensembl chr14:54,438,234...54,438,299
G
Trerf1
transcriptional regulating factor 1
increases expression
ISO
zoledronic acid results in increased expression of TRERF1 mRNA
CTD
PMID:24714768
NCBI chr17:47,451,868...47,673,250
Ensembl chr17:47,451,801...47,672,883
G
Trib3
tribbles pseudokinase 3
increases expression
ISO
zoledronic acid results in increased expression of TRIB3 mRNA
CTD
PMID:20977926
NCBI chr 2:152,179,345...152,185,980
Ensembl chr 2:152,179,342...152,185,952
G
Trim16
tripartite motif-containing 16
increases expression
ISO
zoledronic acid results in increased expression of TRIM16 mRNA
CTD
PMID:24714768
NCBI chr11:62,711,034...62,733,774
Ensembl chr11:62,711,057...62,741,634
G
Trim30a
tripartite motif-containing 30A
increases expression
ISO
Zoledronic Acid results in increased expression of TRIM22 mRNA
CTD
PMID:20977926
NCBI chr 7:104,058,232...104,114,400
Ensembl chr 7:104,058,232...104,114,400
G
Trim37
tripartite motif-containing 37
increases expression
ISO
zoledronic acid results in increased expression of TRIM37 mRNA
CTD
PMID:24714768
NCBI chr11:87,017,675...87,141,700
Ensembl chr11:87,017,903...87,111,509
G
Trim55
tripartite motif-containing 55
increases expression
ISO
zoledronic acid results in increased expression of TRIM55 mRNA
CTD
PMID:24714768
NCBI chr 3:19,698,591...19,746,748
Ensembl chr 3:19,698,611...19,746,756
G
Trip13
thyroid hormone receptor interactor 13
decreases expression
ISO
zoledronic acid results in decreased expression of TRIP13 mRNA
CTD
PMID:24714768
NCBI chr13:74,060,577...74,085,855
Ensembl chr13:74,059,466...74,085,903
G
Triqk
triple QxxK/R motif containing
increases expression
ISO
zoledronic acid results in increased expression of TRIQK mRNA
CTD
PMID:20977926
NCBI chr 4:12,906,837...12,981,485
Ensembl chr 4:12,906,838...12,983,553
G
Trnp1
TMF1-regulated nuclear protein 1
decreases expression
ISO
zoledronic acid results in decreased expression of TRNP1 mRNA
CTD
PMID:24714768
NCBI chr 4:133,218,408...133,226,446
Ensembl chr 4:133,218,411...133,225,861
G
Trp53
transformation related protein 53
affects activity multiple interactions increases expression
ISO
zoledronic acid affects the activity of TP53 protein [Tretinoin co-treated with zoledronic acid] results in decreased expression of TP53 protein Zoledronic Acid results in increased expression of TP53 mRNA
CTD
PMID:20349282 PMID:25596134 PMID:35587103
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Trp53inp1
transformation related protein 53 inducible nuclear protein 1
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of TP53INP1 mRNA
CTD
PMID:16996129
NCBI chr 4:11,156,441...11,174,379
Ensembl chr 4:11,156,431...11,174,379
G
Trpv2
transient receptor potential cation channel, subfamily V, member 2
decreases expression
ISO
zoledronic acid results in decreased expression of TRPV2 mRNA
CTD
PMID:24714768
NCBI chr11:62,465,312...62,491,131
Ensembl chr11:62,465,312...62,491,341
G
Try4
trypsin 4
increases expression
ISO
zoledronic acid results in increased expression of PRSS3 mRNA
CTD
PMID:20977926
NCBI chr 6:41,279,206...41,282,467
Ensembl chr 6:41,279,203...41,282,466
G
Tsc22d1
TSC22 domain family, member 1
increases expression
ISO
zoledronic acid results in increased expression of TSC22D1 mRNA
CTD
PMID:24714768
NCBI chr14:76,652,401...76,745,205
Ensembl chr14:76,652,401...76,745,205
G
Tsc22d3
TSC22 domain family, member 3
increases expression
ISO
zoledronic acid results in increased expression of TSC22D3 mRNA
CTD
PMID:20977926
NCBI chr X:139,440,277...139,501,257
Ensembl chr X:139,440,277...139,501,408
G
Tspan15
tetraspanin 15
increases expression
ISO
zoledronic acid results in increased expression of TSPAN15 mRNA
CTD
PMID:24714768
NCBI chr10:62,021,175...62,067,055
Ensembl chr10:62,021,175...62,067,030
G
Tspan18
tetraspanin 18
increases expression
ISO
zoledronic acid results in increased expression of TSPAN18 mRNA
CTD
PMID:24714768
NCBI chr 2:93,032,105...93,164,898
Ensembl chr 2:93,032,105...93,164,850
G
Tspan7
tetraspanin 7
decreases expression
ISO
zoledronic acid results in decreased expression of TSPAN7 mRNA
CTD
PMID:24714768
NCBI chr X:10,351,355...10,462,843
Ensembl chr X:10,351,397...10,462,844
G
Ttc29
tetratricopeptide repeat domain 29
increases expression
ISO
zoledronic acid results in increased expression of TTC29 mRNA
CTD
PMID:24714768
NCBI chr 8:78,939,911...79,120,955
Ensembl chr 8:78,939,926...79,120,955
G
Ttc39c
tetratricopeptide repeat domain 39C
increases expression
ISO
zoledronic acid results in increased expression of TTC39C mRNA
CTD
PMID:24714768
NCBI chr18:12,716,168...12,872,461
Ensembl chr18:12,732,953...12,871,920
G
Ttc9
tetratricopeptide repeat domain 9
increases expression
ISO
zoledronic acid results in increased expression of TTC9 mRNA
CTD
PMID:24714768
NCBI chr12:81,678,023...81,714,331
Ensembl chr12:81,678,023...81,714,331
G
Ttk
Ttk protein kinase
decreases expression
ISO
zoledronic acid results in decreased expression of TTK mRNA
CTD
PMID:24714768
NCBI chr 9:83,716,704...83,754,442
Ensembl chr 9:83,716,742...83,754,442
G
Tuba1a
tubulin, alpha 1A
decreases expression
ISO
zoledronic acid results in decreased expression of TUBA1A mRNA
CTD
PMID:24714768
NCBI chr15:98,847,728...98,851,382
Ensembl chr15:98,847,718...98,851,584
G
Tuba1b
tubulin, alpha 1B
decreases expression
ISO
zoledronic acid results in decreased expression of TUBA1B mRNA
CTD
PMID:24714768
NCBI chr15:98,829,310...98,832,271
Ensembl chr15:98,829,306...98,832,446
G
Tuba1c
tubulin, alpha 1C
decreases expression
ISO
zoledronic acid results in decreased expression of TUBA1C mRNA
CTD
PMID:24714768
NCBI chr15:98,927,772...98,935,986
Ensembl chr15:98,927,772...98,935,991
G
Tuba3b
tubulin, alpha 3B
decreases expression
ISO
zoledronic acid results in decreased expression of TUBA3D mRNA
CTD
PMID:24714768
NCBI chr 6:145,561,689...145,567,203
Ensembl chr 6:145,561,483...145,567,205
G
Tuba4a
tubulin, alpha 4A
decreases expression
ISO
zoledronic acid results in decreased expression of TUBA4A mRNA
CTD
PMID:24714768
NCBI chr 1:75,190,867...75,197,905
Ensembl chr 1:75,190,872...75,196,509
G
Tubb1
tubulin, beta 1 class VI
increases expression
ISO
zoledronic acid results in increased expression of TUBB1 protein
CTD
PMID:28871336
NCBI chr 2:174,292,388...174,300,173
Ensembl chr 2:174,292,488...174,299,675
G
Tubb2b
tubulin, beta 2B class IIB
decreases expression
ISO
zoledronic acid results in decreased expression of TUBB2B mRNA
CTD
PMID:24714768
NCBI chr13:34,310,991...34,314,337
Ensembl chr13:34,310,731...34,314,449
G
Tubb3
tubulin, beta 3 class III
decreases expression
ISO
zoledronic acid results in decreased expression of TUBB3 mRNA
CTD
PMID:24714768
NCBI chr 8:124,138,292...124,148,754
Ensembl chr 8:124,138,163...124,148,754
G
Tubb4a
tubulin, beta 4A class IVA
decreases expression
ISO
zoledronic acid results in decreased expression of TUBB4A mRNA
CTD
PMID:24714768
NCBI chr17:57,387,061...57,394,600
Ensembl chr17:57,387,066...57,394,782
G
Tubb4b
tubulin, beta 4B class IVB
decreases expression
ISO
zoledronic acid results in decreased expression of TUBB4B mRNA
CTD
PMID:24714768
NCBI chr 2:25,112,170...25,114,714
Ensembl chr 2:25,112,172...25,114,714
G
Tubb5
tubulin, beta 5 class I
decreases expression
ISO
zoledronic acid results in decreased expression of TUBB mRNA
CTD
PMID:24714768
NCBI chr17:36,144,812...36,149,193
Ensembl chr17:36,144,813...36,149,198
G
Txnip
thioredoxin interacting protein
increases expression
ISO
zoledronic acid results in increased expression of TXNIP mRNA
CTD
PMID:20977926
NCBI chr 3:96,465,273...96,469,173
Ensembl chr 3:96,465,273...96,469,199
G
Tymp
thymidine phosphorylase
increases expression multiple interactions
ISO
zoledronic acid results in increased expression of TYMP mRNA Gossypol inhibits the reaction [zoledronic acid results in increased expression of TYMP mRNA]
CTD
PMID:19825521
NCBI chr15:89,255,834...89,261,282
Ensembl chr15:89,256,134...89,261,242
G
Ubd
ubiquitin D
increases expression
ISO
zoledronic acid results in increased expression of UBD mRNA
CTD
PMID:24714768
NCBI chr17:37,504,783...37,506,992
Ensembl chr17:37,504,783...37,506,986
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
ISO
zoledronic acid results in decreased expression of UBE2C mRNA
CTD
PMID:24714768
NCBI chr 2:164,611,849...164,614,822
Ensembl chr 2:164,611,818...164,620,742
G
Ubqln1
ubiquilin 1
increases expression
ISO
zoledronic acid results in increased expression of UBQLN1 protein
CTD
PMID:28871336
NCBI chr13:58,323,970...58,363,467
Ensembl chr13:58,323,970...58,363,467
G
Ugt1a6b
UDP glucuronosyltransferase 1 family, polypeptide A6B
decreases expression
ISO
zoledronic acid results in decreased expression of UGT1A6 mRNA
CTD
PMID:24714768
NCBI chr 1:88,030,979...88,146,720
Ensembl chr 1:88,030,974...88,146,725
G
Ugt8a
UDP galactosyltransferase 8A
decreases expression
ISO
zoledronic acid results in decreased expression of UGT8 mRNA
CTD
PMID:24714768
NCBI chr 3:125,655,071...125,732,301
Ensembl chr 3:125,658,920...125,732,268
G
Uhrf1
ubiquitin-like, containing PHD and RING finger domains, 1
decreases expression
ISO
zoledronic acid results in decreased expression of UHRF1 mRNA
CTD
PMID:24714768
NCBI chr17:56,610,405...56,630,486
Ensembl chr17:56,610,321...56,630,486
G
Ulk2
unc-51 like kinase 2
increases expression
ISO
zoledronic acid results in increased expression of ULK2 mRNA
CTD
PMID:20977926
NCBI chr11:61,666,424...61,750,754
Ensembl chr11:61,666,475...61,745,899
G
Unc13d
unc-13 homolog D
increases expression
ISO
zoledronic acid results in increased expression of UNC13D mRNA
CTD
PMID:20977926
NCBI chr11:115,952,921...115,969,321
Ensembl chr11:115,952,921...115,968,787
G
Unc5a
unc-5 netrin receptor A
increases expression
ISO
zoledronic acid results in increased expression of UNC5A mRNA
CTD
PMID:24714768
NCBI chr13:55,090,545...55,153,831
Ensembl chr13:55,097,224...55,153,831
G
Upp1
uridine phosphorylase 1
decreases expression
ISO
zoledronic acid results in decreased expression of UPP1 mRNA
CTD
PMID:24714768
NCBI chr11:9,068,008...9,086,170
Ensembl chr11:9,068,103...9,086,170
G
Uqcrc1
ubiquinol-cytochrome c reductase core protein 1
decreases expression
ISO
zoledronic acid results in decreased expression of UQCRC1 protein
CTD
PMID:28871336
NCBI chr 9:108,765,716...108,778,709
Ensembl chr 9:108,765,701...108,778,691
G
Uqcrh
ubiquinol-cytochrome c reductase hinge protein
decreases expression
ISO
zoledronic acid results in decreased expression of UQCRH protein
CTD
PMID:28871336
NCBI chr 4:115,924,162...115,932,267
Ensembl chr 4:115,924,162...115,932,268
G
Usp13
ubiquitin specific peptidase 13 (isopeptidase T-3)
decreases expression
ISO
zoledronic acid results in decreased expression of USP13 mRNA
CTD
PMID:24714768
NCBI chr 3:32,870,432...32,992,224
Ensembl chr 3:32,871,695...32,992,220
G
Usp24
ubiquitin specific peptidase 24
decreases expression
ISO
zoledronic acid results in decreased expression of USP24 mRNA
CTD
PMID:20977926
NCBI chr 4:106,173,179...106,303,798
Ensembl chr 4:106,173,417...106,298,519
G
Usp31
ubiquitin specific peptidase 31
increases expression
ISO
zoledronic acid results in increased expression of USP31 mRNA
CTD
PMID:20977926
NCBI chr 7:121,241,244...121,306,683
Ensembl chr 7:121,241,244...121,306,476
G
Uvrag
UV radiation resistance associated gene
increases expression
ISO
zoledronic acid results in increased expression of UVRAG mRNA
CTD
PMID:24714768
NCBI chr 7:98,535,949...98,790,373
Ensembl chr 7:98,534,228...98,790,348
G
Vamp2
vesicle-associated membrane protein 2
increases expression
ISO
zoledronic acid results in increased expression of VAMP2 protein
CTD
PMID:28871336
NCBI chr11:68,979,354...68,983,207
Ensembl chr11:68,979,316...68,983,210
G
Vamp3
vesicle-associated membrane protein 3
increases expression
ISO
zoledronic acid results in increased expression of VAMP3 mRNA
CTD
PMID:20977926
NCBI chr 4:151,131,762...151,142,410
Ensembl chr 4:151,131,757...151,142,420
G
Vangl1
VANGL planar cell polarity 1
decreases expression
ISO
zoledronic acid results in decreased expression of VANGL1 mRNA
CTD
PMID:20977926
NCBI chr 3:102,060,899...102,112,012
Ensembl chr 3:102,060,899...102,112,009
G
Vars1
valyl-tRNA synthetase 1
increases expression
ISO
Zoledronic Acid results in increased expression of VARS1 mRNA
CTD
PMID:20977926
NCBI chr17:35,219,895...35,235,304
Ensembl chr17:35,219,963...35,235,298
G
Vash1
vasohibin 1
increases expression
ISO
zoledronic acid results in increased expression of VASH1 mRNA
CTD
PMID:20977926
NCBI chr12:86,725,474...86,742,462
Ensembl chr12:86,725,474...86,738,865
G
Vegfa
vascular endothelial growth factor A
increases expression
ISO
zoledronic acid results in increased expression of VEGFA mRNA
CTD
PMID:20977926
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Vim
vimentin
multiple interactions increases expression
EXP ISO
SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of VIM mRNA]
CTD
PMID:28871336
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
G
Vipr1
vasoactive intestinal peptide receptor 1
increases expression
ISO
zoledronic acid results in increased expression of VIPR1 mRNA
CTD
PMID:25596134
NCBI chr 9:121,471,782...121,502,020
Ensembl chr 9:121,471,782...121,502,020
G
Vnn1
vanin 1
increases expression
ISO
zoledronic acid results in increased expression of VNN1 mRNA
CTD
PMID:24714768
NCBI chr10:23,770,586...23,781,242
Ensembl chr10:23,770,586...23,781,241
G
Vnn3
vanin 3
increases expression
ISO
Zoledronic Acid results in increased expression of VNN3P mRNA
CTD
PMID:24714768
NCBI chr10:23,727,360...23,745,741
Ensembl chr10:23,727,360...23,745,741
G
Vps13a
vacuolar protein sorting 13A
increases expression
ISO
zoledronic acid results in increased expression of VPS13A protein
CTD
PMID:28871336
NCBI chr19:16,592,730...16,758,433
Ensembl chr19:16,592,730...16,758,297
G
Vps53
VPS53 GARP complex subunit
decreases expression
ISO
zoledronic acid results in decreased expression of VPS53 protein
CTD
PMID:28871336
NCBI chr11:75,937,052...76,070,464
Ensembl chr11:75,937,052...76,070,473
G
Vtcn1
V-set domain containing T cell activation inhibitor 1
increases expression
ISO
zoledronic acid results in increased expression of VTCN1 mRNA
CTD
PMID:24714768 PMID:25596134
NCBI chr 3:100,732,775...100,805,555
Ensembl chr 3:100,732,775...100,804,238
G
Vwa3b
von Willebrand factor A domain containing 3B
increases expression
ISO
zoledronic acid results in increased expression of VWA3B mRNA
CTD
PMID:24714768
NCBI chr 1:37,068,372...37,226,689
Ensembl chr 1:37,065,677...37,226,694
G
Vwf
Von Willebrand factor
increases expression
ISO
zoledronic acid results in increased expression of VWF mRNA
CTD
PMID:24714768
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
G
Wdr1
WD repeat domain 1
increases expression
ISO
zoledronic acid results in increased expression of WDR1 mRNA
CTD
PMID:20977926
NCBI chr 5:38,684,149...38,720,265
Ensembl chr 5:38,684,156...38,720,564
G
Wdr72
WD repeat domain 72
decreases expression
ISO
zoledronic acid results in decreased expression of WDR72 mRNA
CTD
PMID:24714768
NCBI chr 9:74,017,608...74,190,485
Ensembl chr 9:74,017,638...74,190,590
G
Wdtc1
WD and tetratricopeptide repeats 1
increases expression
ISO
zoledronic acid results in increased expression of WDTC1 mRNA
CTD
PMID:20977926
NCBI chr 4:133,019,777...133,080,811
Ensembl chr 4:133,019,770...133,080,792
G
Wfdc21
WAP four-disulfide core domain 21
increases expression
ISO
zoledronic acid results in increased expression of WFDC21P mRNA
CTD
PMID:24714768
NCBI chr11:83,637,766...83,643,472
Ensembl chr11:83,637,766...83,643,468
G
Wfdc5
WAP four-disulfide core domain 5
increases expression
ISO
zoledronic acid results in increased expression of WFDC5 mRNA
CTD
PMID:24714768
NCBI chr 2:164,018,245...164,024,662
Ensembl chr 2:164,018,247...164,024,662
G
Whamm
WAS protein homolog associated with actin, golgi membranes and microtubules
increases expression
ISO
zoledronic acid results in increased expression of WHAMM mRNA
CTD
PMID:20977926
NCBI chr 7:81,220,403...81,246,585
Ensembl chr 7:81,221,014...81,246,584
G
Wls
wntless WNT ligand secretion mediator
decreases expression
ISO
zoledronic acid results in decreased expression of WLS mRNA
CTD
PMID:24714768
NCBI chr 3:159,545,287...159,644,302
Ensembl chr 3:159,545,309...159,644,300
G
Wnk1
WNK lysine deficient protein kinase 1
decreases expression
ISO
zoledronic acid results in decreased expression of WNK1 mRNA
CTD
PMID:20977926
NCBI chr 6:119,900,930...120,015,659
Ensembl chr 6:119,900,930...120,015,633
G
Wnt11
wingless-type MMTV integration site family, member 11
multiple interactions
ISO
[zoledronic acid co-treated with fluvastatin] results in increased expression of WNT11 mRNA
CTD
PMID:16996129
NCBI chr 7:98,484,293...98,503,954
Ensembl chr 7:98,484,319...98,504,402
G
Wnt5a
wingless-type MMTV integration site family, member 5A
increases expression
ISO
zoledronic acid results in increased expression of WNT5A mRNA
CTD
PMID:24714768
NCBI chr14:28,224,962...28,249,405
Ensembl chr14:28,226,707...28,249,405
G
Wscd1
WSC domain containing 1
decreases expression
ISO
zoledronic acid results in decreased expression of WSCD1 mRNA
CTD
PMID:24714768
NCBI chr11:71,640,719...71,680,475
Ensembl chr11:71,640,746...71,680,473
G
Wtap
WT1 associating protein
increases expression
ISO
zoledronic acid results in increased expression of WTAP mRNA
CTD
PMID:24714768
NCBI chr17:13,185,686...13,211,430
Ensembl chr17:13,185,683...13,213,056
G
Xdh
xanthine dehydrogenase
increases expression
ISO
zoledronic acid results in increased expression of XDH mRNA
CTD
PMID:24714768
NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
G
Xiap
X-linked inhibitor of apoptosis
decreases expression
ISO
zoledronic acid results in decreased expression of XIAP mRNA
CTD
PMID:19036117
NCBI chr X:41,148,483...41,198,541
Ensembl chr X:41,148,556...41,198,533
G
Xpo6
exportin 6
increases expression
ISO
zoledronic acid results in increased expression of XPO6 protein
CTD
PMID:28871336
NCBI chr 7:125,700,890...125,799,715
Ensembl chr 7:125,700,887...125,799,673
G
Yars1
tyrosyl-tRNA synthetase 1
decreases expression
ISO
Zoledronic Acid results in decreased expression of YARS1 mRNA
CTD
PMID:25596134
NCBI chr 4:129,083,595...129,113,033
Ensembl chr 4:129,083,553...129,113,400
G
Ythdf3
YTH N6-methyladenosine RNA binding protein 3
increases expression
ISO
zoledronic acid results in increased expression of YTHDF3 mRNA
CTD
PMID:20977926
NCBI chr 3:16,237,309...16,271,201
Ensembl chr 3:16,237,376...16,271,201
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
decreases expression
ISO
zoledronic acid results in decreased expression of YWHAZ protein
CTD
PMID:28871336
NCBI chr15:36,770,505...36,803,228
Ensembl chr15:36,771,014...36,797,173
G
Zbtb4
zinc finger and BTB domain containing 4
decreases expression
ISO
zoledronic acid results in decreased expression of ZBTB4 mRNA
CTD
PMID:20977926
NCBI chr11:69,656,738...69,674,852
Ensembl chr11:69,656,738...69,674,849
G
Zc3h12a
zinc finger CCCH type containing 12A
increases expression
ISO
zoledronic acid results in increased expression of ZC3H12A mRNA
CTD
PMID:24714768
NCBI chr 4:125,012,207...125,021,674
Ensembl chr 4:125,012,216...125,021,633
G
Zc3h12c
zinc finger CCCH type containing 12C
increases expression
ISO
zoledronic acid results in increased expression of ZC3H12C mRNA
CTD
PMID:24714768
NCBI chr 9:52,020,869...52,080,028
Ensembl chr 9:52,022,644...52,079,872
G
Zc3hav1
zinc finger CCCH type, antiviral 1
increases expression
ISO
zoledronic acid results in increased expression of ZC3HAV1 mRNA
CTD
PMID:20977926
NCBI chr 6:38,282,221...38,332,859
Ensembl chr 6:38,282,221...38,331,538
G
Zfp146
zinc finger protein 146
increases expression
ISO
zoledronic acid results in increased expression of ZNF146 mRNA
CTD
PMID:20977926
NCBI chr 7:29,859,912...29,869,225
Ensembl chr 7:29,860,694...29,869,175
G
Zfp36l2
zinc finger protein 36, C3H type-like 2
increases expression
ISO
zoledronic acid results in increased expression of ZFP36L2 mRNA
CTD
PMID:20977926
NCBI chr17:84,491,352...84,495,375
Ensembl chr17:84,491,359...84,495,375
G
Zfp385b
zinc finger protein 385B
decreases expression
ISO
zoledronic acid results in decreased expression of ZNF385B mRNA
CTD
PMID:24714768
NCBI chr 2:77,240,966...77,648,050
Ensembl chr 2:77,240,978...77,649,983
G
Zfp46
zinc finger protein 46
increases expression
ISO
zoledronic acid results in increased expression of ZNF436 mRNA
CTD
PMID:20977926
NCBI chr 4:136,011,479...136,021,163
Ensembl chr 4:136,011,994...136,021,253
G
Zfp467
zinc finger protein 467
increases expression
ISO
zoledronic acid results in increased expression of ZNF467 mRNA
CTD
PMID:20977926
NCBI chr 6:48,404,626...48,422,926
Ensembl chr 6:48,404,631...48,422,759
G
Zfp644
zinc finger protein 644
increases expression
ISO
zoledronic acid results in increased expression of ZNF644 mRNA
CTD
PMID:20977926
NCBI chr 5:106,764,605...106,844,696
Ensembl chr 5:106,764,605...106,845,153
G
Zfp775
zinc finger protein 775
increases expression
ISO
zoledronic acid results in increased expression of ZNF775 mRNA
CTD
PMID:24714768
NCBI chr 6:48,578,937...48,598,482
Ensembl chr 6:48,578,997...48,600,161
G
Zfp809
zinc finger protein 809
decreases expression
ISO
Zoledronic Acid results in decreased expression of ZNF684 mRNA
CTD
PMID:24714768
NCBI chr 9:22,136,980...22,165,413
Ensembl chr 9:22,137,010...22,154,650
G
Zfp827
zinc finger protein 827
increases expression
ISO
zoledronic acid results in increased expression of ZNF827 mRNA
CTD
PMID:24714768
NCBI chr 8:79,753,754...79,920,397
Ensembl chr 8:79,755,066...79,920,395
G
Znrf3
zinc and ring finger 3
decreases expression
ISO
zoledronic acid results in decreased expression of ZNRF3 mRNA
CTD
PMID:24714768
NCBI chr11:5,226,329...5,394,847
Ensembl chr11:5,226,324...5,394,847
G
Zp3r
zona pellucida 3 receptor
increases expression
ISO
zoledronic acid results in increased expression of C4BPA mRNA
CTD
PMID:24714768
NCBI chr 1:130,474,847...130,557,371
Ensembl chr 1:130,504,450...130,557,358
G
Zscan25
zinc finger and SCAN domain containing 25
increases expression
ISO
zoledronic acid results in increased expression of ZSCAN25 mRNA
CTD
PMID:20977926
NCBI chr 5:145,217,261...145,229,050
Ensembl chr 5:145,217,310...145,228,088
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all